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Abstract 
 Mutation of tumor suppressor protein Adenomatous Polyposis Coli (APC) has 
been shown to be an early, if not rate limiting step in the progression of both 
hereditary and sporadic colorectal cancers.  The observation that APC can shuttle in 
and out of the nucleus, and the identification of two highly conserved nuclear 
localization sequences (NLSs) strongly support a role for APC in the nuclear 
compartment.  Little is currently known about the function(s) of nuclear APC or how 
nuclear functions contribute to tumor suppression. 
 To further evaluate the role of APC in the nucleus we generated the APC 
mNLS mouse.  The APC mNLS mice carry amino acid changes in both APC NLSs 
designed to inhibit interaction with importin-α without disrupting APC’s other 
cellular functions.  Generation of the mNLS mice is ongoing, with fully congenic 
animals expected in early 2009.  In the interim, I have conducted a preliminary 
analysis of the phenotype of the non-congenic APC mNLS animals.  Evaluation of 
the subcellular localization of APC in the intestinal epithelium of the APC mNLS 
animals revealed that APC retains its ability to shuttle in and out of the nucleus, even 
in the homozygous mutant mice.  While a mild defect in nuclear import could be 
detected in the differentiated cells at the colonic luminal surface, the more 
undifferentiated cells in the lower regions of the intestinal crypts displayed a normal 
localization of APC.  The APC mNLS-/- mice were viable and did not display 
intestinal polyposis.  However, subtle differences were detected between mice that 
carry the APC mNLS mutations and their wild type (WT) littermates.  These 
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differences included higher levels of β-catenin in the intestinal epithelium of the APC 
mNLS mutant mice and an increased incidence of lymphoid nodules compared to 
their littermates with WT APC. 
 To further evaluate the need for APC in the nuclear compartment, I exposed 
cultured cells expressing WT APC or APC with mutant NLSs to ultraviolet (UV) 
light.  UV-irradiated cells displayed a nuclear accumulation of both the mutant and 
WT forms of APC with implications for an importin-α independent mechanism of 
nuclear import.  Further characterization of the nuclear accumulation of APC revealed 
that nuclear translocation was transient and cell cycle dependent.  Finally, the nuclear 
localization of APC could be partially suppressed using inhibitors of G2/M 
checkpoint kinases. 
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CHAPTER 1 
INTRODUCTION:  APC AND THE INTESTINAL EPITHELIUM 
 
The Architecture of the Intestine 
 The alimentary canal is the tube that extends through the body from the mouth 
to the anus, the lumen of which is considered open to the external environment (1).  
The function of the alimentary canal is to facilitate the physical and chemical 
breakdown of food and absorb nutrients into the body.  The small intestine and the 
large intestine, or colon, make up the distal region of the alimentary canal.  
Absorption of nutrients takes place primarily in the small intestine while the colon 
reabsorbs valuable water and electrolytes from the undigested material and waste 
products before they are expelled from the body (1).   
The structural organization of tissues making up the alimentary canal is 
largely conserved along its entire length and can be classified into four distinct layers 
(1).  The innermost layer that lines the lumen is called the mucosa and consists of the 
epithelium and underlying connective tissue, the lamina propria.  Below the mucosa 
is the dense irregular connective tissue of the submucosa followed by two layers of 
smooth muscle known as the muscularis externa.  The final layer is a membrane of 
simple squamous epithelium and associated connective tissue that marks the 
boundary between the gastrointestinal tract and the organs of the body (1).  The 
primary focus of this project is on the structure and maintenance of the epithelial 
layer of the mucosa.  Over 80% of life-threatening human cancers are carcinomas, 
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which, by definition, arise from cells of epithelial origin (2).  The epithelial layer 
lining the lumen of the intestine is a highly proliferative tissue that is continuously 
exposed to physical, chemical and pathogenic stresses.  When considering these 
factors it is no surprise that the intestinal epithelium is one of the most common sites 
for cancer development in the human body (3). 
 
The intestinal epithelium and its normal functions 
 The mucosal layer of the intestine serves three main functions.  First, the 
mucosa forms a protective barrier between the external environment of the lumen and 
the organs and tissues of the body.  Second, the epithelial surface is where the 
absorption of nutrients, water and electrolytes from digested food occurs. Finally, a 
great deal of secretion takes place along the length of the intestine.  Specialized cells 
within the epithelium secrete antibacterial enzymes, hormones and mucus important 
for the continued maintenance and function of the intestine (1).  The evidence of 
these functions is apparent in both the architecture of the mucosal layer and the cell 
types contained therein.   
 The mucosa of both the small intestine and the colon are lined with a single 
layer of columnar epithelial cells and contain numerous straight, tubular glands 
known as the crypts of Lieberkühn (1) (Figure 1.1A).  These invaginations of the 
colonic epithelium are arranged in an orderly fashion and extend the full thickness of 
the mucosa.  The crypts of the small intestine are slightly shallower than those found 
in the colon (Figure 1.1B).  In addition the small intestinal mucosa also projects  
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Figure 1.1
Longitudinal slices of frozen intestinal tissue.  Tissue was stained with Hematoxylin and Eosin 
dyes to visualize the cells.  Hematoxylin dye carries a net positive charge giving it a high 
affinity for nucleic acids.  The nuclei therefore appear as dark ovals in the image above.  Eosin 
carries a negative charge and shows a high affinity for the enzymes in the granules of the Paneth
cells as well as a lesser affinity for proteins of the cytoplasm.  (A) Crypts of Lieberkühn from 
the colon with vesicles of non-staining mucin in the goblet cells visible in the upper half of the 
crypts.  (B) Crypt-villus structure from the small intestine.  The inset from the base of the crypt 
shows the Paneth cells (arrow heads) two large oval nuclei with dark staining granules in the 
apical space above. Also visible is a Crypt Base Columnar cell (CBC), the wedge shaped 
nucleus between the two Paneth cells (arrow).  The CBC cells are hypothesized to be the stem 
cells. 
A B
3
 4
outward into the lumen to form villi.  These villi greatly increase the surface area 
available for the absorption of nutrients.   
 There are five main cell types found in the intestinal epithelium; the 
enterocytes,  goblet cells, paneth cells, enteroendocrine cells and microfold cells 
(Table1.1).  The enterocytes are the absorptive cells.  Because the main function of 
the intestine is the absorption of water, salts and nutrients, enterocytes are the primary 
cell type in the intestine.  Goblet cells are each independent mucus secreting glands 
that function to lubricate the intestine and provide a protective barrier against 
pathogens (4).  Goblet cells become increasingly necessary as more and more 
moisture is removed from the undigested material as it continues through the 
intestine.  Therefore, while there are relatively few goblet cells in the small intestine, 
the ratio of goblet cells to enterocytes can approach 1:1 in the distal region of the 
colon (1).  Paneth, enteroendocrine and microfold cells have specialized functions 
and are found in lower abundance in the intestine.  Paneth cells are found primarily in 
the small intestine, though they can occasionally be seen in the colon.  They reside at 
the base of the crypts of Lieberkühn and secrete antibacterial enzymes to stabilize the 
appropriate levels of bacterial flora in the gut (5).  Enteroendocrine cells secrete 
peptide hormones that regulate secretion by the pancreas, gallbladder and stomach 
(6).  Microfold cells, also known as M-cells are found associated with nodules of 
lymph tissue and facilitate the uptake of microorganisms for presentation to the 
immune system (7).
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Table 1.1 The cell types of the intestinal epithelium.  
Adapted from Ross, M. H., and Pawlina, W. (2005) Histology: A text and atlas, Lippincott Williams & Wilkins, 
Baltimore, MD
Cell type Function Location Appearance
Enterocytes Absorbtion of water and nutrients.
The primary cell type in the intestine.  
Found all along the crypt-villus 
structures.
Columnar epithelia.  Apical surface is 
covered with microvilli
Goblet cells
Secretion of mucus for the 
protection and lubrication of 
the intestine
Interspersed with the enterocytes at an 
increasing ratio moving distally
Large apical surface filled with 
mucous.  The nucleus and organells 
are in the narrow basal region.  Goblet-
shaped
Paneth cells Secretion of antibacterial enzymes
Primarily in the small intestine at the 
base of the crypts
Oval base with a large nucleus.  Apical 
portion is filled with refractile 
acidophilic granuals
Enteroendocrine 
cells
Secretion of peptide 
hormones Interspersed throughout the intestine
Difficult to distinguish without special 
preperation of the tissue
Microfold cells
Endocytosis of antigens for 
presentation to the immune 
system
Associated with lymphoid nodules 
along the length of the intestine
Relativly flat with apical folds rather 
than microvilli
  The entire epithelial layer of the intestine is in a constant cycle of cell death 
and renewal.  Cells of the intestinal epithelium arise from adult stem cell progenitors.  
Although the exact number and location of the intestinal stem cells has been a source 
of controversy in the past (8), recent evidence from the Clevers lab (9) has 
demonstrated rather convincingly that there are a 4-6 stem cells at the base of each 
crypt of Lieberkühn.  In the small intestine, the stem cells are interspersed amongst 
the paneth cells which also reside at the base of the crypt (9) (Figure 1.1B).  These 
stem cells give rise to the precursors of all five cell types.  These precursors, also 
known as transit amplifying cells, divide several times as they migrate upward along 
the walls of the crypts where they cease division and undergo differentiation.  The 
differentiated cell types continue to migrate to the luminal surface of the colon or to 
the tops of the villi in the small intestine, then undergo apoptosis and are shed into the 
lumen.  In the mouse, the cells of the intestinal epithelium are completely replaced in 
approximately a week’s time (10).  Tight control over this system is maintained 
through a complex coordination of external and internal cell signaling events (11).  
The processes of proliferation, migration, differentiation and apoptosis must be in 
perfect balance.  The loss of control over any part of the system can result in the 
formation of tumors.   
 
Cancer and the intestine 
Colorectal cancer was responsible for an estimated 52,180 deaths in 2007 and 
accounts for almost 10% of all cancer deaths making it second only to lung cancer as 
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a leading cause of cancer related mortality in the United States (3).  The lifetime risk 
of developing colorectal cancer for men and women is 1:17 and 1:19, respectively 
(3).  Unlike a bacterial or viral infection that can be traced to a distinct external 
source, cancer is a disease in which an organism is overcome by rogue cells of its 
own body (2).  Because cancer cells are unique to each host, there are, in essence, as 
many types of cancer as there are patients that develop the disease.  There are 
attributes, however, that seem to be shared by a vast majority if not all cancers (12).  
These attributes, conferred through the mutation of regulatory proteins, allow the 
tumor cells to grow and invade the surrounding tissues.  In a 2000 review, Weinberg 
and Hannan outlined six molecular, biochemical and cellular traits which they 
designated the “Hallmarks of Cancer” (12).  This set of traits, outlined below, is 
currently the best biological descriptions of what constitutes cancer. 
Cells forming a tumor must be able to produce their own proliferative signals 
and ignore or overcome inhibitory signals from the body.  This allows for the 
abnormal growth of individual cells to create a tumor mass within an otherwise 
properly functioning tissue.  With each cell division, the telomeres at the ends of the 
chromosomes are shortened; creating a built-in “fuse” that when finally exhausted 
causes either senescence or cell death (reviewed in(13).  Therefore, the increased 
proliferation of dysplastic cells must eventually be accompanied by an 
immortalization of the cell, usually through an aberrant lengthening of the telomeres, 
as well as an insensitivity to intracellular and exogenous apoptotic signals.  Any cell 
cluster is limited in its size by the ability of oxygen and nutrients to reach the 
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innermost cells.  Cells become hypoxic and will begin to undergo necrosis if they are 
not within a fraction of a millimeter from a blood supply (2).  Consequently tumor 
progression must be accompanied by the ability to stimulate capillary growth to 
supply the dysplastic cells with blood.  A tumor that has obtained these attributes has 
the potential to grow very large but is still isolated within its tissue of origin and 
therefore considered benign.  To be considered cancerous, the cells must be able to 
migrate outward from the site of the primary tumor, invading the surrounding tissues 
and metastasizing to distant sites in the body.  With the acquisition of malignancy, the 
tumor has become a cancer.   
A cell of the intestinal epithelium does not convert immediately from a 
normal, healthy cell to a carcinoma in one step.  The development of a malignant 
carcinoma is a multi-step process that begins with an initial mutation in a vital area of 
the genome resulting in an abnormal or dysplastic cell.  Through continued cell 
divisions and mutational events this cell’s progeny must advance through various 
stages of polyposis beginning as an early benign adenoma and progressing to an 
invasive cancer by continuing to acquire genetic mutations that will confer the 
necessary attributes on the cells (2).  The high number of mutations that must occur 
within a single population of cells to result in a carcinoma strongly supports the 
conclusion that there is a certain amount of genetic instability required for cancer 
development as well (14). 
Because the colon is one of the more common sites of tumor development and 
the polyps are relatively accessible, colorectal cancer is currently one of the best 
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characterized forms of human cancer.  In 1990 Fearon and Vogelstein published a 
review outlining the types of mutations typically seen in human intestinal polyps and 
the stage at which those mutations were most commonly observed, compiling a 
tentative time line of cancer development in the intestine.  This and subsequence 
genetic models of colorectal tumorigenesis place the mutation of the Adenomatous 
Polyposis Coli (APC) gene as one of the initiating steps in the progression of colon 
cancer (11, 15).  Though very little was known about the APC gene at the time, it was 
clear that understanding its function in the cell could be a valuable tool in both the 
detection of early benign tumors and the prevention of cancer development in the 
intestine. 
 
Adenomatous Polyposis Coli 
Adenomatous Polyposis Coli (APC) is a 312 kDa multifunctional protein that 
is expressed in a wide variety of epithelial tissues (16, 17).  The loss of functional 
APC through inactivating mutations has been closely linked to carcinogenesis and led 
to the initial identification of the APC gene in the early 1990s by several labs 
searching for a genetic cause to hereditary colon cancer (17-19).  The hereditary 
syndrome, Familial Adenomatous Polyposis (FAP), results from germline mutation of 
APC, and is characterized by the development of hundreds to thousands of polyps in 
the colon and rectum.  Polyposis begins, on average, at 16 years of age in a person 
who has inherited a mutant copy of APC, and if left untreated the average age for the 
detection of a colorectal carcinoma in a FAP patient is 39 years (20).  This disease, 
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while rather rare in the population, is a dominant, autosomal condition that is nearly 
100% penetrant.   
In addition to being the causative agent of a familial syndrome, sporadic loss 
of APC in somatic cells was identified in over 80% of human colon carcinomas (21).  
Furthermore, investigation into early adenomas found APC mutations in a majority of 
precancerous lesions (polyps) as well (22).  It is now widely accepted that APC 
mutation is an initiating, and possibly rate-limiting, step in the development of most 
colon carcinomas.   
Like a majority of tumor suppressor proteins, it appears that a single copy of 
APC is sufficient to prevent polyposis at the tissue level.  This is supported by the 
observation that in both humans and in animal models a loss of both copies of APC is 
detected in nearly all tumors tested (21, 22).  Cells that have lost both copies of APC 
initially develop benign polyps.  These early adenomas, however, contain the 
potential to progress to malignant carcinomas, making our understanding of APC’s 
function as a tumor suppressor vitally important in the pursuit of better methods of 
diagnosis and treatment for patients with colon cancer (15). 
 More than 700 different disease causing mutations of the APC gene have been 
described, nearly all of which cause a truncation of the protein product through frame 
shift mutations or point mutations leading to premature stop codons (23).  These 
mutations take place, primarily, within the mutation cluster region of APC which lies 
in exon 15 between codons 1000 and 1600 (Figure 1.2).  The most common disease-
causing mutation of APC results in a protein truncation at amino acid 1309, closely  
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Figure 1.2
A scale diagram of APC exons (intron locations are indicated; however, the amount of sequence 
removed is not shown to scale).  Exon 15 makes up over 75% of the 2843 amino acid APC 
protein and contains the APC “mutation cluster region” (indicated in red).  The three most 
common human mutations associated with disease result in an alteration of amino acids 1309, 
1061 or 1465 (indicated in blue).
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followed by truncations at amino acids 1061 and 1465.  Together, mutations at these 
three sites are responsible for approximately 33% of the recorded tumors (24).  In 
both humans and in mouse models, the exact location of the APC truncation greatly 
affects the severity of the phenotype.  For example patients who have truncating 
mutations between codons 1250 and 1330 typically develop over 5000 polyps, while 
patients with mutations beyond codon 1578 may develop fewer than 100 polyps and 
have an average age of onset that is 10-15 years later than patients with the more 
severe form of the disease (25).   Different APC truncations are also associated with 
different extra-intestinal manifestations of the disease.  For example 70% of all FAP 
patients develop dental abnormalities such as extra or missing teeth.  Other common 
benign manifestations include epidermoid cysts, desmoid tumors and hamartomas of 
the pigmented retinal epithelium (25).  This diversity of symptoms originally 
supported the belief that FAP was, in fact, several different syndromes.  It is now 
known that characteristic forms of congenital hypertrophy of the retinal pigment 
epithelium (CHRPE), Gardner Syndrome, Turcot Syndrome and hereditary desmoid 
disease are all caused by different mutations resulting in various  
truncations of the APC protein, (reviewed in(23).  The variation in phenotypes caused 
by different mutations of the APC gene supports the idea that APC has a 
multifunctional role  
in tumor suppression and makes the understanding of APC’s various cellular roles all 
the more important.  
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APC protein structure 
 The functional domains of APC were originally estimated based on amino 
acid sequence (17, 19) and were later confirmed with in vitro biochemical  methods 
and in cultured cells (26).  The conventional APC protein contains 2843 amino acids 
and is approximately 312kDa (Figure 1.3).   APC has 15 exons, the last of which 
encodes over 75% of the total protein (Figure 1.2).  The structure and binding 
partners of the APC protein have been extensively reviewed (26, 27).  Briefly, the 
extreme N-terminal portion of APC is made up of heptad repeats that have been 
predicted to form a coiled-coil domain and facilitate oligomerziation of the APC 
protein (17, 19).  However, a function for APC as an oligomer has yet to be revealed.  
The N-terminal region also contains two nuclear export sequences (NES) which 
directly interact with Crm-1/Exportin and play a role in nuclear/cytoplasmic shuttling 
of the protein (28, 29).  One of the primary motifs in the N-terminal region of the 
APC protein is the ARM or armadillo domain.  This region, made up of seven copies 
of a 42 amino acid motif, is named because of similarity to a region of repeats in the 
protein β-catenin (armadillo in fruit flies) (30).  The armadillo repeats have been 
shown to interact with a number of other protein partners including the B56α 
regulatory subunit of phosphatase 2a (PP2A) (31), APC-stimulated guanine  
nucleotide exchange factor (Asef) (32), and the Rac1 and Cdc42 effector protein 
IQGAP1 (33).  The APC Arm domain has also been shown to interact with kinesin 
superfamily-associatied protein 3A (KAP3A) in both yeast-two hybrid analysis and 
by co-immunoprecipitation from cell lysate (34).  Staining of full length APC and  
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Figure 1.3
A simplified diagram of the binding domains of the APC protein. APC is represented here as a 
linear peptide with the amino acid scale above.  Asterisks represent the characterized nuclear 
localization sequences (NLS) and nuclear export sequences (NES).
14
KAP3A reveals that these two proteins co-localized in clusters at the tips of 
membrane protrusions in migrating cells.  Truncated forms of APC commonly 
associated with disease no longer form these clusters, suggesting that a C-terminal 
region of APC is also important for APC/KAP3A accumulation at the membrane 
(34). 
The middle third of APC interacts with proteins of the canonical Wnt 
signaling pathway.  Several repeats responsible for binding to and down-regulating β-
catenin are located in this region along with the SAMP domains which mediate 
binding to axin, a scaffolding protein of the β-catenin destruction complex (35).  This 
region also contains the two major nuclear localization sequences (NLS) which are 
required for optimal nuclear import and are regulated through phosphorylation (28, 
36).  The observation that APC fragments lacking both of these NLSs appear to 
maintain some nuclear/cytoplasmic shuttling suggests that there may also be a weaker 
NLS in the N-terminal domain (31). Experiments performed using fragments of APC 
suggest that the armadillo repeats can contribute to nuclear transport of smaller pieces 
of APC lacking the central NLSs (31).  Finally, within the central region of APC 
there are three additional sequences predicted to function as NESs (37).  However, 
direct comparison of the export properties of all of the APC NES suggest that the 
central NESs exhibit only moderate activity relative to the N-terminal NESs and 
probably have a minimal role in nuclear shuttling (31). 
 The C-terminal third of APC is typically lost in the truncation mutants 
associated with disease.  This region is thought to mediate interaction with a variety 
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of protein binding partners.  There is a 200 amino acid stretch composed primarily of 
positively charged residues which shares some biochemical similarities with the MT 
binding protein tau; this region has been shown to interact with tubulin and promote 
microtubule polymerization (38).  Also in the C-terminal region of APC is a motif 
that binds to the PDZ domain of the human homologue of the Drosophila discs large 
protein (hDLG) and to the protein tyrosine phosphatase PTP-BL (39, 40).  Both of 
these proteins are involved in the maintenance of cell polarity, migration, and control 
of cellular proliferation.  A fragment of APC containing the final 155 amino acids has 
been shown to interact with the human homologue of Drosophila seven in absentia 
(Siah).  Siah is a p53 inducible mediator of cell cycle arrest, tumor suppression and 
apoptosis which down-regulates β-catenin in an APC dependent manner.  
Furthermore, Siah induced β-catenin degradation is not dependent on Gsk-3β or axin 
and therefore does not involve the traditional β-catenin destruction complex (41).  
The C-terminal 170 amino acids have also been found to bind to the microtubule 
interacting protein End Binding protein-1 (EB1).  In wild type ES cells EB1 decorates 
the mitotic spindle and localizes to the kinetochores; however, cells with APC 
truncation mutations showed a loss of EB1 accumulation at the kinetochores and an 
increase in chromosomal instability (42).   This suggests that APC interaction with 
EB1 may be necessary for proper chromosome segregation during mitosis.   
 
APC functions 
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 APC can be seen in a variety of subcellular locations and is able to shuttle in 
and out of the nucleus.  APC has been observed dispersed in the cytoplasm as well as 
localized near the ends of microtubules and along the leading edge of migrating cells 
(43).  APC has also been observed in the nucleus, usually in a discrete punctate 
pattern and appears to transiently localize to the nucleolus (44).  The plethora of 
reported binding partners and cellular localizations suggests that APC has a number 
of roles within the cell.  APC has been hypothesized to participate in the regulation of 
protein phosphorylation and downregulation (45), cytoskeletal rearrangement (46), 
chromosome segregation (42), DNA repair (47), differentiation (48), transcription 
(49, 50) and apoptosis (51, 52).  
 
APC in Wnt Signaling 
 Currently the best characterized role for APC is its function in the canonical 
Wnt signaling pathway (Figure1.4).  The Wnt pathway was originally described as 
the Wingless pathway in Drosophila, but has been shown to be highly conserved in 
flies, frogs and mammals (reviewed in(53).  Wnt signaling plays a key role in 
development and tissue homeostasis and is found to be compromised in many 
cancers.  Extracellular Wnt binds to and activates membrane receptors which in turn 
mediate phosphorylation of downstream signaling molecules. Wnt signaling leads to 
decreased phosphorylation of the oncogene β-catenin.  Unphosphorylated β-catenin 
can accumulate in the cytoplasm, translocate to the nucleus and bind to transcription 
factors of the T-cell factor/lymphoid-enhancer factor (Tcf/Lef) family to activate  
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Figure 1.4
A simplified diagram of the canonical Wnt signalling pathway showing the role of APC in the β-
catenin destruction complex.  On the left APC, Axin and Glycogen Synthase Kinase-3β
associate to form the core of the β-catenin destruction complex.  This complex binds to and 
phosphorylates β-catenin protein in the cytoplasm. Once phosphorylated, β-catenin is 
ubiquitinated which marks it for proteolysis.  On the right, a soluble Wnt factor interacts with its 
receptor complex (Frizzled) on the cell surface.  This signaling event leads to an inhibition of 
the destruction complex allowing for increased cytoplasmic levels of β-catenin.  This increase in 
β-catenin levels leads to the translocation of β-catenin into the nucleus where it acts as a 
transcription co-activator and leads to increased expression of Wnt targets, many of which are 
associated with promoting cellular proliferation.
transcription of specific target genes.  These genes, including c-Myc, cyclin D1 and 
axin 2, are predominantly associated with progression of the cell cycle.  Thus, in 
general terms, the presence of a Wnt signal leads to cellular proliferation.  In the 
absence of a Wnt signal the β-catenin destruction complex containing axin, glycogen 
synthase kinase 3β (Gsk3β) and APC, phosphorylates excess β-catenin in the 
cytoplasm, targeting it for destruction and therefore down-regulating its  
activity as a transcription factor.  This assures that in the absence of a Wnt signal, 
there is no aberrant cellular proliferation (reviewed in(54).   
APC contains three SAMP repeats that bind to axin, a scaffolding protein of 
the β-catenin destruction complex.  There are also three 15 amino acid repeats that 
facilitate binding of APC to β-catenin and seven 20 amino acid repeats that appear to 
be required for the down-regulation of β-catenin.  It is interesting that in cancer tissue, 
APC is often truncated so that one or two of these 20 amino acid repeats are 
maintained (55).  This APC truncation results in a destruction complex that is 
deficient in its ability to down-regulate β-catenin, but still retains some residual 
activity, suggesting that the complete loss of β-catenin regulation is less advantageous 
to growth than a decrease in the regulation of the β-catenin levels (55).  Without 
proper down-regulation of β-catenin, the cell will respond as if it has received a signal 
to proliferate even in the absence of an actual Wnt ligand.   
 In addition to its role regulating β-catenin levels in the cytoplasm, it has been 
suggested that the function of APC in the control of β-catenin’s transcriptional 
activity extends to the nucleus.  This hypothesis is supported by the finding that APC 
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and β-catenin can co-immunoprecipitate from the nuclear fraction of cells (56).  A 
further indication that APC may be interacting with β-catenin in the nucleus comes 
from an experiment in which APC’s nuclear export signals were mutated, trapping a 
majority of the cell’s APC inside the nucleus.  With APC trapped in the nucleus, it is 
no longer available to participate in the cytoplasmic destruction complex and levels of 
β-catenin increase in both the nuclear and cytoplasmic compartments.  In cells that 
have truncated APC, an increase in the level of nuclear β-catenin coincides with an 
increase in β-catenin transcription activity.  However, with both β-catenin and full-
length APC located predominantly in the nucleus, β-catenin transcriptional activity is 
low, suggesting APC can sequester β-catenin from TCF/LEF-1 (56).  There is also 
evidence that APC is recruited to the enhancer region of Wnt target genes and may 
participate in the dissociation of β-catenin and other Wnt enhancer proteins and co-
activators from their targets at the termination of a Wnt signal (49).  APC’s role as a 
direct repressor of Wnt/β-catenin signaling at the DNA is further supported by 
findings that phosphorylation of APC at the first two 20 amino acid repeats enhances 
the interaction between APC and β-catenin by 300-500 fold and that this 
phosphorylated fragment of APC can effectively disrupt Tcf binding to β-catenin in 
vitro (57).   
 
A role for APC beyond Wnt signaling. 
Because uncontrolled proliferation is a classic early marker of cancer 
development, regulation of cellular proliferation through β-catenin stability is 
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considered by some, to be the primary tumor suppressor function of APC (58).   This 
is supported by the observation that adenomas with no mutations in APC commonly 
have activating mutations in β-catenin which make β-catenin resistant to 
phosphorylation.  However, the idea that APC may have a more complex 
responsibility in cellular homeostasis is supported by a number of observations.  First, 
APC shuttles in and out of the nucleus and interacts with a variety of nuclear proteins 
including DNA polymerase-β, Flap endonuclease-1 (Fen-1), PCNA and 
topoisomerase IIα (47, 59, 60).  All of these APC partners are involved in DNA 
maintenance rather than β-catenin regulation.  Second, the Wnt signaling pathway 
offers a variety of other proteins, the mutation of which would disrupt β-catenin 
stability.  Yet, statistically, it is much more prevalent for both alleles of APC to be 
inactivated than for a single oncogenic mutation to occur at any other step in the 
pathway including in β-catenin itself (21).  Some studies even suggest that activating 
mutations in β-catenin, in addition to being much rarer in cancers, may result in a less 
aggressive lesion than those that show mutations in APC (61).  Taken together, these 
observations support a multifunctional role for APC in tumor suppression. 
  
APC and DNA repair. 
One of the first suggestions that there might be a link between APC and DNA 
repair was published in 1982, nearly 10 years before the APC gene was identified in 
the early 1990s (17-19).  Investigators working with cultured skin fibroblast lines 
derived from patients with Gardner’s Syndrome noticed that the cells taken from 
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patients with colorectal polyps were more sensitive to both ultraviolet (UV) 
irradiation and X-rays than cells taken from healthy Non-Gardner donors (62).  It is 
now known that Gardner’s Syndrome is a form of Familial Adenomatous Polyposis 
(FAP) caused by an inherited mutation in APC.  While polyps typically arise only 
after the loss of the second allele of APC, it is interesting to note that the cultured 
FAP fibroblasts, expected to maintain one WT APC allele, were defective in their 
ability to respond to DNA damage.  Similar work using whole animals suggests that 
mice heterozygous for APC truncation are more sensitive to gamma irradiation than 
their wild type counterparts (63).   
Other intriguing links between APC and DNA maintenance have since been 
revealed.  When cultured HCT116 human cancer cells were treated with a variety of 
DNA damaging agents, the levels of APC mRNA and protein increased up to 12 fold 
(64).  This up-regulation of APC was shown to require p53 and could be mimicked by 
over-expression of wild type p53, suggesting that APC is a downstream target of p53 
and expression is up-regulated in response to DNA damage.  Further supporting this 
theory was the identification of two p53 binding sites in the APC promoter sequence, 
which promoted the expression of a reporter construct in response to DNA alkylation 
damage.  However, the mutation of these sites did not completely eliminate reporter 
construct activation in response to DNA damage, suggesting that the APC promoter 
contains additional uncharacterized sequences that are also responsive to DNA 
damage (65). 
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Another interesting piece of evidence, when considering a role for APC in 
DNA repair, comes from the study of mice mutant for both APC and the DNA repair 
protein Fen-1.  The APC1638N/+ mutation interferes with the expression of the APC 
mutant allele resulting in a null mutation.  Heterozygous mice, therefore express only 
half of the normal level of APC (normal expression from the WT allele and only ~ 
2% expression from the mutant allele).  APC1638N/+ mice display a mild intestinal 
polyposis phenotype, developing, on average, three tumors per mouse (66).  The Fen-
1 mutation is also a null mutation, with embryonic lethality in homozygous mice.  
Mice heterozygous for Fen-1, however, are viable and fertile, with a lifespan 
indistinguishable from their wild type littermates and little to no intestinal phenotype.  
When the APC1638N+/- mice were crossed with the Fen-1+/- mice, the resulting double-
mutant offspring displayed a shortened lifespan, increased tumor incidence and a 
more aggressive polyposis phenotype.  Polyps in the double-mutant mice were 10 
times more likely to progress to malignancy than polyps from mice carrying only a 
mutation in APC.  Furthermore, while none of the polyps from the APC1638N/+ mice 
showed microsatellite instability (MSI), all of the polyps from the APC1638N/+Fen-1+/- 
double-mutant mice displayed extensive MSI (67) .  The observation that the double-
mutant mice exhibited a phenotype that was more severe than the phenotype observed 
in mice with either of the mutations individually suggests that APC and Fen-1 both 
contribute to the same end goal, presumably DNA maintenance, but that they do so in 
parallel pathways.  
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Numerous parallel pathways exist to maintain DNA integrity.  Different types 
of DNA damage are resolved through different mechanisms (reviewed in(68).  For 
example, there is a subset of DNA repair proteins responsible for fixing mismatched 
base pairs in newly synthesized DNA, while other types of damage such as bulky 
DNA adducts or pyrimidine dimers, more typically resulting from exposure to UV 
irradiation, are predominantly fixed using the nucleotide excision repair (NER) 
pathway.  Replacement of DNA bases that have been oxidized, reduced, alkylated, 
methlylated or deaminated is usually carried out by the base excision repair (BER) 
pathway, and repair of double-stranded DNA breaks can be accomplished through 
either the homologous recombination (HR) or non-homologous end joining (NHEJ) 
pathways (68).  The Fen-1 protein discussed above, is associated with the process of 
BER (69) suggesting that APC does not aide in BER, but rather, plays a role in 
maintaining DNA stability by participating in one or several of the other pathways.  
APC is implicated in both the NER pathway and in the repair of DNA double-strand 
breaks by the previously described data in which human cell lines and mice deficient 
in APC show increased sensitivity to gamma irradiation and UV light (62, 63).   
APC may also be involved in the sensing or repair of mismatched base-pairs, 
a hypothesis that is supported by studies of double-mutant APC1638N/+Exo-1+/- mice.  
Exonuclease-1 (Exo-1) is a 5’-3’ DNA exonuclease in the same family as Fen-1 (70).  
Though similar in sequence (70), these two proteins operate in different repair 
pathways.  Fen-1 participates in BER while Exo-1 is associated with mismatch repair.   
Unlike the APC1638N/+Fen-1+/- mutants, the double-mutant APC1638N/+Exo-1+/- mice 
 
 
24
show no significant increase in tumor incidence, no increase in the rate of tumor 
advancement and no MSI in any of the polyps tested (71).  Because the combined 
phenotype is the result of the additive effects of the mutations to the individual tumor 
suppressors, we hypothesize that APC’s role in DNA maintenance also includes a 
function in mismatch repair. 
Further complicating the search for APC’s role in the maintenance of the 
genome is that, contrary to what is expected of a proven tumor suppressor protein, 
APC appears to actively hinder DNA repair by inhibiting the BER pathway.  Cells 
with wild type APC are more sensitive to DNA methylating agents than cells in 
which APC has been mutated or knocked down by siRNA (59).  Cells deficient in 
APC were also more efficient in repairing a BER-dependent reporter construct, 
showing a quicker and more complete repair of the damage than cells with wild type 
APC (47).  Further analysis of this phenotype demonstrated a direct interaction 
between the APC protein and several components of the BER repair pathway 
including DNA polymerase-β, Fen-1 and PCNA (47, 59).  With its suspected role in a 
number of DNA repair pathways, it might be hypothesized that APC inhibits BER in 
favor of one of the other repair pathways.  However, this does not explain why p53 
up-regulates APC expression in response to DNA damaging agents that cause DNA 
adducts, a type of damage traditionally thought to be repaired by the BER pathway.  
Another prevalent theory is that APC blocks repair of DNA to induce apoptosis in 
cells with extensive DNA damage, a function that would be in agreement with the 
tumor suppressor identity of APC.  Colony survival studies suggest that APC assists 
 
 
25
in the survival of cells after exposure to other types of DNA damage (62), implying 
that induction of apoptosis is specific to the BER pathway.   
Though the exact nature of APC’s role in DNA maintenance is still unclear, 
the evidence that there is a function for APC in DNA repair is beginning to 
accumulate.  Even with the limited work that has been done in this field, there 
appears to be a link between APC and members of every major DNA repair pathway. 
 
APC in Animal Models 
 While some aspects of APC are more easily investigated in cultured cells, 
other aspects of APC’s role in development and tissue homeostasis can only be 
effectively explored in situ.  Originally research on intestinal cancer was conducted in 
rodent models that were induced to develop neoplasms by exposure to carcinogens; 
however, nearly all of the current animal studies in this area are of mouse models that 
carry germline mutations in the APC gene (72).  Below is a summary of some of the 
more common mouse models used to study APC function in suppression of intestinal 
carcinogenesis (Table 1.2 and Figure 1.5). 
 
The Min mouse: a beginning 
 The first APC mutant mouse model to be developed was the Multiple 
Intestinal Neoplasia or APC Min mouse which resulted from an ethylnitrosourea 
(Enu) mutagenesis screen (73).  The APC Min mice now represent one of the most 
widely used mouse model systems in the study of APC and intestinal cancer research  
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 Table 1.2 A summary of the phenotypes of common APC mouse models
APC Mutation Truncation Average Polyp Number* Lifespan*
Homozygous 
Lethal
Extra Intestinal 
Manifestations
Min** aa 850 100 <120 days Yes No
1638N aa 1638       2% expression 3 365 days Yes
Desmoid tumors, 
Cutaneous cysts
1638T aa 1638 0 Normal No Cutaneous cysts and Postnatal mortality in -/-
Δ1309 aa 1308 60 120 days Yes None reported
Δ716 aa 716 254 >112 days Yes None reported
Δ14 or 580S/D aa 580 100 120 days Yes none reported
Δ474 aa 474 122 185 days Yes Mammary tumors
NeoR
10% 
expression of 
full length
<1
Not reported, 
pressumably 
normal
Yes None reported
** on the C57BL/J6 background
* Heterozgous phenotype
(73)
(84)
(87)
(89)
(90)
(92)
(96)
(83)
Figure 1.5
A diagram of the APC motifs found in several of the common mouse models for truncated 
APC.  (A) Full length APC with labeled motifs. Asterisks denote NLS and NES locations 
(green=NLS; purple=NES). (B) Amino acid scale.  (C) APC truncations found in the 
indicated mouse models.
A
B
C
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with over 435 published references to date (Pubmed search: APC Min mouse). Min 
mice develop adenomatous polyps in the intestine with moderate dysplasia, mild 
nuclear atypia and frequent mitotic figures.  The similarity of the Min mouse 
phenotype to the human disease FAP led to the identification of a germline mutation 
in Min mice that interrupted the murine Apc gene.  The mouse Apc gene is 86% 
identical to the human gene at the nucleotide level with the protein 90% identical to 
the human APC making it a very suitable model in which to study human APC loss 
(74).  The Min mutation is a transversion of nucleotide 2594 from a T to an A which 
converts a leucine (TTG) to a stop codon (TAG), truncating the protein at amino acid 
850 (74).  The truncated Min APC protein maintains the armadillo region which is 
thought to bind to the actin regulator as well as the N-terminal nuclear export 
sequences.  Absent from the Min APC protein are the regions of APC that bind to β-
catenin and aid in its down-regulation as well as the SAMP motifs which bind to axin.  
The Min mutation eliminates both of the central nuclear localization sites as well as 
the basic domain that is thought to interact with microtubules.  Truncated Min APC 
also lacks a variety of sites thought to interact with various protein binding partners, 
including DNA polymerase-β, the kinetochore protein EB1 and hDLG.  
The polyposis phenotype of the heterozygous Min mice further confirms that 
APC serves as a tumor suppressor and functions, at least in part, to maintain 
homeostasis in adult tissue.  The Min mouse model also provides strong evidence for 
a role for APC during development. The Min mutation causes embryonic lethality 
when homozygous.  Embryos with an APCMin/Min genotype are able to implant, but 
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begin showing obvious abnormalities around embryonic day 6.5 and die due to an 
apparent failure in the maintenance and development of the early egg cylinder (75). 
Following the detection of the Apc Min mutation, the mutant mice were 
crossed with C57BL/J6 mice to obtain a congenic strain.  The average lifespan for a 
C57BL/6J APCMin/+ mouse is less than 120 days at which point death usually occurs 
due to anemia caused by rectal bleeding (73).  The Min mutation has also been 
introduced into other mouse strains and the severity of the Min phenotype can vary 
greatly depending on the genetic background of the mouse strain being used.  While a 
typical heterozygous Min mouse will develop approximately 100 tumors, the number 
of polyps developed per mouse can vary significantly, ranging from less than one per 
mouse to over 200 depending on the specific genetic background (76, 77).  
Since the Min mutation can give rise to phenotypes that differ in severity 
depending on the genetic background, this model is an excellent tool to search for 
genes that have positive and negative effects on polyp development.  The first gene to 
be isolated from such a genetic search was named Modifier of Min 1, or Mom-1 (76).  
Some mouse lines including CAST, BALB, DWR, DBA, MA and AKR were 
observed to be more resistant to Min tumors than other lines such as the B6, 129 and 
BTBR mouse lines (76, 78, 79).  These “sensitive” lines were all revealed to carry a 
frame shift mutation in the type II secretory phospholipase A2 (Pla2s) gene, 
suggesting that tumor sensitivity stems in part from either the production of the 
truncated protein or the loss of the full length WT protein.  Pla2s is one of several 
enzymes involved in generating arachidonic acid which is a rate limiting substrate in 
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the generation of prostaglandins (80).  While the Mom-1 mutation explains some of 
the variability, it is only able to account for about 50% of the genetic variation that is 
observed, which suggests the presence of additional modifier proteins (76).  The 
second modifier locus,Mom-2, was shown to have an even greater effect on polyp 
number and size.  Mom-2 was mapped to the mouse chromosome 18 and can reduce 
polyp number by 88-95%.  Though the mechanism of tumor resistance is currently 
unclear, the effects of Mom-1 and Mom-2 together are greater than the effects of 
either alone, suggesting that they work in different pathways (81).   
The APC Min mouse has proven to be an excellent tool in the study of 
intestinal tumorigenesis; however, this model is still an imperfect system.  The 
phenotype of the Min mouse does not directly parallel human colorectal cancer.  As 
with many mouse models, the Min mouse develops polyps predominantly in the small 
intestine rather than in the colon where polyps most commonly occur if there are 
germline or somatic APC mutations in humans (23).  Tumors induced by a Min 
mutation do not follow the same steps in progression as human tumors; for example, 
Min mouse tumors do not develop mutations in K-ras which is commonly mutated in 
the development of human colon cancers (15, 72). Also, because of the short lifespan 
of Min mice, few of the polyps have time to invade and metastasize, making it 
difficult to study these processes in the APC Min mouse model.  Since the somewhat 
serendipitous development of the APC Min mouse, several targeted APC mouse 
models have been developed allowing a more in-depth look at APC’s function in 
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tissue homeostasis and tumor progression as well as intestinal carcinogenesis in 
general. 
 
More mouse models: The ever shrinking APC molecule 
Molecular biology techniques allowing a mutation to be targeted to a specific 
location on a specific gene and the ability to create a mouse line from mutant 
embryonic stem cells have allowed the creation of a myriad of mouse models with 
very precise APC genotypes (reviewed in(82).  Many APC mutants have been created 
that code for APC protein products truncated at a variety of specific locations (Table 
1.2).  This allows for inquiry into the regions of APC that are critical for different 
cellular functions.  As techniques have advanced, there has been an increase in the 
number of inducible and hypomorphic APC mutations as well.  All of these APC 
mouse models have added to our understanding of APC function in development, 
homeostasis, and tumor suppression. 
 
APC1638Nand APC1638T 
Using a targeting vector for mouse embryonic stem cells, a neomycin 
phosphotransferase expression cassette was inserted into exon 15 of the APC gene at 
nucleotide 4913.  The resulting frame shift truncated the APC protein at amino acid 
1638 (83).  The 182kD truncated APC protein lacks the domains thought to interact 
with DLG, EB1 and PTP-BL and Siah.  APC aa1-1638 contains only three of the 
seven β-catenin  down regulating repeats and only one axin binding or “SAMP” motif 
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(84).  However, little to no truncated APC could be detected when lysate from the 
mutant cells was analyzed by western immunoblot.  It was hypothesized that the lack 
of expression of the truncated protein was due to the Neor cassette which had been 
inserted in the opposite direction as the APC gene.  Originally this was thought to be 
a null mutation and so was named APC1638N.  Later, it was shown that the mutation 
created a hypomorphic allele which expressed the truncated APC protein at only 2% 
of the endogenous level. (48).   
The mice heterozygous for the 1638N APC mutation showed polyploid 
hyperplastic lesions in the colon by 10 weeks, and colonic and small intestinal polyps 
by 20 weeks (66).  Malignant adenocarcinomas developed in the duodenum and 
jejunum, and mice began to die at 32 weeks of age.  The average lifespan of a 
heterozygous APC1638N mouse is just over 1 year and on average they develop only 
about three tumors per mouse (66).  Because the phenotype of this mouse model is 
less severe than many of the APC Min mutant mice, they live long enough for their 
tumors to progress into carcinomas making it possible to study of tumor advancement 
in this model.  However, such studies have shown that while the WT copy of APC is 
lost in nearly all of the adenomas, there were no mutations found in K-ras, H-ras or 
N-ras, nor were there any detectable abnormalities in the p53 gene (85), all of which 
are common mutations in human colon carcinogenesis (15).  Nonetheless, this 
APC1638N mouse model does show other similarities to human APC loss. For example, 
in addition to the intestinal polyps APC1638N mice manifest extra-intestinal lesions 
similar to those common to FAP patients (25, 86).   
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Extra-intestinal lesions observed in the APC 1638N mouse model included 
cutaneous cysts which began developing when the mice were between 1 and 3 
months old, and desmoid tumors that developed when APC1638N mice are between 1.5 
and 2 months of age (86).  Interestingly, these extra-intestinal lesions were not 
commonly observed in APCMin/+ mice.  This difference could reflect expression of 
APC Min protein at WT levels, whereas mice containing the Apc 1638N mutation 
produce very little APC protein from the mutant allele.  Perhaps this suggests that 
outside of the intestine, the expression level of the N-terminal region of APC is more 
important than the presence of the full length protein. As with the APCMin mice, the 
APC1638N mutation results in embryonic lethality when homozygous (83), suggestive 
of an important role for APC in early development.   
To further study the 1638 amino acid truncation product of APC, a second 
mutant mouse was created using the same techniques, but the antibiotic resistance 
cassette was inserted in the same direction as the reading frame of the Apc gene (84).  
This mutation, named 1638T, expressed the truncated protein at the same level as WT 
protein, confirming that the reverse orientation of the Neor cassette was the cause of 
the reduced expression of truncated APC seen in the 1638N mutants.  Mice 
heterozygous for APC 1638T were indistinguishable from their WT littermates.  
Unlike the previously described mouse lines, mice homozygous for the 1638T 
mutation were viable.  Surprisingly even Apc1638T/1638T homozygous mice are not 
prone to intestinal polyposis, suggesting that the regions of APC important for 
continued tissue homeostasis are N-terminal to amino acid 1638.  The Apc1638T/1638T 
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mouse does, however, have some developmental defects.  Homozygous 
APC1638T/1638T mice are growth retarded and develop cutaneous cysts which appear to 
be associated with the pilosebacious unit.  There is a higher rate of postnatal mortality 
which increases as the mice are crossed with the more sensitive C57BL/J6 mice (84).  
 
APCΔ1309 
APC truncation at amino acid 1309 is the most common mutation found in 
humans with Familial Adenomatous Polyposis.  Furthermore, truncation at this site is 
associated with a relatively severe form of the disease (24).  It therefore was logical to 
create a mouse model that expresses a mutant form of APC truncated at amino acid 
1309.  The APCΔ1309 mouse was developed by the Itoh lab in Japan and was created 
by introducing a nonsense mutation at codon 1309 of the Apc gene (87).  The 
APCΔ1390 mouse has an average lifespan of 120 days, nearly identical to the APCMin/+ 
mouse, but only develops ~60 polyps along the entire gastrointestinal tract.  The 
polyps are located primarily in the upper region of the small intestine which differs 
from Min mice which mainly develop polyps in the lower region of the small 
intestine, suggesting that this mutation has a somewhat different mechanism for polyp 
initiation. (88). 
 
APCΔ716 
APC Δ716 mice were created with an insertion in Apc nucleotide 2150 which 
results in truncation of the APC protein at amino acid 716 (89).  The APC Δ716 mouse 
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expresses a shorter version of APC than the Min mouse which is truncated at amino 
acid 850.  Heterozygous APC Δ716/+ mice have a severe intestinal polyposis 
phenotype, developing polyps within 5 weeks of birth.  The polyps develop primarily 
in the small intestine and by 16 weeks of age there was an average of 254 polyps per 
mouse, over twice the average number of polyps that develop in the original Min 
mouse (73, 89).  If APC functioned as a tumor suppressor entirely through its ability 
to down-regulate a Wnt signal by aiding in the destruction of cytoplasmic β-catenin, 
one would expect these two APC truncations to result in a similar phenotype.  While 
the truncation in the Min mouse already removes all of the known β-catenin binding 
and down-regulation domains, the loss of the additional 134 amino acids in the APC 
Δ716 mouse still increases the severity of the polyposis phenotype.  Similar to the Min 
mice, all of the polyps tested had lost the WT copy of APC, suggesting again that one 
WT Apc allele is enough to prevent polyp formation at the tissue level.  APC Δ716/ Δ716 
mice die prior to day 8 of gestation (89).  
 
APCΔ14 (APC 580S) 
Unlike in many of the previously described APC mutant mouse models, the 
Δ14 mutation was not a truncation due to the insertion of a drug resistance cassette.  
In this mouse Lox P sites were introduced into introns 13 and 14 so that the entire 
region of exon 14 was flanked with Lox P sites, or “floxed” (90).  When exposed to 
Cre DNA recombinase, DNA undergoes a rearrangement that removes the floxed 
sequence.  This deletion of exon 14 caused a frame shift resulting in truncation of the 
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APC protein at amino acid 580.  This truncation removed all of the domains involved 
in β-catenin  binding and down regulation as well as some of the armadillo repeats 
which stretch from approximately amino acid 435 to amino acid 766 (30).  These 
mice have a severe polyposis phenotype and begin dying at 4 months of age, with 
similar average lifespans as the Min mouse (90).  Interestingly, while these mice also 
develop similar numbers of polyps as the Min mice, the distribution of their polyps 
differs.  In the APCΔ14/+ mice there are comparatively more polyps in the colon and 
fewer in the small intestine when compared to the APCMin/+ mice grown under the 
same conditions.  This phenotype more closely resembles the human symptoms 
associated with mutation of APC.  However, a control group of APCΔ14/+ mice raised 
under specific pathogen-free (SPF) conditions did not show the same shift in polyp 
distribution.  Their phenotype more closely resembled the APC Min mouse 
distribution of polyps with the vast majority in the small intestine and very few in the 
colon (90).  This suggests that the differences in the polyp distribution between 
humans and mouse models has a genetic component and is also influenced by the 
intestinal environment.  As in other mouse models, APC Δ14/Δ14 mice die during 
embryogenesis (91).   
 
APCΔ474 
In humans, germline mutations in APC 5’ of nucleotide 1578 usually give rise 
to a milder form of the disease known as Attenuated Familial Adenomatous Polyposis 
(AFAP).  AFAP is associated with fewer polyps and a later age of onset compared to 
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FAP (25, 50).  A mouse model of AFAP was developed by inserting a targeting 
construct that would result in truncation of APC at amino acid 474.  The APCΔ474/+ 
mutant mice began developing intestinal tumors at around 8 weeks of age and 
averaged 122 tumors per mouse similar to mice with an APCMin/+ mutation.  However, 
the average lifespan of the APC Δ474/+ mutant mice was nearly double that of the APC 
Min mouse.  The mice lived approximately 6 months before they died of anemia.  In 
addition to the intestinal lesions 18% of the APC Δ474/+ mice also developed mammary 
tumors that usually arose between 3-5 five months of age.   No APC Δ474/ Δ474 mice 
were born, suggesting that, like most other APC truncations, homozygous APC 
truncation at amino acid 474 results in embryonic lethality (92). 
 
Homozygous loss: Learning about APC in embryonic stem cells 
 Severe defects in APC result in embryonic lethality in the absence of wild 
type (WT) APC.  Therefore, it can be difficult to study the complete loss of WT APC 
in situ because death results before differentiated tissue can develop.  However, 
undifferentiated tissue, specifically embryonic stem cells carrying Apc mutations can 
be studied.  Much can be learned about the role of APC in β-catenin regulation, 
differentiation and proliferation in these tissue precursor cells.  Embryonic stem cells 
will grow into tumors called teratomas when injected into syngenic (immune 
compatible) mice (93).  Because these ES teratoma cells differentiate in a manner that 
closely parallels the normal behavior of ES cell in an embryo, teratomas provide 
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valuable insights into the processes required for the development and maintenance of 
more differentiated tissues (94). 
One common method for examining the effect of APC mutation on β-catenin 
transcription activity is a luciferase assay using the TOPFLASH and FOPFLASH 
reporter constructs (50).  TOPFLASH contains three copies of the consensus Tcf 
binding motif, and the negative control, FOPFLASH, contains three copies of a 
mutant motif.  Both motifs are upstream of a minimal c-Fos promoter driving 
luciferase expression.  In cells transfected with TOPFLASH, luciferase expression is 
correlated with the ability of β-catenin to interact with Tcf at the promoter binding 
site and initiate transcription (50). The TOPFLASH assay was used to examine the 
level to which the mutant APC alleles can regulate β-catenin’s ability to act as a 
transcription factor in vivo (84).  Embryonic stem cells homozygous for the APC 
1638T mutation show β-catenin activities similar to WT cells. The phenotype 
observed in mice homozygous for the APC 1638T mutation is therefore unlikely the 
result of unregulated β-catenin.  A lack of β-catenin up-regulation in cells that carry 
the APC 1638T mutations also correlates to the absence of a polyposis phenotype in 
the APC1638T/1638T mice.  These observations also suggest that the removal of APC’s 
carboxy-terminus does little to affect APC’s ability to regulate β-catenin.  Stem cells 
with an APC1638T/1638N genotype have β-catenin activity levels slightly over twice the 
WT levels, while cells homozygous for the APC 1638N mutation showed a 30-fold 
increase in β-catenin transcriptional activity compared to WT cells.  The much more 
dramatic TOPFLASH activation in cells that are homozygous for the APC 1638N 
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mutation suggests that there is a dose response effect to APC’s regulation of β-
catenin.  It appears that the less APC available in the cell, the less β-catenin is 
regulated (84).  
To examine the importance of axin binding to APC, another APC mutation 
was designed.  A targeting construct was created to interrupt the APC gene and 
produce a truncation protein that ended at amino acid 1572.  Compared to the APC 
1638T mice, the APC 1572T mice lack the 3’ 197 base pairs of APC sequence, thus 
eliminating the last SAMP motif that is present in the 1638T mutants.  The 
APC1638N/1572T double mutant cells had β-catenin activity levels over four times that of 
WT cells and twice that of APC1638T/1638N cells.  However, the APC1638N/1572T cells still 
expressed significantly less luciferase than the APC1638N/1638N cells.  These findings 
suggests that while the loss of the last SAMP motif significantly decreased APC’s 
ability to regulate β-catenin  activity, it does not completely eliminate it (84).  
To look at APC’s role in differentiation WT and APC-mutant stem cells were 
injected into syngenic mice to induce teratoma formation (84).  APC1638N/1638N cells 
showed severe defects in teratoma formation when compared to WT stem cells.  
Teratomas made using APC1638N/1638N showed an absence of neural ectoderm markers 
which represent 50-75% of the WT teratomas.  Other missing cell types include bone, 
cartilage and ciliated epithelial cells.  Gut-like tissues such as smooth muscle, 
secretory epithelia and non-ciliated epithelia, as well as keratinized, epithelia showed 
normal or enhanced differentiation.  Teratomas formed using APC1638T/1638T stem cells 
were indistinguishable from WT teratomas.  This later result suggests that much of 
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the phenotype observed in the 1638N cells is due to the reduced level of APC not the 
truncation of the protein (48).  Interestingly the 1638T truncation protein lacks the 
known nuclear localization sites at amino acids 1773 and 2054, however APC is still 
found in the nuclear compartment of cells homozygous for the mutation (84).  This 
indicates that there are additional regions that contribute to the nuclear import of 
APC.  These may include other endogenous sites that contribute to APC’s import or 
indicate that APC is able to interact with other nuclear proteins that can facilitate its 
entry into the nucleus in the absence of APC’s endogenous NLSs. 
 
Inducible Apc mutations: The next generation of mouse models 
 The existing mouse models that carry Apc mutations almost always display 
embryonic lethality in the absence of wild type APC, most likely due to a role for 
APC in development.  Recently, due to advances in the technology for making knock-
out mice, APC mutations can be induced in adult mice.  This allows the observation 
of homozygous Apc loss in the fully developed mouse intestine.  One such mouse 
model is the APCΔ14 mouse, also referred to as APC580D mice (for mice containing the 
full length un-recombined gene) or APC580S mice (for the mice that have the 
recombined and therefore mutant gene resulting in a truncated APC protein) (95).  
Because the targeting vector used to create these mice utilized Lox P sites inserted 
around exon 14 of the genomic APC sequence, the mutation can be induced at any 
time using Cre recombinase.  When exposed to Cre, the DNA will recombine, 
removing the exon that is “floxed”, causing a frame shift that truncates APC at amino 
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acid 580.  In the absence of Cre the un-recombined gene will express normal protein.  
Mutant mice that are homozygous for the un-recombined gene are called APC580D/580D 
mice and are normal (95). They are not prone to intestinal polyps nor do the animals 
show any obvious phenotype.  However, the APC580D/580D mice display a 30% 
decrease in APC RNA as detected by northern blot in intestinal tissue (95).  The 
APC580D/580D mice were then crossed with an inducible Cre transgenic mouse (10).  
When exposed to β-napthoflavone, Cre expression was induced specifically in the 
intestine under the control of the Cyp1A promoter (10).  The APC truncation was 
induced when the mice were 8-10 wks of age and the Cre+APCfl/fl mice are visibly 
sick within 5 days, while the Cre+APC+/+ mice showed no symptoms of illness.  Mice 
homozygous for the induced APC truncation in the intestine developed a crypt-villus 
architecture that was noticeably altered so that a discrete crypt was no longer 
identifiable and all of the recombined tissue had a “crypt-like” appearance (10).  This 
crypt-like phenotype included cells that were more densely packed and therefore 
clearly distinguishable from normal tissue when stained with hematoxylin and eosin.  
There was a loss of histological markers for differentiated cells and an increased zone 
of proliferation that stretched up the entire crypt-like region instead of being confined 
to the lower mid-region of the crypt.  While staining did not show an overall increase 
in β-catenin, there was an increase in dephosphorylated β-catenin which was 
relocalized from the cytoplasm to the nucleus by the third day after induction of Cre 
expression.  Microarray analysis also showed a significant change in gene expression 
between the induced and uninduced tissue (10).  These data strongly indicate that the 
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function of APC is not only important for development and tumor suppression, but 
the maintenance of the gut as well.   
 
Altering expression levels: How much APC is enough? 
 By studying the phenotypes associated with mutations in the Apc gene, it has 
become apparent that the degree to which APC is truncated plays a role in 
determining the severity of the phenotype.  However, truncating the APC protein is 
not the only way to induce polyp formation.  Mouse models that affect only the level 
at which wild type APC is expressed can also have dramatic cellular affects.   In the 
APCNeoR mouse, a PGK-neo cassette was inserted into intron 13 of Apc through 
homologous recombination.  In these mice, the cassette is spliced out during RNA 
processing and only full-length mRNA was detected in the mutants (96).  However, 
the expression of APC protein from the mutant allele was attenuated.  Western 
immunoblot of cell lysate revealed that APC was expressed at only 60% of the WT 
level in cells heterozygous for this mutation, and in homozygous cells APC was 
expressed at only 20% of the WT level (96).  It was hypothesized that this attenuation 
was likely due to the disruption of an enhancer element.  Mice heterozygous for this 
mutation were viable and showed a limited polyposis phenotype.  At 15 months of 
age, the tumor incidence was 19% with the mean tumor number of 0.26 ±0.54 (97) .  
Histologically, the polyps consisted of dysplastic adenomas similar to those seen in 
other mouse models with mutant Apc.  Unlike polyps found in other Apc mutant mice, 
the dysplastic cells of the APCNeoR mice only rarely showed an accumulation of 
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nuclear β-catenin suggesting that nuclear β-catenin localization does not necessarily 
correlate with adenoma cell proliferation in this model (97).   In the ES cells there 
was a subtle increase in the amount of dephosphorylated and presumably stable β-
catenin present.  Heterozygous cells had nearly normal levels of β-catenin, while 
homozygous cells had 2.8 times the WT amount.  β-catenin protein level also 
correlated with the TOPFLASH measurements of β-catenin activity.  While 
heterozygous cells showed β-catenin transcriptional activity nearly identical to WT 
cells, homozygous ES cells showed an increase in β-catenin activity that measured 
about 7 times that of WT cells (97).  As is commonly seen in APC mouse models, 
heterozygous animals were born, however homozygous APCNeoR mice were not 
viable.  The observation that APCNeoR mice had a much less dramatic increase in β-
catenin activity and yet still displayed embryonic lethality when homozygous may 
suggest a function for APC in development beyond simply regulating Wnt signaling. 
  
A Mouse Model to Study the Role of APC in the Nucleus 
 Like the initial cellular studies of APC, the current mouse models focus 
primarily on the role of APC in the control of β-catenin and cellular proliferation.  
These mutant mice primarily reproduce various APC truncations associated with 
human disease and have shown in multiple studies that polyposis can indeed be 
reproduced in an animal model.  However, a comprehensive role of APC as a tumor 
suppressor still eludes us.  The role of APC in the nuclear compartment remains 
uncertain.  While evidence suggests that APC may play a role in the cellular 
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maintenance of DNA, the methods by which APC may carry-out such a task along 
with the exact nature of the task itself are enigmatic.  Fragments of APC which 
should lack nuclear import domains can still be observed shuttling into the nucleus; 
however, whether or not they are capable of carrying out any normal nuclear function 
is unclear because almost nothing is known about the domains of APC necessary for 
its nuclear tasks.  Perhaps most importantly we still have not established how the 
nuclear function of APC contributes to its role as a tumor suppressor. Currently this 
information is impossible to derive from the available mouse model systems and 
previous studies indicate that cellular phenotypes may not correlate with observations 
in a whole animal.  
In this dissertation we investigate the function of nuclear APC, both in cells 
and in an animal model.  We have generated an original mouse model in which the 
nuclear localization sequences have been specifically disrupted.  The resulting mouse 
expresses full length mNLS APC at normal levels under its endogenous promoter.  
APC is only minimally altered so as to preserve the cytoplasmic functions.  However, 
these mice lack the primary nuclear import sequences in APC which direct its 
interaction with importin-α (98).  We are using these APC mNLS mice to further our 
understanding the role of nuclear APC is whole tissue.   
In conjunction with the APC mNLS mice, we will also characterize the role of 
APC in DNA maintenance.  By exposing cultured epithelial cells to ultraviolet light 
to induce pyrimidine dimers and observing APC during the cellular response to DNA 
damage we hope to further define the role that APC plays in this process.   With these 
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model systems we will further delineate the function of APC in the nucleus to provide 
a better understanding of its role as a tumor suppressor.   
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CHAPTER 2 
GENERATION OF THE APC mNLS MOUSE:  
AN ANIMAL MODEL DEFECTIVE IN  
NUCLEAR IMPORT OF APC 
 
Abstract 
 To evaluate how nuclear APC is involved in the homeostasis of the intestinal 
epithelium, a mouse model with specific inactivating mutations in the nuclear 
localization signals (NLS) of Apc was generated.  In vitro, these mutations inhibit the 
nuclear import of APC protein (1).  The generation of a mouse model containing 
these NLS mutations in the endogenously expressed APC protein is described in this 
chapter. 
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Introduction 
The Innovation of Mouse Transgenics 
 The ability to generate transgenic mice has revolutionized the use of the 
mouse as a model organism.  The contribution of this technology to advancing 
scientific discovery has been so significant that the 2007 Nobel Prize in physiology or 
medicine was awarded to Drs. Capecchi, Evans and Smithies for their work 
developing the techniques that make murine transgenics possible.  These techniques 
enable an investigator to introduce specific mutations into particular genes of interest 
and study how those alterations influence growth, development and tissue 
maintenance in a whole-animal mammalian model system.  The process of creating a 
transgenic mouse involves a number of steps, each of which exploits the innate 
cellular machinery and properties of mouse embryonic stem cells. 
 The first mouse embryonic stem (ES) cells to be successfully grown in culture 
were isolated from the inner cell mass of the early embryo in 1981 (2, 3).   These 
pluripotent cell lines possess a number of unique properties that lend themselves to 
the creation of transgenic animals.  First, ES cells contain the capacity for nearly 
unlimited self-renewal in culture while maintaining a normal diploid genotype as well 
as their pluripotency (2, 3).  While this alone is enough to make mouse ES cells a 
valuable tool for tissue culture, their significance is further enhanced by their ability 
to undergo cellular process of homologous recombination.  Homologous 
recombination is an inherent method by which the cell can repair DNA damage by 
using the homologous undamaged allele on the sister chromatid (4).  Exploitation of 
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homologous recombination by introducing exogenous DNA with sequence nearly 
homologous to a gene of interest facilitates the insertion of engineered mutations into 
the targeted gene (5).  Using this method to precisely alter the genome allows 
investigators to produce ES cells of virtually any genotype.  ES cells altered in this 
way can be induced to undergo differentiation in culture to produce cell types of all 
three germ layers, allowing further exploration of the effect of the mutation on the 
cellular processes required in more differentiated tissues (2).  Moreover, genetically 
altered ES cells can be re-introduced into an early embryo where they colonize the 
tissues of the growing animal (6).  These exogenous cells, when injected into the 
hollow portion of young embryos, incorporate into the inner cell mass where they 
give rise to all of the cell types of the growing mouse, including the germ line cells 
(6).  In this way mouse lines can be created with specifically engineered genotypes, 
allowing investigators to collect information about the function of their gene of 
interest in a whole animal, information that would be impossible to obtain using 
tissue culture cells alone. 
 
The Process of Creating a Transgenic Mouse 
The first step in the creation of a transgenic mouse model is to specifically 
alter the genotype of mouse embryonic stem cells in culture.  This requires the design 
and creation of a gene replacement vector, a DNA plasmid which is then carried into 
the nuclear compartment via microinjection or electroporation (5).  This plasmid must 
contain all of the genetic material that needs to be introduced into the cells.  This 
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includes not only the sequences necessary to introduce a specific mutation via 
homologous recombination, but also the sequences that will allow subsequent 
selection and screening of the engineered ES cells.  Even under optimal conditions, 
the likelihood that a targeting vector will correctly alter the cellular DNA and give 
rise to the desired genotype is nearly 1 in 1000 (5).  For this reason, selectable 
markers, usually in the form of drug resistance genes, have become an essential 
component of DNA constructs used for targeted genetic manipulation.  Targeting 
constructs generally contain both a positive selector, and a negative selector, to select 
for cells that have incorporated the targeted sequence into the genome, and to select 
against random insertions, respectively (7). 
 While the initial elimination of incorrect recombinants using the incorporated 
selectable markers greatly reduces the number of cell lines that must be screened, it 
does not eliminate the need to verify that the remaining cells have undergone the 
desired recombination.  The early method of choice for screening the remaining 
potential cell lines was to use Southern blot analysis to verify that the desired 
mutation had been accurately introduced into the target gene (5).  More recently, 
however, it has also become common for investigators to use PCR as a method to 
screen and verify correct cell lines (8-10).   
 After cell lines that contain the appropriate mutation in their genome have 
been identified, those cell lines are further assessed to identify which of them are the 
most suitable for creating a mouse model.  At this stage, the ES cells have grown in 
culture, endured either microinjection or electroporation and have grown in selective 
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media (8).  These factors increase the probability that the cells have acquired 
additional genetic alterations, so an initial characterization of the cell lines is 
recommended before continuing on to the next steps in the process (8).   
It is very important that the cells injected into the blastocysts are euploid, so 
the candidate transgenic cell lines must be karyotyped to assure that they have 
maintained the correct number of chromosomes.  The possibility of random mutation 
in addition to the targeted mutation is another concern (11).  For this reason it is 
desirable to have multiple cell lines with the correct gene mutation, which allows the 
growth and phenotype of these duplicate lines to be compared to each other.  While it 
is possible that some of the cell lines may have additional mutations to the genome, it 
is unlikely that more than one cell line will have acquired the same random mutation. 
Though the phenotype of the transgenic cells might differ from the parental wild type 
(WT) ES cells, any altered characteristics not shared by the majority of the transgenic 
lines are likely due to random genetic alterations.  Cell lines displaying a dramatically 
different phenotype should not be used to make chimeric mice (11).  It is possible that 
random alterations may be subtle enough so as to present no noticeable effect at the 
level of the ES cells and must be eliminated at a later stage.  For this reason, once 
chimeric mice are generated multiple generations of breeding to mice from an inbred 
WT line ensures that the resulting mouse line is congenic, differing from WT only at 
the selected locus (12). 
 The cell line(s) that qualify for further investigation can be utilized in a 
number of ways.  The transgenic ES cells can be further evaluated in culture 
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employing the ability of ES cells to self-renew indefinitely as well as their potential to 
become a variety of more differentiated cell types.  In some cases, the transgenic 
cells, which are heterozygous for the desired mutation, are used in a second round of 
selection to produce cell lines that are homozygous for the targeted mutation.  
However, the main goal in creating ES cells is usually the production of a mouse line.  
For this procedure, early embryos are isolated from a pregnant female approximately 
3 days after mating.  At this phase, the embryo consists of a ball of cells called the 
blastocyst.  Within the ball is a hollow cavity known as the blastocoel and the inner 
cell mass made up of pluripotent embryonic stem cells (8).  Cells of the transgenic 
line that are microinjected into the blastocoel will incorporate into the inner cell mass 
(6).  These chimeric embryos are then implanted into a pseudopregnant female where 
they will continue to develop into chimeric mice.  The tissues of these chimeras, 
including the gonads, are made up of a mixture of both the endogenous stem cells of 
the original blastocyst and the transgenic stem cells introduced by microinjection(6).  
 Most ES cell lines used for genetic manipulation are derived from male 
embryos and therefore carry an X and a Y chromosome (11).  When these male cells 
are injected into an early embryo several outcomes may arise depending on the sex of 
the embryo and the number of transgenic cells that successfully incorporate into the 
inner cells mass.  When male transgenic cells are injected into a male embryo, the 
cells combine to form a male mouse (11).  The sperm cells of that mouse can be 
derived from either the transgenic cells or the endogenous cells of the embryo; 
accordingly the progeny will be a mixture of mice that are transgenic and mice that 
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carry only WT genomic sequence. When male transgenic cells are injected into a 
female embryo, the sex of the resulting mouse will be dependent on the level of 
incorporation of the transgenic cells.  If the male transgenic cells and female 
endogenous cells make up approximately equal portions of the resulting chimeric 
embryo, the mouse will display characteristics of both sexes and will likely be 
infertile.  If there are more of the endogenous female cells present, the mouse will 
display female sex characteristics only.  She may be fertile but will only rarely give 
rise to any transgenic progeny because the female stem cells, not the male transgenic 
cells, will give rise to the majority of the reproductive organs and germline cells of 
the female mouse.  However, if the embryo is female but the male transgenic cells 
contribute to more of the inner cell mass, the resulting mouse will be physiologically 
male and if fertile, will give rise to only transgenic progeny.  In this case the 
endogenous female stem cells will be unable to give rise to any portion of the male 
reproductive organs and germline cells, therefore all of the sperm will be derived 
from the targeted ES cells. 
 Progeny of the chimeric mice must be screened for the presence of the 
targeted mutation and mated with an inbred wild type mouse strain of choice.  This 
series of backcrosses is required because there is enough variation between mouse 
strains that it is seldom possible to distinguish more subtle effects of a targeted 
mutation from background differences between mice (12). To be sure that the 
phenotype being observed is a consequence of the targeted mutation with no 
contributions from other genes, it is essential that the mutant and WT mice differ 
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genetically at only the locus being targeted.  Mouse strains that have been bred with 
an inbred strain for multiple generations until they differ only in a selected 
differential chromosomal segment are called congenic strains.  Statistically, by the 5th 
generation of crosses the developing congenic line will be identical to the inbred line 
across 94% of the genome.  By the 10th generation that identity will have increased to 
99.8% of the genome at which point the mouse strain can be considered congenic 
(12).  This process not only eliminates the natural variations that exist between 
outbred mice, it also eliminates any genetic variation that may have been introduced 
during the electroporation and subsequent selection of the initial ES cell line used to 
create the mouse model. 
  
Materials and Methods 
Creating the Gene Replacement Vector 
 The homologous sequences of DNA used for this construct were obtained 
from a lambda phage library of genomic DNA isolated from mouse 129 ES cells 
(generously provided by Kirk Thomas and Mario Cappechi, University of Utah).  
This library was screened for fragments of Apc containing the primary Apc nuclear 
localization sites (NLSs).  Following identification of a correct plaque by 
hybridization to a radioactive probe, 14kb of mouse genomic DNA (Apc exons 14, 15 
and surrounding introns) were cloned from the phage and inserted into a pBluescript 
KSII+ vector (Stratagene).  An EcoRI fragment containing both NLSs was subcloned 
into a pUC19 vector where mutations that both inactivated the NLSs and introduced 
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novel restriction sites were inserted by PCR mutagenesis.  A second pUC19 vector 
was modified to destroy its EcoRI restriction site and introduce Nhe I and Not I sites.  
An 11,537 bp region of Apc (NheI/NotI) was then subcloned into this modified 
vector.  The EcoRI fragment of Apc containing the mutant NLSs was then introduced 
into this vector in place of the WT NLSs.  A neomycin resistance (Neor) gene driven 
by the promoter for RNA polymerase II and linked to a gene encoding Cre- 
recombinase driven by the testes-specific murine angiotensin-converting enzyme 
(tACE) promoter (13) made up the tACE-Cre-Neor cassette.  This cassette which was 
also flanked by two LoxP sites was introduced into the pUC19 vector containing the 
mNLS Apc gene fragment between restriction sites for KpnI and AflII in the non-
coding region 3’ of exon 15.    The HSV thymidine kinase gene driven by the PGK 
promoter was inserted upstream of the APC homology sequences in the pUC19 
vector to create the 19,947 bp targeting vector (Figure 2.1). 
 
Electroporation into Embryonic Stem Cells 
 Once completed, the targeting construct was linearized in a large scale 
digestion with Not I restriction endonuclease, to cleave the DNA at a unique site 3’ of 
the region homologous to Apc.  Digestion was followed by two phenol/chloroform 
extractions before the linear gene replacement vector was electroporated into R1 
mouse embryonic stem cells (14) at the Transgenic and Gene-Targeting Institutional 
Facility at The University of Kansas Medical Center.  Cells were selected for growth 
in 300μg/mL G418 (Cellgro) and 2μM ganciclovir (Roche).   Following 8-10 days of  
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Figure 2.1
A diagram of the targeting vector with the components labeled by color and the mNLS sites 
indicated in red. 
culture in selective medium colonies were picked and expanded into two separate 
wells.  DNA was isolated from one well for genotypic analysis and the cells in the 
remaining well were frozen in 96 well plates while the DNA was analyzed. 
 
Maintaining Stem Cells in Culture 
 Wild type and electroporated R1 mouse embryonic stem cells were received 
from the KU Medical Center and grown in ES media [81% High Glucose DMEM 
(Gibco), 15% Fetal Bovine Serum (ES cell certified from Hyclone), 1mM sodium 
pyruvate (Gibco), 0.1mM Non-essential amino acids (Gibco), 100ng/ml of ESGRO 
(Chemicon), 2mM L-glutamine (Gibco), 0.01mM 2-mercaptoethanol (Fisher)] in a 
37°C water jacketed incubator with 7% CO2.  Cells were split ~1:9 every 2 to 3 days 
as needed and plated directly on a mitomycin C-treated mouse fibroblast feeder layer. 
 
Screening ES cell lines 
 PCR was used to identify the correct recombinants.  Identification of ES cell 
lines containing mutations in APC NLSs was accomplished using a two step PCR 
screen and the following primer sets.  Step 1: to the WT NLS1 (5’-CTA AGA AAA 
AGA AGC CTA CTT CAC), to the WT NLS2 (5’-GGC CTT TTC TTT TTT GGC 
ATG GC), to the mNLS1 (5’-GCA GCC GCG GCA CCT ACT) and to the mNLS2 
(5’-TTG AAG GCC TTT TTG CGG CC) (Figure 2.2).  Step 2: to a portion of the 
LoxP/tACE promoter region of the tACE, Cre, Neo cassette (5’-CCT GGCC CCA 
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TGG AGA TCC AT) and to a region of genomic APC 3’ of the targeting construct 
(5’-CAT ACC ACC CAC CAT CCC TA) (Figure 2.3).   
 
Verifying the ES cell lines  
Cell lines that were determined to be correct homologous recombinants were 
further evaluated based on karyotype, growth rate and β-catenin transcriptional 
activity (See chapter 3 for a more detailed discussion of the analysis of the APC NLS 
mutation in cultured cells).  Prior to generation of chimeric mice, candidate cell lines 
were screened for the correct incorporation of the 5’ side of the targeting construct 
using PCR.  The primers to the mNLS2 and WT NLS2 previously described were 
used in conjunction with the following primer to a region of genomic DNA beyond 
the 5’ end of the targeting construct: (5’-AAA TTG AAC TCA GGA CCT TCT C) 
(Figure 2.4) 
 
Generation of Chimeric Mice 
 The first mutant stem cell line that was chosen based on criteria further 
described in Chapter 4.  For the generation of chimeric mice APC mNLS cells of the 
chosen line were injected into C57BL/6J blastocysts at the Gene-Targeting and 
Transgenic Facility at the University of Virginia. Chimeric mice were bred to 
C57BL/6J females.  Black progeny were culled and progeny with agouti coloring 
were genotyped using tail DNA (15) and PCR to screen for the presence of the 
mutant nuclear localization sites.  Verification of the loss of the selection cassette in  
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wtNLSs 900bp
mNLS 900bp
m wt m wt m wt m wt m wt m wt m wt m wt m wt -c
1          2           3          4           5           6           7    8            9       
A
B
Figure 2.2
Step 1 in the PCR screen for recombinant cell lines.  (A) A diagram of the targeting construct 
colored as in previous figure.  Locations of the primers to the mutant and WT NLSs are 
indicated along with the expected sizes of the amplification products.  (B) A representative 
0.7% agarose gel.  DNA products were visualized using ethidium bromide.  DNA extracted 
from 9 different cell lines was screened.  DNA from cell lines 2, 4, 5, 6 and 7 gave 
amplification products from both primer sets and so these lines were further screened.  DNA 
from cell lines 1, 3,7, 8 and 9 could only be amplified when primers specific to the wild type 
NLS were used.  These cell lines were assumed to lack one or both of the mutant NLSs and 
were discarded.  
Kbp
5
2
1
 A
B
TC cont. 2000bp
1          2            3           4           5           6          7           8          9       
Properly integrated 2500bp
TC PI TC PI TC PI TC PI TC PI TC PI TC PI TC PI TC PI -c
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Figure 2.3
Step 2 in the PCR screen for correct recombinant cell lines.  (A) A diagram of the targeting 
construct colored as in Figure 2.1.  Locations of the primers are indicated along with the 
expected sizes of the amplification products.  (B) A 0.7% agarose gel of the PCR reactions 
from all seven of the correct cell lines as well as two of the incorrect cell lines.  DNA 
products are visualized using ethidium bromide.  DNA was extracted from 9 different cell 
lines.  Cell lines 1-7 gave amplification products of the appropriate size from the primer 
extending into the genomic DNA sequence (PI).  Cell lines 8 and 9 were only able to amplify 
product when primers specific to sequence contained within the targeting construct, 
suggesting that the construct is present but is not integrated into the Apc locus.  These cell 
lines were discarded.  
Kbp
5
3
2
1
  
Sst II
wtNLS2 ~7000bp
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mNLS2 ~6100bp & 900bp
mNLS2 ~7000bp
digest with Sst II
Markers wtNLS2+ mNLS2+ NLS2+
5’APC     5’APC 5’APC
Sst II digest
Figure 2.4
The PCR strategy to verify that the 5’ end of the targeting construct had correctly 
incorporated into the APC gene.  A diagram of the targeting construct colored as in 
Figure 1.1 shows the location of the primer sets used. A primer specific to the wtNLS2 
and a primer specific to the mNLS2 were used in conjunction with a common primer 
specific to a region of the APC gene outside of the targeting construct.  The WT and 
mutant primer sets amplified a large region of DNA spanning a 7000bp piece of the WT 
genome or the 5’ end of the targeting construct respectively.  Genomic DNA was isolated 
from mutant and WT ES cells.  The PCR products are shown resolved on an 0.7%  
agarose gel and visualized with ethidium bromide.  PCR products from the mutant and 
WT primers amplified a product of the correct size and the far right lane shows the 
mutant product after digestion with Sst II to verify the presence of mNLS1 within the 
PCR product.
Genomic
DNA
7kb
6.1kb
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Cre 700bp
removable 
selection
cassette
mNLS wtNLS Cre mNLS wtNLS Cre mNLS wtNLS Cre
WT ES cells                   mNLS ES cells           F2 mNLS mouse
A
B
Figure 2.5
The PCR strategy to verify the excision of the selection cassette in the mNLS progeny. 
(A) A diagram of the targeting construct colored as in Figure 2.1. Location of the PCR 
primers sets are indicated along with the expected sizes of the PCR products. (B) A 
representative 0.7% agarose gel stained with ethidium bromide showing PCR products 
from each of the primer set for DNA isolated from WT R1 stem cells, APC mNLS stem 
cells, or tail DNA from a heterozygous mNLS mouse (generation F2).
wtNLSs 900bp
mNLSs 900bp
the APC mNLS progeny was conducted using PCR and the following primers:  
Forward primer, 5’-TCG GCC ATT GAA CAA GAT GGA-3’ and Reverse primer, 
5’-ATT CGC CGC CAA GCT CTT CA-3’ (Figure 2.5). 
 
Mouse Husbandry 
 Mice were maintained in the University of Kansas Animal Care Unit 
according to animal use statement number 137-01.  The chimeric progenitor mice as 
well as offspring that carry the mutant copy of Apc were crossed with C57BL/6J mice 
from Jackson Labs to create a congenic line. 
 
Results 
Introduction of the mNLS Apc to ES cells 
 A gene targeting vector was generated to introduce specific point mutations 
into both primary nuclear localization signals of APC in ES cells (Figure 2.1).  The 
targeted mutations alter a total of six amino acids, four in NLS1 and two in NLS2 
(Figure 2.6A).   
These mutations exchange the basic lysine and arginine residues for neutral alanine 
residues and thus destroy their ability to interact with importin-α and target full length 
APC to the nucleus (1).  These mutations do not affect the SAMP binding domains as 
the ability of APC mNLS to interact with axin/conductin is unaffected (unpublished 
observations of Neufeld and White).  These point mutations also introduce two novel  
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human APC     NLS1 GKKKKP         NLS2 PKKKKP
mouse APC     NLS1 TKKKKP         NLS2 PKKKRP
mNLS APC mNLS1 TAAAAP       mNLS2 PAAKRP
.SstII/SacII .
mNLS1  ACT GCT GCC GCG GCA CCT
T       A      A      A       A P 
NLS1 ACT AAG AAA AAG AAG CCT
T      K       K      K      K     P
. EagI .
mNLS2 CCG GCC GCA AAA AGG CCT
P       A      A K       R      P
NLS2 CCA  AAA AAG AAA AGG CCT
P       K      K      K      R      P  
A
B
Figure 2.6
The APC mutations knocked-in to the endogenous Apc.  (A)The amino acid sequences of 
the NLSs in the human and mouse APC proteins as well as the mutant NLSs used in the 
targeting construct.  The amino acid changes made in the targeting vector are indicated in 
red. (B) The nucleotide sequences of the genomic mouse APC NLSs 1 and 2 and the 
nucleotide changes implemented to inactivate the nuclear localization signal and introduce 
novel restriction sites.  Restriction sites are indicated in blue and purple.  The amino acids 
are labeled below each line of nucleotides with altered amino acids in red.  Underlined 
nucleotides in the genomic sequence represent the base pairs that were mutated in the 
targeting construct.
restriction sites into the genomic sequence, inserting Sac II and EagI sites into NLS1 
and NLS2 respectively (Figure 2.6B).   
The targeting vector contains an 11.5 kb genomic Nhe I/ Not I fragment 
encompassing exons 14 and 15 of Apc as well as the surrounding introns. The 
decision to use at least 10kb of homologous sequence was based on work by Thomas 
and Capecchi showing that the gene-target efficiency relative to the frequency of 
random integration was based on the extent of the homology between the exogenous 
and endogenous genomic sequences (5). With greater than 10kb of homologous DNA 
in the targeting vector, the ratio of correct recombinants should be greater than 1 in 
1000 (5).    
To facilitate selection of recombined cell lines with G418, a Neor gene under 
the control of the constitutive promoter responsible for the expression of RNA 
polymerase II was also incorporated into the targeting construct.  Others have shown 
that integration of a strong promoter into Apc gene sequence can adversely affect the 
expression level of APC in vivo (10, 16, 17).  Therefore, to be certain that the only 
effects on APC function were the result of the mutations being introduced, the Neor 
gene was removed before evaluation of the phenotype in a whole animal. To 
accomplish this, a germ-line-induced self-excision cassette was employed (13).  A 
floxed Cre recombinase/Neor cassette was inserted into the non-coding homologous 
sequence 3’ of the last Apc intron.  In mice the tACE promoter initiates transcription 
of Cre-recombinase during spermatogenesis, which induces Cre-mediated self-
 
 
72
excision of the selectable marker in the germ line of the transgenic animals leaving 
only one 34bp minimal LoxP element in the last Apc intron.   
Further screening was required to distinguish homologous recombinants from 
cells that have taken up the Neor cassette through random integration of the plasmid.  
This negative selection against random events was accomplished by inserting the 
thymidine kinase gene from the herpes simplex virus at one end of the targeting 
construct. (18).  Unlike homologous recombination, non-homologous insertion 
incorporates the ends of a linearized DNA plasmid (19).  When this occurs the tkHSV 
gene is also incorporated into the genome (18).  Expression of tkHSV results in a cell 
that is sensitive to ganciclovir.  Unlike the endogenous form of thymidine kinase, 
TKHSV is able to triphosphorylate various nucleoside analogues such as ganciclovir.  
Ganciclovir triphosphate is incorporated into the DNA strand being synthesized, 
halting chain elongation and ultimately resulting in cell death (18, 20).   
 
Screening ES cells for targeted recombination 
In total, 161 G418-resistant, ganciclovir insensitive ES cell clones were received from 
the Transgenic and Gene-Targeting Institutional Facility at the University of Kansas 
Medical Center (Table 2.1A and B).  While the initial screening with selective media 
greatly enhances the ratio of correct recombinants, it only selects for cells that have 
incorporated the Neor cassette without incorporating the tkHSV gene.  This selection 
does not distinguish between correct recombinants and cells that have recombined so 
that they contain just the Neor gene along with only one or neither of the mNLSs.  It  
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Table 2.1A The PCR screening results for the cell lines from the first round of 
targeting
Cell line KUmed name mNLSs+ Cre 
KN1 PK1 I A1 No
KN2 PK1 I A2 Yes Yes
KN3 PK1 I A3 Yes No
KN4 PK1 I A4 Yes No
KN5 PK1 I A5 No
KN6 PK1 I A6 No
KN7 PK1 I A7 No
KN8 PK1 I A8 Yes No
KN9 PK1 II A1 No
KN10 PK1 II A2 Yes No
KN11 PK1 II A3 Yes No
JC1 PK1 I C4 No
JC2 PK1 I C3 No
JC3 PK1 I C2 Yes No
JC4 PK1 I C1 Yes No
JC5 PK1 II C3 Yes No
JC6 PK1 II C2 No
JC7 PK1 II C1 Yes No
JC8 PK1 I D4 No
JC9 PK1 II B1 No
JC10 PK1 II B2 Yes No
JC11 PK1 II B3 Yes No
JC12 PK1 II D1 No
JC13 PK1 II D3 Yes No
JC14 PK1 I D1 No
JC15 PK1 I D2 No
JC16 PK1 I D3 No
JC17 PK1 A12 No
JC18 PK1 I B1 Yes No
JC19 PK1 I B2 No
JC20 PK1 I B3 Yes No
JC21 PK1 I B4 Yes No
JC22 PK1 I B5 Yes No
JC23 PK1 B7 Yes No
JC24 PK1 B11 Yes No
JC25 PK1 A9 Yes No
JC26 PK1 A10 Yes No
JC27 PK1 A11 No
Cell lines highlighted in grey failed the first round of screening were not screened in the 
second round.  They amplified a WT band but not a Mutant band.  Cell lines in white 
failed the second round of screening.  They did not amplify a correct Cre band.  Cell lines 
highlighted in yellow passed both rounds of screening and were characterized further (see 
Chapter 4 for details).
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Table 2.1B The PCR screening results for the cell lines from the second round of targeting
Cell line KUmed name mNLSs+ Cre Cell line KUmed name mNLSs+ Cre
ES1 PK2I C11 Yes Yes ES66 PK2II B1 No
ES2 PK2II A5 No ES67 PK2II D3 No
ES3 PK2II B1 Yes No ES68 PK2III D7 No
ES4 PK2I E4 No ES69 PK2III C5 Yes No
ES5 PK2I C1 Yes No ES70 PK2I B10 Yes No
ES6 PK2I E1 Yes No ES71 PK2I E5 Yes No
ES7 PK2I D6 No ES72 PK2III D5 Yes No
ES8 PK2I A5 Yes No ES73 PK2I A7 Yes No
ES9 PK2III B2 No ES74 PK2I D1 Yes No
ES10 PK2III B7 Yes No ES75 PK2I D9 Yes No
ES11 PK2II D2 Yes No ES76 PK2I E3 Yes No
ES12 PK2II A2 Yes No ES77 PK2I E6 Yes No
ES13 PK2II D6 No ES78 PK2II C1 Yes No
ES14 PK2III C6 Yes No ES79 PK2III B4 Yes No
ES15 PK2I G2 Yes No ES80 PK2I B2 Yes No
ES16 PK2II A4 Yes No ES81 PK2III B5 Yes No
ES17 PK2II C2 Yes Yes ES82 PK2III B5 Yes No
ES18 PK2III C4 Yes No ES83 PK2I B3 Yes No
ES19 PK2I C2 Yes No ES84 PK2III B6 Yes No
ES20 PK2I E2 No ES85 PK2II C4 Yes No
ES21 PK2I G4 Yes No ES86 PK2I B7 No
ES22 PK2I C4 No ES87 PK2I G6 Yes No
ES23 PK2I A4 Yes No ES88 PK2I A8 Yes No
ES24 PK2II B4 Yes No ES89 PK2III C2 Yes No
ES25 PK2I D4 Yes Yes ES90 PK2I D11 Yes No
ES26 PK2III A6 No ES91 PK2I D10 Yes No
ES27 PK2I A2 No ES92 PK2I C10 No
ES28 PK2II A3 Yes No ES93 PK2III C3 Yes No
ES29 PK2I D2 No ES94 PK2I F5 Yes No
ES30 PK2I F3 Yes No ES95 PK2I A10 Yes Yes
ES31 PK2II A1 Yes No ES96 PK2I A6 Yes No
ES32 PK2II D7 Yes No ES97 PK2I B1 No
ES33 PK2III A3 No ES98 PK2II B3 Yes No
ES34 PK2III B1 No ES99 PK2II C8 Yes No
ES35 PK2I F4 Yes No ES100 PK2III C1 Yes No
ES36 PK2II B5 Yes No ES101 PK2III B3 Yes No
ES37 PK2II B2 No ES102 PK2I D8 No
ES38 PK2I H2 Yes No ES103 PK2I A3 Yes No
ES39 PK2I F1 Yes No ES104 PK2I B8 Yes No
ES40 PK2II C5 Yes No ES105 PK2III D1 Yes Yes
ES41 PK2II B6 Yes No ES106 PK2II A6 Yes No
ES42 PK2I D3 Yes No ES107 PK2I B9 No
ES43 PK2II C6 Yes No ES108 PK2II A7 Yes No
ES44 PK2II D1 Yes No ES109 PK2I A1 Yes No
ES45 PK2II B8 Yes No ES110 PK2I F6 No
ES46 PK2I C12 No ES111 PK2I B6 Yes No
ES47 PK2II D5 No ES112 PK2I C5 Yes No
ES48 PK2II D4 No ES113 PK2I D11 No
ES49 PK2I B4 No ES114 PK2III A7 Yes No
ES50 PK2III A4 Yes No ES115 PK2I H5 No
ES51 PK2I A12 No ES116 PK2I C9 No
ES52 PK2I H6 No ES117 PK2I C6 Yes No
ES53 PK2III A5 Yes No ES118 PK2I H4 Yes No
ES54 PK2I A9 No ES119 PK2I C7 No
ES55 PK2I A11 Yes No ES120 PK2I B11 No
ES56 PK2III D2 No ES121 PK2I H3 Yes Yes
ES57 PK2I C3 Yes No ES122 PK2I C8 Yes No
ES58 PK2I D7 Yes No ES123 PK2II A8 Yes Yes
ES59 PK2II B12 No ES124 PK2III D6 No
ES60 PK2I F2 No ES125 PK2I B5 No
ES61 PK2I G3 Yes No ES126 PK2II C7 No
ES62 PK2III A1 No ES127 PK2I G1 Yes No
ES63 PK2I G5 No ES128 PK2III D3 Yes No
ES64 PK2I D5 Yes No ES129 PK2II C3 No
ES65 PK2III C7 Yes No ES130 PK2III D4 Yes No
ES131 PK2I H1 Yes No
also allows for the growth of cells that have incorporated the targeting vector 
randomly but have lost tkHSV expression through other means.  To identify which of 
the remaining cell lines were correct recombinants, the clones were screened using 
PCR.   
Identification of ES cell lines containing mutations to the endogenous NLSs 
was accomplished using a two step PCR based screen.  In the first step, DNA 
extracted from the transgenic cell lines was used in two separate PCR reactions.  
Primers for the first reaction were specific for the wild type APC NLS1 and NLS2 
genomic sequences and amplified a product from the wild type APC allele.  Primers 
for the second reaction were specific for the mutant NLS1 and NLS2 sequences from 
the targeting construct and amplified a product from the inserted mutant sequence 
(Figure 2.2A).  Amplification from the wild type allele was detected for all cell lines 
verifying that all targeted cells retained at least one WT allele of APC.  While it was 
possible that both alleles of APC homologously recombined with the gene 
replacement vector in a single ES line, this is an unlikely outcome, and was not 
observed in this screen.  The WT reaction therefore served as a positive control for 
successful DNA isolation. Candidate cell lines in which one of the APC alleles was 
successfully targeted would also produce an amplification product in the mutant PCR 
reaction utilizing the primers specific to the targeted mNLSs. Therefore candidate ES 
cells in which a band was amplified from both the wild type and the mutant NLS 
primers were further screened to verify that the mutations had incorporated into the 
endogenous Apc gene (Figure 2.2B).   
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Because the conditions used for the initial PCR screen would amplify product 
from the mutant reaction regardless of where the mutations were inserted into the 
genome, the second step of the PCR screen was carried out to verify that the knock-in 
mutations had incorporated into the Apc locus.  This step of the screening process was 
carried out using a primer homologous to a portion of the LoxP/tACE promoter 
region of the Cre/Neo selection cassette and primer specific to a region of genomic 
APC sequence that should be 3’ of the targeting construct if it had incorporated into 
the Apc gene.  A second reaction used the same LoxP/Cre specific primer along with 
a second primer homologous to sequence located within the targeting construct 
(Figure 2.3A).    This PCR reaction served as a positive control because all cell lines 
that passed first step of screening should contain the targeting construct.  It was 
observed, however, that incorrect incorporation of the gene replacement vector did 
not always preserve the ends of the construct.  A number of the cell lines gave no 
PCR product for either reaction.  Amplification a 2.5 Kbp region of DNA 
encompassing the 3’ side of the targeting construct and a region of the adjacent 
endogenous genomic sequence indicated the targeting construct inserted accurately 
into the Apc gene (Figure 2.3B).  The cell lines that failed either step of the screen 
were discarded and the remaining cell lines were thawed and expanded by the 
Transgenic and Gene-Targeting Institutional Facility at The University of Kansas 
Medical Center.  The results of both phases of the screen are summarized in Tables 
2.1A and 2.B). 
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The initial screen, used to identify cell lines that carried both of the mutant 
NLS sequences, revealed that 107 of the ES clones (>66%) incorporated both mNLS 
in addition to the Neor cassette somewhere in the genome.  These candidates were 
then further screened for cell lines in which the targeting construct had incorporated 
correctly into the endogenous Apc gene.  Eight of the ES cell clones (~5%) gave 
amplification products indicative of correct placement of the targeting construct in the 
context of the genome.  Of these 8 cell lines, 7 cell lines survived the freeze/thaw 
process to be expanded and further evaluated (Table 2.2).  Three of these cell lines 
showed growth patterns and/or β-catenin transcriptional activity that were divergent 
from the majority.  These 3 cell lines were eliminated from consideration for further 
study.  The 4 remaining cell lines were extensively karyotyped.  The chromosomes of 
40 to 50 individual cells were counted for each cell line, revealing that two of the cell 
lines had abnormal karyotypes in over 25% of the cells screened.  These were also 
eliminated from consideration for further study.  Finally, a PCR reaction that 
amplified over 6500bp of DNA extending from mNLS2 past the 5’ end of the 
targeting construct revealed an amplification product identical in size to the product 
produced when the same reaction was performed using a primer to the wtNLS2 
(Figure 2.4).  This confirmed that there was no major loss or addition of DNA during 
recombination and that the 5’ region of the targeting construct had integrated 
properly.  When the products from this PCR reaction were incubated with Sac II 
restriction endonuclease, the mutant, but not the WT product showed cleavage of the 
DNA strand, verifying that the mNLS1 was also present in the amplified region  
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Table 2.2 Screening the targeted ES cell lines.
Stage of screening Number of cell lines % of total cell lines
Survived on selective 
media 161 100%
Contained both 
mNLSs (Step 1 PCR) 107 66%
Targeting construct 
correctly integrated 
(Step 2 PCR)
8 4.90%
Survived freeze/thaw 7 4.30%
(Figure 2.4 and data not shown).  The first cell line to complete this final 
confirmation step (ES121-PK2I-H3 from Table 2.1B) was sent to the Gene Targeting 
and Transgenic Facility at the University of Virginia where the targeted APC+/mNLS 
ES cells were injected into C57BL/6J blastocysts to generate chimeric mice.  A 
second ES cell line (KN2-PK1 I A2 from Table 2.1A) was sent for chimeric mouse 
generation at a later date.   
 
Generation of the mNLS mouse line 
Eleven chimeric mice, 4 females and 7 males, were received from the Gene-
Targeting and Transgenic Facility at the University of Virginia.  All chimeric mice 
showed substantial agouti coat coloring indicating that there was significant 
contribution from the transgenic stem cells (agouti color) to the otherwise black-
haired animals.  The chimeras were crossed with C57BL/6J mice from Jackson Labs 
(Bar Harbor, Maine).  Because the 129/Sv-CP mice from which the R1 transgenic ES 
cells were originally derived carry a dominant gene for agouti coat color, any F1 
offspring carrying transgenic DNA will be agouti while the pups that carry only genes 
from the original C57BL/6J blastocyst will be black.  As expected two of the female 
mice proved to be infertile were unable to pass the mutation through the germline and 
the other two produced only black pups.  Four of the male chimeras also produced 
only black pups suggesting low incorporation of the APC mNLS ES cells in the germ 
line.  The remaining three chimeric males produced only agouti offspring.  Because 
the transgenic ES cells were APC+/mNLS, only half of the agouti progeny are expected 
 
 
80
to carry a mutant copy of APC.  All F1 agouti pups were therefore screened for the 
presence of the mNLS using the PCR primers previously described (Figure 2.2A).  
Pups that tested positive for the presence of APC mNLS were either crossed with 
C57BL/6J mice to continue towards a congenic line or were crossed with other 
heterozygous siblings in an attempt to produce homozygous animals. 
 
Transgenic mice do not carry the Neor/Cre selection cassette 
 In the APC1638N mouse model, a Neor selection gene was inserted in exon 
15 of the Apc gene (21).  This insertion resulted in a dramatic decrease in the 
expression of the mutant protein (22).  Because the Neor  gene was oriented so in the 
reverse orientation compared to the Apc gene, it was hypothesized that the strong 
promoter driving the Neor expression interfered with the expression of the Apc gene 
product (22).  A second mouse model, in which the Hygr gene was oriented the same 
direction as the Apc gene, showed normal expression levels from the mutant allele 
(17, 22).  In the APC NeoR and APC NeoF mouse models a Neor gene was inserted 
into the non-coding sequence of intron 13 and resulted in a similar repression of APC 
expression.  In these mice the mutant allele expressed APC at only 10-20% of the WT 
level.  Furthermore, this repression occurred when the selection cassette was inserted 
into the gene in either the forward (NeoF) or the reverse (NeoR) orientation (10, 16).  
Although the selection cassette used to create the APC mNLS mutant stem cells was 
not inserted into a coding region of APC as it was in the APC 1638N mouse model, it 
is in the reverse orientation compared to the Apc gene.  Knowing that the selection 
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cassette has the potential to adversely affect APC expression, the linear targeting 
vector was designed so that the Neor gene and promoter could be removed from the 
genome once selection of the correct ES cell lines was complete.   
The removal of the Neor gene and promoter is accomplished through the 
insertion of Lox P elements around the selection cassette (Figure 2.1).  In the 
presence of the DNA recombinase Cre there is a directed self-induced deletion of the 
sequence between these two Lox P elements (13).  The result is a single Lox P 
sequence 34 bp in length which remains in the genome, and the removal of the entire 
selection cassette.  To facilitate the removal of the selection cassette in the mouse 
model, the Cre gene, under the control of a testes-specific promoter, was included in 
the selection cassette which was flanked by the Lox P sites.  In the chimeric males the 
cassette will be maintained in the somatic cells, but recombination occurs in the ES-
cell-derived sperm (13).  Therefore all of the APC mNLS progeny from the chimeric 
mice will carry the recombined gene without the Neor/Cre expression cassette.   
The absence of the Neor/Cre selection cassette was verified by PCR analysis 
of genomic DNA isolated from several of the heterozygous mNLS mice in the F1 and 
F2 generations.  Genomic DNA isolated from WT and knock-in mNLS ES cell lines 
was used as negative and positive controls, respectively.  Parallel PCR reactions using 
primers specific to the wtNLS and mNLS sites were preformed to verify that the 
mouse being screened carried the APC mNLS mutation and that an absence of PCR 
product was not due to poor DNA quality.  As expected, primers specific to the WT 
APC NLSs amplified a product of the correct size from all DNA samples.  DNA 
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isolated from the knock-in ES cells and the F2 APC mNLS+/- mouse also produced a 
strong PCR product in the presence of primers specific to the APC mNLSs.  Primers 
within the Neor/Cre selection cassette amplified product from knock-in ES cell 
genomic DNA, but this amplification product was absent in a similar reaction using 
genomic DNA isolated from the mNLS mouse (Figure 2.5).  PCR amplification using 
primers specific for the selection cassette was never achieved with any of the APC 
mNLS progeny, confirming that the NeoR/Cre cassette was correctly excised in the 
mouse model.  
 
Mice homozygous for APC mNLS are viable 
 The homozygous mutant animals of many APC mouse models display early 
embryonic lethality.  However, the APC-mNLS mutation results in a comparatively 
subtle alteration to the APC protein.  The role of nuclear APC in development is 
generally unknown; therefore, it was of particular interest to see if this mutation 
would result in prenatal mortality.  When mice heterozygous for the APC mNLS 
mutation were bred together, homozygous mice were obtained at a frequency 
expected based on Mendelian genetics (Table 2.3).  Mice up to generation F5 show 
no noticeable growth retardation or difference in the lifespan of the homozygous mice 
when compared to their WT littermates.  Furthermore, homozygous mice are fertile 
and give birth to litters of typical size.  The regular growth of homozygous animals 
suggests that the normal nuclear localization of APC is not essential during 
development.      
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Table 2.3 
The progeny of the APC mNLS chimeric mice.  The table covers the F1-F5 litters.  The APC 
mNLS+/- x APC mNLS+/- portion of the table summarizes the sex and genotypes of the litters 
born to APC mNLS heterozygous mice bred to APC mNLS heterozygous siblings to produce 
litters containing all three APC NLS genotypes.  The APC mNLS+/- x APC wt portion of the 
table summarizes the litters born to APC mNLS heterozygous mice crossed with C57BL/J6 wild 
type mice.
APC +/+ APC +/- APC -/- APC +/+ APC +/-
Male 20 27 23 70 31 32 63 133
Female 15 21 17 53 38 35 73 126
Total 35 48 40 123 64 72 136 259
Expected 31 61 31 123 68 68 136
χ² value
p value
0.471
0.4927
5.9
0.0524
APC mNLS+/- x APC mNLS+/- APC mNLS+/- x APC wt
TotalTotal Total
Discussion 
 Adenomatous polyposis coli is a large multifunctional protein that serves as a 
tumor suppressor both in humans and in animal models.  Typical disease-associated 
forms of APC are truncations lacking the C-terminal region of the protein.  
Truncation of APC at different sites results in varying phenotypes, supporting a 
model in which APC maintains tissue integrity and suppresses tumor formation 
through numerous cellular pathways.  While a role for APC in canonical Wnt 
signaling has been established, other cellular functions for APC, including its role in 
the nuclear compartment, have only begun to be explored.  
 Part of the difficulty in establishing a better, more comprehensive picture of 
APC’s multiple cellular roles, is finding a suitable model system.  While studies 
concerning various individual domains of APC have been conducted in cultured cells, 
fully understanding APC’s role in tissue maintenance ultimately requires a more 
complex model.  The mouse has been the primary model organism associated with 
the study of APC to date.  The mouse contains an intestinal epithelium that is similar 
in structure to human intestine, allowing the study of APC in development, 
maintenance and prevention of tumorigenesis in this tissue.  It has been shown in 
numerous mouse models that the human disease FAP, caused by the heterozygous 
truncation of APC, can be recapitulated in this model system.   
Unfortunately, the current APC mouse models primarily truncate the APC 
protein or inhibit expression of the endogenous gene product.  While this effectively 
results in a tumorigenesis phenotype, this type of modification does not allow detailed 
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analysis of the various functional domains of APC or how they sustain homeostasis 
within the intestinal epithelium.  Ideally, to separate and define the individual 
responsibilities of the APC protein, domains required for specific pathways must be 
inhibited without eliminating domains required in other cellular activities.  
 Using established techniques we have successfully knocked in an APC 
mutation in mouse embryonic stem cells that targets the nuclear localization 
sequences of the endogenous Apc gene.  These cell lines were used to generate 
chimeric mice, three of which produced progeny heterozygous for the APC mNLS 
genotype.  The creation of a mouse model with specific point mutations in the Apc 
gene is unique to this field.  The specific loss of nuclear shuttling mediated by the 
endogenous NLSs allows us to better define the tasks that APC performs in the 
nuclear compartment without inhibiting its cytoplasmic responsibilities.  The role of 
APC in the nucleus is currently poorly understood.  With this mouse model we intend 
to further delineate the nuclear function of APC and determine how that function 
contributes to the overall tumor suppressor function of the protein. 
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CHAPTER 3 
 
INITIAL CHARACTERIZATION OF THE 
APC mNLS MOUSE MODEL 
 
 
Abstract 
 
 We have generated a mouse line that carries specific point mutations in the 
NLSs of the endogenous Apc gene.  To fully characterize the phenotype of these mice 
requires the production of a congenic line.  This chapter describes the ongoing 
process of generating the congenic APC mNLS line, as well as the preliminary 
characterization of the APC mNLS phenotype in the non-congenic mice.  An analysis 
of APC localization in the small intestinal epithelium showed little to no difference in 
the subcellular targeting of APC in the APC mNLS mutant mice.  A slight defect in 
the nuclear targeting is visible in the colonic epithelium, however.  There is also 
preliminary evidence of a role for APC in the regulation of intestinal lymphoid tissue 
that is altered by mutation of the APC NLSs. 
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 Introduction 
 The need for inbred, genetically homogenous lines of mice was recognized in 
the early 1900s.  Clarence Little began production of the first inbred mouse line in 
1909, and he and his associates are responsible for the development of some of the 
most well known mouse lines in use today including the CBA, BALB/c and C57BL/6 
mouse lines (1).  There are now thousands of inbred and standardized mouse lines 
available.  The Jackson Laboratory distributes over 3,500 inbred strains of laboratory 
mice (2).  The current availability of standardized strains is one of the advantages of 
working in a mouse model system.  The introduction of inbred mice allowed research 
conducted in any laboratory to be compared with research conducted using mice of 
the same background strain in any other laboratory, even if the work was conducted 
halfway around the world or decades earlier.  Working with inbred strains of mice 
also eliminates the variability in development and physiology that is associated with 
outbred mice, allowing the more subtle effects of a targeted mutation to be revealed 
(1). 
 If a single new mutation occurs within a strain of mice that is already inbred, 
then the mutant and wild type animals are said to be coisogenic (identical across the 
entire genome with the exception of the mutant locus).  For a variety of reasons the 
mouse strain in which the mutation was initially created may differ from the mouse 
strain in which the mutation will be studied.  For example, targeting a specific 
mutation into the mouse genome begins with the mutation of ES cells in culture (3, 
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4). Most ES cell lines have been derived from the 129/SvJ mouse strain (5).  To study 
the new mutation in a different mouse strain therefore requires the creation of a 
congenic strain.  This is accomplished by breeding mice that carry the targeted 
mutation with mice from an inbred strain until it is essentially isogenic except at a 
selected differential chromosomal segment and therefore it approximates a coisogenic 
strain to the greatest extent possible (1).  To be considered congenic a mouse line 
must be identical to the inbred line across 99.8% of the genome; mathematically, this 
occurs after being bred with mice of the inbred line for 10 generations (6).  Once 
congenic, the mice that carry the targeted mutation can be directly compared to the 
WT mice of the parental line.  If mice homozygous for the desired mutation are viable 
and fertile, the mutation can be maintained by breeding homozygous mice, which 
eliminates the labor intensive step of tagging and genotyping every litter.  
Furthermore, once congenic, the mice can be bred with other congenic mouse models 
of the same strain to generate animals that carry multiple targeted mutations(1).  This 
allows the interaction of two or three mutant proteins to be examined in a live animal.  
Because it is most efficient if these matings occur with other mice that are congenic 
and are the same strain, it important to consider which background lines will allow 
the best evaluation of the targeted mutation when choosing to generate a congenic 
mouse line. 
 Developing a congenic line is a time consuming process.  With a 19-21 day 
gestation period and 5-7 weeks to reach sexual maturity, the generation time for a 
mouse is effectively 10 weeks.  This process, from the birth of the chimeric mice to 
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the birth of the first litter of congenic mice ten generations later, requires roughly two 
years.  For this reason, it is not uncommon to begin a preliminary analysis of the 
phenotype of the mutant animals in the earlier generations (6-8).  While the earlier 
generations would be too dissimilar from the inbred WT line for more subtle effects 
of the mutation to be reliably detected, some phenotypes might be observable at this 
stage.  However, even obvious phenotypes must be pursued carefully.  The process of 
making a congenic line also serves to eliminate any additional mutations induced 
during the process of creating the mutant ES cells (5).  Because these untargeted 
mutations may not be entirely eradicated in the earlier generations of mice, it is 
difficult to be certain that a given phenotype is the result of the targeted mutation 
until that phenotype is observed in the fully congenic line.  Because any non-targeted 
mutations would be expected to appear at a similar frequency in the WT and mutant 
animals, littermates of the mutant animals, rather than the inbred WT mice, were used 
as the controls when conducting experiments using non-congenic animals.   
The APC mNLS mouse line is currently at generation F6 towards becoming a 
fully congenic line with the C57BL/6J background.  In the interim we have begun 
analyzing the F1-F5 generations of mice. The APC NLS mutations were designed to 
block the nuclear import of APC without affecting other functions or the expression 
of endogenous APC.  It was therefore important to verify that full length APC was 
expressed at the correct level in intestinal tissue and to evaluate the localization of the 
mutant APC protein.  Another area of focus for preliminary characterization was the 
oncogene β-catenin.  Because one of the established functions of APC involves the 
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regulation of β-catenin levels, the level and localization of the β-catenin protein in the 
intestinal epithelium was of particular interest (9).  Finally, to further characterize the 
tumor suppressor function of nuclear APC, proliferation of the intestinal epithelium, 
average lifespan of the mice and the gross intestinal histology were examined in the 
early pre-congenic generations. 
 
Materials and Methods 
Mouse Husbandry 
 Mice were maintained in the University of Kansas Animal Care Unit 
according to animal use statement number 137-01.  The chimeric progenitor mice as 
well as offspring that carry the mutant copy of Apc were bred with C57BL/6J mice 
from Jackson Labs (Bar Harbor, Maine) to generate a congenic line.  Detailed records 
including the date of birth, lineage, coat color, sex, genotype and date of sacrifice 
were maintained for each pup.  For the survival curve the male and female mice were 
housed with same sex siblings rather than individually, which resulted in a fairly even 
mixture of APC mNLS+/+, APC mNLS+/- and APC mNLS-/- mice in each cage.  All 
mice received the same food, water and bedding and were housed at the same 
temperature.  As soon as dead mice were discovered, they were removed and 
recorded.  Necropsies were performed when possible. 
 
Necropsy to preserve tissue from dead mice 
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 When histological analysis of mouse organs other than the intestine was 
required, necropsies were performed following a protocol provided by Dr. David 
Pinson from the Veterinary Lab Resources Department of the University of Kansas 
Medical Center.  Following death or sacrifice, the mouse was placed in dorsal 
recumbence and soaked in 70% ethanol.  The abdomen was opened along the ventral 
midline and organs including the tongue, trachea, esophagus, heart, lungs, liver, 
spleen, kidneys, reproductive organs and brain were placed in10% buffered formalin.  
Any apparent abnormalities were recorded and the organs were sent by courier to the 
Veterinary Lab Resources Department of the University of Kansas Medical Center 
for complete histological analysis by Dr. Pinson. 
 
Tagging and DNA isolation for genotyping 
 Mouse pups were tagged after weaning.  Each mouse was injected with an 
implantable electronic transponder (Bio Medic Data Systems Inc.) using a 
prepackaged implant device. The transponders were inserted into the subcutaneous 
space above the hips and shoulders.  Transponders transmit a unique 10 digit mouse 
ID number to a radio scanner (Bio Medic Data Systems Inc.) which was used to 
identify the mice.  Following insertion of the transponder, approximately 2mm of 
tissue was removed from the tip of the tail for DNA isolation as previously described 
(10).  Briefly, the tail tissue was placed directly into labeled ependorf tubes 
containing 200μl of 1X PCR Buffer with Nonionic Detergents (PBND) [50mM KCL, 
10mM Tris-HCl pH 8.3, 2.5mM MgCl2-6H2O, 0.1 mg/ml gelatin, 0.45% v/v Nonidet 
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P40, 0.45 v/v Tween 20 made up in H2O].  1X PCR Buffer was autoclaved, aliquoted 
and stored at -20°C.  A fresh aliquot was thawed for each round of DNA isolation.  
Proteinase K (5μL of a 20mg/mL stock) was added to each tube containing a section 
of tail tissue and tubes were incubated at 55°C with occasional vortexing until the tail 
tissue dissolved (~2 hours).  Samples were heated to 95°C for 10 minutes to 
deactivate the Proteinase K.  Between 3μL and 6μL of each sample was used in two 
PCR amplification reactions to determine the genotype of each mouse. 
  
Determining the Apc NLS genotype of mice 
 The Apc genotype of the mouse pups was determined using tail DNA and 
PCR to screen for the presence of the WT and mutant nuclear localization sites.  The 
following primer set was used to screen for the WT allele of APC: NLS1-forward (5’-
CTA AGA AAA AGA AGC CTA CTT CAC) and NLS2-reverse (5’-GGC CTT TTC 
TTT TTT GGC ATG GC).  In a separate reaction the following primer set was used 
to screen for the presence of the mutant allele of APC: mNLS1-forward (5’-GCA 
GCC GCG GCA CCT ACT) and mNLS2-reverse (5’-TTG AAG GCC TTT TTG 
CGG CC).  PCR reactions utilized Taq or GoTaq polymerase (Promega) in the 
supplied buffer and 1.5mM MgCl2 and were carried out as follows: hot start at 95°C 
for 15 minutes followed by 30 cycles of 94°C for 1 minute, 58°C for 1 minute, 72°C 
for 2 minutes.  After the last cycle, tubes were incubated for 7 minutes at 72°C before 
samples were held at 4°C.  
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Western blot analysis of APC and β-catenin in intestinal tissue 
 Isolation of  intestinal epithelial cells was performed with modifications to a 
previous protocol (11).  At the time of sacrifice, the mouse small and large intestines 
were removed, opened lengthwise and rinsed with cold PBS.  Tissue was incubated in 
0.04% sodium hypochlorite for 15 minutes on ice and again rinsed in cold PBS.  The 
colon and small intestine were placed into individual 15mL conical tubes containing 
EDTA/DTT solution (3mM EDTA and 0.5mM DTT in PBS).  Tubes were incubated 
on ice for 15 minutes, after which the EDTA/DTT was poured off and replaced with 
cold PBS.  Tubes were shaken forcefully for about 10 seconds to release the epithelial 
cells from the underlying tissue.  The intestinal tissue was removed and placed in a 
fresh 15mL conical tube of EDTA/DTT solution and the process was repeated two 
additional times.  The released epithelial cells were collected by centrifugation at 
700xg for 5 minutes at room temperature.  Pellets of the colonic epithelia resulting 
from all three rounds of extraction were combined into one sample.  Because the 
surface area of the small intestine is significantly greater, there was no need to 
combine the epithelial tissue from the replicate extractions.  The small intestinal 
epithelial cells from the second round of extraction were used in the experiments 
described here.  Cells pellets were lysed in Reporter Lysis Buffer (Promega) and 
briefly sonicated.  Samples were boiled in 3X Loading Dye [6% w/v Sodium Dodecyl 
Sulfate, 30% Glycerol, 150mM Tris pH 6.8, ~0.2mg/mL Bromophenol Blue in water] 
before proteins were resolved using SDS-PAGE and transferred to nitrocellulose 
membranes.  Immunoblotting was performed using standard protocols.  Membranes 
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were probed with the following primary antibodies diluted as indicated in 5% nonfat 
dry milk: rabbit anti-APC M2 (1:3000, generated by the Neufeld and Azuma labs), 
rabbit anti-β-catenin (1:1000, Sigma), mouse anti-α-tubulin (1:50, Developmental 
Studies Hybridoma Bank).  The following secondary antibodies were diluted as 
indicated in 5% non-fat dry milk: HRP goat anti-mouse (Zymed) 1:10,000 and HRP 
goat anti-rabbit (Bio-Rad) 1:10,000.  Blots were developed using Western Lightning 
Chemiluminescence Reagent Plus (PerkinElmer) or SuperSignal West Femto 
Maximum Sensitivity Substrate (Pierce) and a Kodak Image Station 1000.  Band 
analysis was conducted using Kodak ID Image Analysis Software. 
 
Confocal evaluation of the intestinal epithelia 
 Mouse intestines were prepared for cryosectioning and immunostaining based 
on methods previously described (12). At the time of sacrifice, mouse small and large 
intestines were removed, filled with PLP fixative [1% paraformaldahyde 0.01M m-
sodium periodate, 0.075 M lysine, 0.037 M Na-phosphate (13)] and open lengthwise.  
The colon, and proximal, middle and distal regions of the small intestine were 
individually rolled as described (14) to form multiple “Swiss Rolls”.  The sections of 
rolled colon and small intestine were incubated in fixative on ice for 1 hour then cryo-
preserved in 2.5M sucrose at 4°C overnight.   Rolled tissue sections were then frozen 
in OTC tissue freezing media (VWR) under the cryostat heat sink at -20°C.  Sections 
were sliced immediately or stored at -80°C.  Tissue was sliced into 7μm thick 
sections using a Leica CM1900 cryotome and mounted onto glass slides for 
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immunohistochemistry.  Slides were air dried for approximately 1 minute and stored 
in room temperature PBS for no more than 15 minutes.  Tissue slices were 
permeabilized in CSK buffer (50mM NaCl, 300mM sucrose, 10mM Pipes pH 6.8, 
3mM MgCl2, 0.5% Triton X-100) for 10 minutes then blocked for 2 hours (1% BSA, 
5% goat serum, 50mM NH4Cl) at room temperature.  After block, slides are washed 3 
times for 20 minutes in wash buffer (0.2% BSA in TBS) and incubated in primary 
antibody overnight at 4°C.  Slides were washed 3 times for 40 minutes at room 
temperature and incubated in secondary antibody for 2 hours in the dark.  To 
visualize the DNA, slides were co-stained with DAPI for the last 5 minutes of the 
incubation with secondary antibody.  Antibodies for immunohistochemistry of frozen 
sections included the following: mouse anti-β-catenin (1:1000, Transduction 
Laboratories), anti-APC-M2 rabbit polyclonal antibody made against amino acid 
1000-1326 and affinity purified (1:3000), rat anti-Ki67 (1:300, Dako) goat anti-mouse 
IgG Alexa 488 (1:1000, Molecular Probes), goat anti-rat IgG Alexa 488 (1:1000, 
Molecular Probes), goat anti-rabbit IgG Alexa 568 (1:1000, Molecular Probes).   
Finally, slides were washed 3 times for 40 minutes in wash buffer, coverslips were 
mounted using ProLong AntiFade (Invitrogen) and the edges were sealed with nail 
polish.  Images were collected at 400X, 600X or 1000X magnification using an 
Olympus 3I spinning disc confocal TIRF inverted microscope and analyzed using 
SlideBook software.  Analysis of proliferation in the colon was conducted using 15-25 
separate crypt images for each genotype.  Measurements of crypt length were made 
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using SlideBook software.  The p-values were calculated using Prism GraphPad 
software. 
 
Analysis of the gross histology of the intestine 
 The gross and cellular histology of the intestinal tissue were examined in the 
F1-F3 generations of APC mNLS mice.  At the time of sacrifice, the mouse ID 
number from the implanted transponder was recorded and the small intestine and 
colon were removed.   Thread was used to tie off the proximal and distal ends of each 
organ and a 25 gauge syringe was used to fill the entire length of both the small 
intestine and the colon with 10% buffered formalin.  The intestinal tissue was allowed 
to fix for 30 minutes before being opened longitudinally.  A dissecting microscope 
was used to examine the intestinal luminal surface for irregularities.  Regions of 
tissue with abnormalities were recorded, removed from the surrounding tissue, stored 
in 10% buffered formalin and sent by courier to The Veterinary Lab Resources 
department at the University of Kansas Medical Center for histological analysis.  The 
mouse ID numbers were later used to correlate the number of lesions in each mouse 
with the age and genotype of the animal.   
 
Analysis of the organs and cells of the immune system 
At the time of sacrifice the thymus, spleen, inguinal lymph nodes (located 
near the groin), peyers patches (small intestinal lymph nodes) and bone marrow cells 
(from the femur) were harvested with the assistance of the lab of Dr. Steven Benedict 
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(Molecular Biosciences, KU).  Analysis of the splenocytes was conducted as 
described previously (15).  Thymocyte analysis was conducted using the same 
protocol with the omission of the step to lyse red blood cells. 
 
Results 
Generation of a congenic APC mNLS mouse 
When choosing a background strain in which to study the APC NLS 
mutations it was important to select a strain that would allow direct comparison 
between the APC mNLS mouse model and other existing APC mouse models.  
Another consideration was that the knock-in APC NLS mutations only change six 
amino acids in the entire APC protein and therefore might result in a subtle 
phenotype.  Such a phenotype would make it difficult to characterize mice that carry 
the APC mNLS mutations.  To more fully evaluate the phenotype, it may be 
necessary to characterize the APC mNLS mutation in combination with mutations in 
other proposed nuclear binding partners.  Evaluation of the APC mNLS phenotype in 
the presence of specific mutations in other genes of interest would require that the 
APC mNLS mice be bred with other mouse models.  Therefore the background strain 
chosen for the APC NLS mutations should also facilitate intercrossing of the APC 
mNLS mice with other mouse lines that carry mutations of interest.   
The C57BL/6J line was selected for our study of the targeted APC NLS 
mutations.  This line is one of the most common background strains for the evaluation 
of targeted mutations (6).  Most of the other APC mouse models generated to date are 
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also maintained in C57BL/6J mice (7, 8, 16-21) as are the Fen-1 and Exo-1 mouse 
models (22, 23), which carry mutations in genes important for DNA repair (Table 
3.1).  C57BL/6J mice are also more prone to intestinal polyposis upon loss of full 
length APC than many other mouse strains (24), making them especially useful for 
the study of the tumor suppressor function of APC.   
APC mNLS chimeric males were crossed with C57BL/6J females.  The F1 
generation was initially evaluated for coat color.  The APC mNLS+/- ES cells were 
generated by electroporating the gene replacement vector into cells of the WT R1 ES 
cell line (4).  The R1 ES cells were derived from inbred 129/SvJ mice which carry a 
dominant gene for agouti coat color (6).  The blastocysts that were injected with the 
R1 APC mNLS+/- ES cells to generate chimeras were taken from a C57BL/6J mouse, 
a line which carries genes that result in black coat coloring (6).  Therefore, agouti 
(brown) F1 offspring represented germline transmission of the APC mNLS ES cells 
while back offspring carried only genetic material from the C57BL/6J blastocyst.  
Black F1 pups were culled and brown F1 pups were further evaluated.  Because the 
APC mNLS+/- ES cells where heterozygous for the APC NLS mutations, brown coat 
color indicated that the pups had received one Apc allele from the knock-in ES cells, 
but did not indicate if they had received the mutant or the WT allele.  At the time of 
weaning all brown pups were tagged and genotyped to determine which ones carried 
the targeted APC NLS mutations.  F1 mice that were heterozygous for the APC NLS 
mutations where bred with C57BL/6J mice to produce the F2 generation.  The 
process of tagging the pups in each litter, screening them for the APC mutation, and  
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 Mouse line Genetic Background Description of mutation
APC Min C57BL/6J; AKR APC truncation at aa850
APC 1638N C57BL/6JIco APC null allele (2% expression of the truncated allele)
APC 1638T C57BL/6JIco APC truncation at aa1638
APC 1309 C57BL/6J APC truncation at aa1309
APC 716 C57BL/6 APC truncation at aa716
APC 580S/D C57BL/6 APC inducible truncation at aa580
APC 474 C57BL/6J APC truncation at aa474
APC NeoR C57BL/6N APC hypomorphic allele-reduced experssion of FL protein
Fen-1 C57BL/6 Null allele of DNA repair protein Fen-1
Exo-1 C57BL/6 Null allele of DNA repair protein Exo-1
*For many of the mouse lines above the strain name (C57BL/6) is followed by a 
laboratory code (J, N, etc).  Laboratory codes are added to the strain names due to the 
potential of genetic drift when mouse colonies are maintained independently (1).  The 
above laboratory codes signify the following mouse colonies: J-Jackson Laboratories; 
N-National Institute of Health; Ico-a retired laboratory code for IFFA-Credo.  The 
absence of a laboratory code denotes that the origin of the inbred strain was not 
indicated in the initial description of the mutant line. 
Table 3.1 
A list of the common APC mutant mice as well as other mouse models of interest and the 
background strain of the WT mice they were bred to for the purpose of generating a 
congenic line
*
(18)
(23)
(19)
(8)
(16)
(20)
(7)
(17)
(21)
(22)
then breeding the heterozygous APC mNLS mice to WT C57BL/6J mice was 
continued for each generation with the goal of establishing a congenic line.   
After the F1 generation, coat color could no longer be used as an indication of 
genotype.  As expected, breeding the APC mNLS+/- mice to C57BL/6J mice resulted 
in a gradual loss of the agouti phenotype.  For the most part, an increasing ratio of 
black to brown mice was observed in litters with each subsequent generation (Table 
3.2).  At generation F5, APC mNLS mice should be identical to the WT C57BL/6J 
mice across 95% of their genome and all pups were black.   
The following analysis of the APC mNLS phenotype was conducted in pups 
that were the product of mating F4 or F5 heterozygous mice to their heterozygous 
siblings to achieve litters of mixed genotypes.  For other analyses the generation of 
the mice used is indicated.  In all cases the WT control mice are the APC mNLS+/+ 
littermates of the APC mNLS heterozygous and homozygous mutant animals.  
 
Full length APC is expressed at normal levels in the intestine of APC mNLS-/- mice 
The observation that endogenous APC could be seen in the nucleus of 
cultured cells led to the characterization of two classic monopartite NLSs in the 
central region of the APC protein (25, 26).  Furthermore, mutation of these NLSs led 
to the nuclear exclusion of exogenously expressed APC in cultured cells (25).  By 
generating a mouse line that carries these mutations in the endogenous Apc gene we 
intend to better define the function of nuclear APC in intestinal tissue.  Prior to fully 
analyzing the phenotype in the APC mNLS mice it was important to establish that the  
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Table 3.2 
A summary of the percentage of black pups and brown pups born in each generation.  
Litters from black heterozygous mice bred to black WT mice contain only black pups, 
litters from brown heterozygous mice crossed to black WT mice contain both brown and 
black pups.  Therefore the number of brown pups in each of the first three generations 
decreases.  While the total number of brown pups in the F3 generation was fewer than in 
the F2 and F1 generations, the heterozygous mice in this generation were brown resulting 
in the increase in the percentage of brown pups in the F4 generation.  Black heterozygous 
F4 pups were bred to WT C57BL/6J animals and the resulting F5 generation was an all 
black litter
Generation Total mice % Brown % Black
F1 47 100% 0%
F2 40 32% 67%
F3 24 29% 71%
F4 13 62% 38%
F5 7 0% 100%
mutation was having the expected effect on the levels and localization of APC.  The 
Apc NLS mutations were designed to block nuclear import of APC through the 
classical importin-α nuclear import pathway without affecting the overall level of 
protein expression from the Apc gene.  Western blot analysis of protein from the 
intestinal epithelium revealed that full length APC was expressed in the APC NLS-/- 
animals.  Furthermore, there was no discernable difference in the level of APC 
expression when comparing the homozygous mutant animals with their APC mNLS 
WT littermates (Figure 3.1).   
 
Analysis of APC localization in mouse intestine  
  The pattern of APC localization in the small intestine has been challenging to 
observe.  Paraffin embedding has been the preferred method for analysis of protein 
localization in the delicate crypt-villus structures of the small intestinal epithelium 
(27).  However, it is suspected that the processing required to paraffin embed tissue 
can result in the permanent loss of APC epitopes, making paraffin embedding a poor 
choice for tissue in which APC will be examined (Anderson and White, personal 
communication).  Previous analysis of APC staining has been performed in frozen 
tissue slices (12) and microdisected crypts (26); however, the latter is more suited to 
the colonic crypts than to the villi of the small intestine.  Analysis of APC expression 
and localization in the entire crypt-villus structure from the small intestine has rarely 
been reported in the literature.  Several factors, in addition to the difficulties of 
staining APC in tissue, are likely contributing to the rarity of a complete examination  
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Figure 3.1
Western immunoblot of lysate from mouse intestinal tissue probed with anti-APC M2 antibody.  
Full length APC in intestinal epithelia of the APC mNLS-/- mouse is detected at approximately 
the same level as in the APC mNLS+/+.  
~312KDa
-/- +/+
250KDa
105KDa
50KDa
75KDa
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of intestinal APC.   The process of removing and fixing the small intestinal 
epithelium without shearing the tall slender villi from the mucosal surface is not 
trivial.  Neither is the preparation of tissue slices that allow the visualization of an 
entire crypt-villus structure within a single 7μm tissue slice.  Furthermore, capturing 
images of entire villi generally requires the use of an objective with a large field of 
view due to the size of these structures, while analysis of the subcellular localization 
of APC requires an objective with a higher magnification and numerical aperture.  In 
the following analysis of APC and β-catenin in the mouse intestinal epithelium, a two 
day tissue processing procedure allowed cryo-preservation of the colonic crypt 
structures as well as the fragile crypt-villus structures of the small intestine.  The 
intestinal sections were rolled during fixation and freezing so that each slice 
contained several concentric layers of tissue, maximizing the potential to capture an 
entire crypt-base to villus-tip image with the minimum number of tissue slices.  
Finally, the use of SlideBook software facilitated the creation of montage images.  A 
montage of a single crypt-base to villus-tip region of the epithelium generally 
contained 30-60 individual confocal images captured at 600x magnification to render 
a nearly seamless high-resolution illustration of the subcellular protein localization 
pattern across an entire crypt-villus structure.  Using these techniques we have 
characterized the localization of APC and β-catenin in the small and large intestinal 
epithelia of APC mNLS mutant and WT animals. 
 
APC localization in the small intestine 
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A previous report described APC localized to the lateral junctions in the cells 
that form the base of mouse small intestine crypts (12), a pattern consistent with APC 
localization observed in human colon crypts (26).  Reports also describe a gradient of 
APC with the highest expression levels in the villus tips and the lowest level of APC 
at the base of the crypts (12, 28).  In the villi, the localization of APC has also been 
reported to be more cytoplasmic with less pronounced staining at the plasma 
membrane (12).   
Our analysis of APC expression has also revealed a subtle APC gradient in 
APC mNLS+/+ mice (Figure 3.2).  APC in the cells at the base of the crypts displayed 
a slightly lower intensity of APC staining with more of the APC signal localized to 
the plasma membrane (Figure 3.2 and 3.5). In agreement with previous reports, an 
increased staining intensity of APC was observed in the villi (Figure 3.2).  The most 
intense APC staining in the villus cells was observed basal to the nuclei, a staining 
pattern that was not observed in the cells of the crypt.  Furthermore APC localization 
was less nuclear in the cells of the villi, displaying a predominantly cytoplasmic 
distribution (Figure 3.2 and 3.7).  When stained in conjunction with β-catenin, APC 
in cells of the villus was observed beyond the apical edge of the β-catenin at the 
plasma membrane, suggesting that APC localizes to the microvilli extensions of the 
intestinal enterocytes.   
The same overall pattern of APC expression was also observed in mice that 
carry the APC NLS mutations.  Both heterozygous and homozygous APC mNLS 
mice displayed the same relative levels of APC with a pattern of localization  
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APC mNLS+/+ small intestine
β-catenin                            APC
APC β-catenin  DAPI
Figure 3.2
APC and β-catenin localization in the small intestine of a APC mNLS+/+ mouse.  The colored 
image on the left is a montage generated from multiple confocal images taken at 600X 
magnification and shows the entire crypt-villus structure.  The black and white images on the 
right show APC or β-catenin localization in the regions of the crypt indicated by the white 
boxes.  The confocal images on the right are taken at 1000x magnification and may be on a 
slightly different focal plane compared to the montage on the left.  (The images of DAPI, used 
to indicate the location of the nucleus are epifluorescent images not confocal).  Scale bar on 
montage = 30μm.  Scale bar for 1000X confocal images= 3μm.
  
APC mNLS+/- small intestine β-catenin                           APC
APC β-catenin  DAPI
Figure 3.3
APC and β-catenin localization in the small intestine of a APC mNLS+/- mouse.  The colored 
image on the left is a montage generated from multiple confocal images taken at 600X 
magnification and shows the entire crypt-villus structure.  The black and white images on the 
right show APC or β-catenin localization in the regions of the crypt indicated by the white 
boxes.  The images on the right are confocal images taken at 1000X magnification and may be 
on a slightly different focal plane compared to the montage on the left.  (The images of DAPI, 
used to indicate the location of the nucleus are epifluorescent images not confocal).  Scale bar 
on montage = 30μm.  Scale bar for 1000X confocal images = 3μm.
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APC mNLS-/- small intestine
β-catenin                    APC
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Figure 3.4
APC and β-catenin localization in the small intestine of a APC mNLS-/- mouse.  The colored 
image on the left is a montage generated from multiple confocal images taken at 600X 
magnification and shows the entire crypt-villus structure.  The black and white images on the 
right show APC or β-catenin localization in the regions of the crypt indicated by the white 
boxes.  The confocal images on the right are taken at 1000X magnification and may be on a 
slightly different focal plane compared to the montage on the left.  (The images of DAPI, used 
to indicate the location of the nucleus are epifluorescent images not confocal).  Scale bar on 
montage = 30μm.  Scale bar for 1000X confocal images = 3μm.
APC β-catenin  DAPI
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APC in the crypt  base of the small intestine
APC mNLS+/+ APC mNLS+/- APC mNLS-/-
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Figure 3.5
APC localization in the base of the crypt from the small intestine in APC mNLS+/+, APC 
mNLS+/-, and APC mNLS-/- mice. Images compare APC localization in the base of two separate 
crypts for each genotype.  Confocal images taken at 1000X magnification.  Scale bar = 3.0μm
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β-catenin in the crypt base of the small intestine
APC mNLS+/+ APC mNLS+/- APC mNLS-/-
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Figure 3.6
β-catenin localization in the base of the crypt from the small intestine in APC mNLS+/+, APC 
mNLS+/-, and APC mNLS-/- mice. Images compare β-catenin localization in the base of two 
separate crypts for each genotype.  Confocal images taken at 1000X magnification.  Scale bar = 
3.0μm
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APC in the villi of the small intestine
APC mNLS+/+ APC mNLS+/- APC mNLS-/-
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Figure 3.7
APC localization in the villi from the small intestine in APC mNLS+/+, APC mNLS+/-, and APC 
mNLS-/- mice. Images compare APC localization in cells approximatly halfway up two separate 
villi for each genotype.  Confocal images taken at 1000X magnification.  Scale bar = 3.0μm
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β-catenin in the villi of the small intestine
APC mNLS+/+ APC mNLS+/- APC mNLS-/-
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Figure 3.8
β-catenin localization in the villi from the small intestine in APC mNLS+/+, APC mNLS+/-, and 
APC mNLS-/- mice. Images compare β-catenin localization in cells approximatly halfway up 
two separate villi for each genotype.  Confocal images taken at 1000X magnification.  Scale bar 
= 3.0μm
comparable to the WT animals (Figure 3.3 and 3.4).  APC localization in small 
intestine of the mutant APC mNLS mice did not appear to be less nuclear than APC 
in the WT mNLS mice.  Even the more intense APC nuclear foci, occasionally 
observed in the WT crypt cells, were present in the mutant APC mNLS animals 
(Figure 3.5).  
Nuclear localization of APC in mice mutant for the characterized NLSs 
suggests that there are additional methods by which APC can gain entry into the 
nucleus.  It has been suggested that supplementary sequences with weaker nuclear 
import ability can be found in the N-terminal region of the APC protein (29).  This 
suspected N-terminal nuclear import site has been proposed to account for the 
observation that truncated forms of APC, lacking the characterized NLSs, appear to 
enter the nucleus in human polyp tissue and cancer cell lines (30, 31).  There is also 
the possibility that APC is no longer controlling its own nuclear import, but is 
interacting with other nuclear proteins that can facilitate import and/or retention of 
APC in the nucleus.  A third explanation for the presence of mutant APC in the 
nucleus comes from recent evidence that APC may possess an alternate method of 
nuclear ingress not dependent on the classical importin-α mediated pathway (see 
Chapter 5).  It has been established that cellular stress leads to a blockage of 
conventional nuclear import by inhibiting the nuclear to cytoplasmic recycling of the 
importin-α protein (32).  Heat shock proteins as well as heat shock cognate proteins, 
however, continue to localize to the nucleus, despite this import block, through an as 
yet undetermined method (33, 34).  The recent observation that APC is able to 
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localize to the nuclear compartment in cells following exposure to ultraviolet light 
supports the idea that APC can also enter the nucleus by this alternative mechanism 
(See Chapter 5 for further analysis of APC localization following UV exposure).  
Because the characterized APC NLSs facilitate nuclear import by interacting with 
importin-α, mutation at these sites would not be expected to prevent nuclear import 
through a mechanism that is not reliant on the importin-α nuclear import pathway.  
The APC mNLS mouse model therefore has the potential to be tool to investigate 
alternative nuclear import mechanisms. 
 
Analysis of APC localization in mouse colon 
   In normal human colonic epithelium the APC protein has been observed in 
the nuclear compartment as well as localized to the lateral cell junctions of the 
epithelial cells (30).  A similar staining pattern was observed in the colons of APC 
mNLS+/+ mice.  APC was predominantly localized to the membrane of the epithelial 
cells at the base of the crypt with a more diffuse cytoplasmic staining evident in the 
cells at the luminal surface (Figures 3.9, 3.12 and 3.14).  The overall staining pattern 
for APC was similar in the mutant and WT APC mNLS mice (Figures 3.10, 3.11, 
3.12 and 3.14).  Foci of higher APC intensity similar to those observed in the small 
intestine could occasionally be seen in the cells at the base of the colon crypts as well 
(Figures 3.9, 3.11 and 3.12).  There was no detectable difference in the APC 
localization at the base of the crypts.  However, analysis of the more differentiated 
cells at the tops of the crypts revealed a reduced intensity of APC staining in the  
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APC mNLS+/+ colon
β-catenin                   APC
APC β-catenin  DAPI
Figure 3.9
APC and β-catenin localization in the colon of a APC mNLS+/+ mouse.  The colored image on 
the left is a montage generated from multiple confocal images taken at 600X magnification and 
shows the entire crypt structure.  The black and white images on the right show APC or β-
catenin localization in the regions of the crypt indicated by the white boxes.  The confocal
images on the right were taken at 1000X magnification and may be on a slightly different focal 
plane compared to the montage on the left.  The images of DAPI, used to indicate the location of 
the nucleus are epifluorescent images not confocal.  Scale bar for the montage = 30μm.  Scale 
bar for 1000X confocal images = 3μm.
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APC mNLS+/- colon
β-catenin               APC
APC β-catenin  DAPI
Figure 3.10
APC and β-catenin localization in the colon of a APC mNLS+/- mouse.  The colored image on 
the left is a montage generated from multiple confocal images taken at 600X magnification and 
shows the entire crypt structure.  The black and white images on the right show APC or β-
catenin localization in the regions of the crypt indicated by the white boxes.  The confocal on 
the right were taken at 1000X magnification and may be on a slightly different focal plane 
compared to the montage on the left.  The images of DAPI, used to indicate the location of the 
nucleus are epifluorescent images not confocal.  On the montage scale bar = 30μm.  Scale bar 
for 1000X confocal images = 3.0μm. 
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APC mNLS-/- colon
β-catenin                   APC
APC β-catenin  DAPI
Figure 3.11
APC and β-catenin localization in the colon of a APC mNLS-/- mouse.  The colored image on 
the left is a montage generated from multiple confocal images taken at 600x magnification and 
shows the entire crypt structure.  The black and white images on the right show APC or β-
catenin localization in the regions of the crypt indicated by the white boxes.  The confocal
images on the right were taken at 1000X magnification and may be on a slightly different focal 
plane compared to the montage on the left.  The images of DAPI, used to indicate the location of 
the nucleus are epifluorescent images not confocal.  The scale bar for the montage = 30 μm.  
Scale bar for the 1000X confocal images = 3.0μm.
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APC mNLS+/+ APC mNLS+/- APC mNLS-/-
APC in crypt base of mouse colon
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Figure 3.12
APC localization at the crypt base from the colon in APC mNLS+/+, APC mNLS+/-, and APC 
mNLS-/- mice. Images compare APC localization in cells at the base of two separate crypts for 
each genotype.  Confocal images taken at 1000X magnification.  Scale bar = 3.0μm
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β-catenin in the crypt base of mouse colon
APC mNLS+/+ APC mNLS+/- APC mNLS-/-
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Figure 3.13
β-catenin localization at the crypt base from the colon in APC mNLS+/+, APC mNLS+/-, and 
APC mNLS-/- mice. Images compare β-catenin localization in cells at the base of two separate 
crypts for each genotype.  Confocal images taken at 1000X magnification.  Scale bar = 3.0μm
APC at the colon luminal surface
APC mNLS+/+ APC mNLS+/- APC mNLS-/-
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Figure 3.14
APC localization at the luminal surface from the colon in APC mNLS+/+, APC mNLS+/-, and 
APC mNLS-/- mice. Images compare APC localization in cells at the top of two separate crypts 
for each genotype.  Confocal images taken at 1000X magnification.  Scale bar = 3.0µm
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β-catenin at the luminal surface of the colon
Figure 3.15
β-catenin localization at the luminal surface from the colon in APC mNLS+/+, APC mNLS+/-, 
and APC mNLS-/- mice. Images compare β-catenin localization in cells at the top of two 
separate crypts for each genotype.  Confocal images taken at 1000X magnification.  Scale bar = 
3.0μm
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nuclear compartment of the APC mNLS+/- and APC mNLS-/- animals (Figure 3.14).  
The APC mNLS heterozygous and homozygous mice both displayed a region of 
decreased APC staining that corresponds to the location of the nucleus.  There was no 
such distinction between the nuclear and cytoplasmic compartments in the WT APC 
mNLS animals which displayed a more diffuse APC localization pattern in the cells 
at the luminal surface (Figure 3.14).  While a decreased intensity of the nuclear 
staining existed in regions of the colon, APC protein never appeared to be completely 
excluded from the nuclear compartment, even in homozygous animals in which both 
APC alleles were mutant for the known NLSs.  The continued presence of APC in the 
nuclear compartment of the colonic epithelial cells again supports the existence of 
alternate processes by which APC may gain nuclear entry. 
   
β-catenin levels and localization are altered in the APC mNLS mice. 
 To further characterize the intestinal epithelium of the APC mNLS mice, 
western blot analysis was used to evaluate the level of β-catenin in intestinal tissue.  
APC interacts with β-catenin in the cytoplasm and promotes β-catenin degradation 
(35).  APC also interacts with β-catenin in the nuclear compartment and inhibits β-
catenin’s transcriptional activity (36).  These observations led to the hypothesis that 
APC may facilitate the export of β-catenin from the nucleus to the cytoplasm.  In 
APC mNLS+/- and APC mNLS-/- mice, we observed that APC was not entirely 
excluded from the nucleus, and yet β-catenin levels in the intestinal epithelial cells 
were altered.  When compared to their APC NLS WT littermates, APC mNLS-/- mice 
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expressed more β-catenin in the epithelial cells of their small intestines.  Mice 
heterozygous for the APC NLS mutations expressed an intermediate amount of β-
catenin, less than the homozygous mice, but more than the WT mice (Figure 3.16).  A 
similar trend, albeit more subtle, was also observed in the colonic epithelium, with β-
catenin levels in heterozygous and homozygous mutant animals greater than the 
levels in the WT mice (Figure 3.16).   
Confocal microscopy of the small intestinal epithelia revealed a gradient of β-
catenin staining that was the inverse of the APC expression gradient.  β-catenin was 
expressed at the highest levels in cells at the base of the crypts.  Expression levels 
appeared to decrease as cells migrated upward along the villi towards the tip (Figures 
3.2-4).  At the base of the crypts, β-catenin was localized almost entirely to the 
plasma membrane; however, as the overall fluorescent intensity representing β-
catenin decreased, it also appeared more evenly distributed through the cytoplasm 
(Figures 3.6 and 3.8).  We observed very little nuclear β-catenin in any cell along the 
crypt-villus axis (Figures 3.6 and 3.8).  There was almost no difference in the 
localization pattern of β-catenin when APC mNLS mutant and WT animals were 
compared (Figures 3.2-4, 3.6 and 3.8).  The overall level of β-catenin expression, 
however, did seem to be higher in the intestines of the mutant animals, with the most 
intense β-catenin staining observed in the APC mNLS homozygous mutant mice 
(Figures 3.2-4). 
 The APC NLS mutations do not affect APC’s ability to interact with axin to 
form the β-catenin destruction complex (unpublished observations of Neufeld and  
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-/- -/+   +/+
Small intestine
-/- -/+   +/+
Colon
Figure 3.16 
Immunoblot of protein from mouse intestinal epithelia of the APC mNLS -/-, APC mNLS+/- and 
APC mNLS+/+ mice.  Blot is probed with rabbit anti-β-catenin antibody.  Colon and small 
intestinal epithelia were processed separately.  Below, an identical blot was probed for α-tubulin
to control for loading differences.
β-catenin
α-tubulin
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White). Therefore, this increase in β-catenin level in the mutant animals supports a 
role for nuclear APC in regulation of β-catenin.   The observation that this regulation 
is dependent on the NLSs supports the hypothesis that APC regulates the nuclear 
shuttling of β-catenin. 
    
Colons from APC mNLS+/- mice display a decreased proliferative zone. 
 Most of the target genes for which β-catenin serves as a co-activator are 
associated with cell cycle progression (9).  An increase in the cellular level of β-
catenin would be expected to correlate with an increase in β-catenin’s activity as a 
transcription factor.  If the defective nuclear import of APC results in an increase in 
the transcriptional activity of β-catenin, we would expect to see an elevated level of 
proliferation in the mutant tissue.  To evaluate proliferation levels in the mouse 
epithelial tissue, we used an anti-Ki67 antibody to detect cycling cells.  Ki-67 was 
originally defined as a monoclonal antibody that reacted to nuclei from Hodgkin’s 
lymphoma cells (37).  Little about the cellular function of the Ki-67 antigen is known 
other than its expression pattern (38).  Ki-67 can be detected in the nucleus of actively 
cycling cells but not quiescent cells (39).  This specificity for dividing cells has made 
Ki-67 a widely used proliferation marker (38).    
 For our analysis, frozen sections of colon tissue from APC mNLS+/+, APC 
mNLS+/- and APC mNLS-/- mice were evaluated.  In the colon, new cells arise from 
division of the adult stem cells residing at the base of the crypt (40).  Asymmetric 
division of crypt stem cells generally gives rise to one stem and one transiently 
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amplifying daughter cell which will continue to divide as it migrates up the crypt 
toward the luminal surface.  After several rounds of division, the progeny of the 
transiently amplifying cells become quiescent and differentiate (41).  Therefore, there 
is a proliferative zone at the base of the crypt and a non-proliferative zone of 
differentiated cell types at the luminal surface.  Aberrant proliferation in the upper 
portion of the crypt is usually associated with neoplastic transformation (41).  
Previous analysis of proliferation in the colon revealed actively cycling cells in the 
lower third of the crypt only (41). 
For our analysis, the number of Ki-67 positive cells per crypt was recorded 
along with the length of the proliferative zone compared to the total length of the 
crypt as measured using the SlideBook software.  To determine the length of the 
proliferative zone a measurement was made from a nucleus at the base of the crypt to 
highest cell positive for Ki-67 staining.  Because the total crypt length progressively 
changes from the proximal to distal end of the colon, the length of the proliferative 
zone was divided by the total length of the crypt as measured from a nucleus at the 
base of the crypt to a nucleus at the luminal surface.   
Between 15 and 25 crypts were examined for each genotype and the results 
are summarized in Table 3.3.  The total number of proliferative cells was slightly 
increased in the tissue from mutant mice when compared to WT littermates.  Tissue 
from the APC mNLS+/+ mice displayed an average of 2.8 Ki-67 positive cells per 
crypt slice while tissue from the APC mNLS+/- and APC mNLS-/- mice displayed on 
average 3.4 and 3.6 Ki-67 positive cells per crypt, respectively.  These very subtle  
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Table 3.3 
Proliferation in the colon of APC mNLS mice
Measurements APC mNLS+/+ APC mNLS+/- APC mNLS-/-
Average height of crypt (μm) 166.1 163.7 142.5
Average height of top dividing cells 56.8 37.6 50
Proliferative zone (% of total crypt) 35% 23% 33%
Average number of dividing cells/crypt 2.8 3.4 3.6
Number of crypts measured 21 26 17
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differences in the numbers of dividing cells were not considered significantly 
different from WT using an unpaired t-test (p-values of 0.14 and 0.06 respectively). 
There was very little difference in the size of the proliferative zone in 
homozygous mutant APC mNLS mice and their WT littermates.  Both APC mNLS+/+ 
and APC mNLS-/- mice were observed to have a Ki-67 positive cells only in the 
bottom third of the crypt (35% and 33% respectively).  In contrast, the heterozygous 
mice displayed a reduced proliferative zone.  On average, the Ki-67 positive cells 
were restricted to the bottom 23% of the crypt (Figure 3.17).  This difference was 
significant when analyzed using the unpaired t-test (p=0.0042) suggesting that 
heterozygous APC mNLS mice may have a more severe proliferation defect than the 
homozygous APC mNLSs mice. 
 
Analysis of gross intestinal phenotype in older APC mNLS mice. 
 The initial characterization of the intestinal epithelium of the F5 APC mNLS 
mice established a subtle phenotype at the cellular level.  To determine how this 
cellular phenotype might affect tumor suppression, the gross intestinal phenotype of 
the oldest available APC mNLS mice was examined.  APC mNLS WT and 
heterozygous mutant mice of the F1 and F2 generations were sacrificed at 40 to 70 
weeks of age.  At the time of sacrifice the small intestine and colon were removed, 
fixed and examined for the presence of abnormal tissue.  Any regions of irregularity 
were recorded along with the ID number of the mouse which would later be 
correlated with the sex, age and genotype of the animal.    Pending a more complete  
 
 
131
Figure 3.17
Images of colonic crypts stained for Ki-67 proliferation marker were captured on an Olympus 3I 
spinning disc TIRF inverted microscope and analyzed using Slidebook software.  The length of 
the proliferative zone was determined by measuring the distance between the base of the crypt 
and the most luminal Ki-67 positive nucleus.  Total crypt length was measured from a nucleus in 
the base of the crypt to a nucleus at the intestinal lumen.   *p= 0.0042
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analysis, these regions of abnormal tissue were termed “intestinal lesions”.   
Generally it was found that the number of lesions per mouse increased as the mice 
aged.  This trend of increased numbers of lesions in the older mice was observed for 
both the APC mNLS WT and heterozygous mutant mice (Figure 3.18).  We did not 
have a large cohort of older APC mNLS-/- mice for this analysis. 
 While the overall trend of lesions appearing as a function of time was similar 
in the heterozygous mutant and WT APC mNLS mice, there was a noticeable 
difference in the number of lesions per mouse in these two populations.  APC 
mNLS+/- mice developed lesions earlier and at higher numbers than their WT 
littermates.  While the WT mice displayed no lesions in animals less than 60 weeks of 
age, lesions were found in the heterozygous animals as early as 42 weeks (Figure 
3.18).  Furthermore, over half of the APC mNLS WT mice were found to have no 
lesions.  Less than one third of the WT mice had one or two lesions and less than 10% 
of the WT mice displayed more than two intestinal lesions (Figure 3.19).  The 
opposite trend was observed in the APC mNLS+/- mice.  Only 25% of the 
heterozygous APC mNLS mice were lesion-free, while nearly half of the 
heterozygous animals displayed more than 2 intestinal lesions per mouse (Figure 
3.19). 
The intestinal regions containing abnormal tissue were removed and stored in 
formalin. A subset of these samples was sent for histological analysis at the 
Veterinary Lab Resources department at the University of Kansas Medical Center.  
All of the intestinal lesions examined were determined to be hyperplastic lymphoid  
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Figure 3.18 
Incidence of intestinal lesions per mouse as a function of age in weeks.  Generation F1 and F2 
heterozygous APC mNLS+/- and APC mNLS-/- mice were sacrificed between 40 and 70 weeks 
of age.  The small intestine and colon were fixed and examined for regions of irregular tissue 
physiology.  The number of irregularities for each mouse was recorded along with the animal’s 
ID number.  ID numbers were later used to correlate lesion incidence with the age and genotype 
of the animal.  Each point on the graph above represents one mouse.
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Figure 3.19 
The number of intestinal lesions by genotype.  APC mNLS+/- mutant animals compared to APC 
mNLS+/+ animals.  Mice were assigned to one of three categories based on the total number of 
lesions that were detected in the intestine.  The percent of mice in each category is summarized 
above.  The bars represent the percentage of the total heterozygous (red) or WT (blue) mice in 
each category.  The number of mice in each category is indicated below the graph.
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nodules.  While the presence of gut-associated lymphoid tissue (GALT) in the 
intestinal tract is normal, the disparity in the number of macroscopically observable 
nodules seen in the mutant mice compared to their WT littermates hinted at a 
potential role for APC in intestinal immune regulation.  Tentative links between 
inflammation and APC mutation have been suggested in previous APC mouse model 
systems (42-46).  Further work in congenic APC mNLS animals that are WT, 
heterozygous and homozygous mutant for the APC NLSs is necessary to better define 
this possible role for nuclear APC in the intestinal immune response. 
 
Preliminary analysis of the lymphoid tissue in the mutant and WT APC mNLS mice 
 There is strong evidence supporting a role for the immune system in the 
inhibition of cancer (47) and a suggested role for APC in the regulation of the gut 
associated lymphoid tissue (19-23;)and this chapter).  Therefore the status of the 
immune system in the APC mNLS mice was of interest.  Previously, our analysis 
focused on the APC mNLS phenotype as it pertained to intestinal tissue.  However, 
the APC mNLS mutation is not specific to the intestinal tract; all somatic cells of the 
mutant animals carry the APC NLS mutations.  The APC mNLS mouse model, 
therefore, provides an ideal system for the evaluation of nuclear APC in the 
development of the various immune organs and cells.  The animals used for this 
preliminary investigation were 13 week old APC mNLS mice, the progeny of two 
heterozygous F2 APC mNLS mice.  At generation F2 the mice should be identical to 
the C57BL/6J mice across approximately 75% of the genome.  Two mice, one APC 
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mNLS+/+ and one APC mNLS-/-, were sacrificed for this analysis.  Analysis of the 
splenocytes revealed no significant differences in the white blood cell count, the ratio 
of T-cells to B-cells, or the ratio of cytotoxic T-cells to helper T-cells in the spleen.  
There were also no significant differences in the percentage of cells in the various 
stages of thymocyte development or in the ratios of T-cells to B-cells or cytotoxic T-
cells to helper T-cells in the inguinal lymph nodes, peyers patches or bone marrow 
(personal communication, K. Cool, A. Dotson and S. Benedict).  While these data do 
not support a role for nuclear APC in the development of the immune system, there 
are several factors to take into account, including the extremely small number of mice 
analyzed, the young age of the mice analyzed and that these mice are far from 
congenic.  A comprehensive analysis of immune function in the APC mNLS mice 
would require the use of congenic mice and involve analyzing a larger pool of 
animals.  Another factor to consider is that the appearance of irregular intestinal 
lymph nodules was associated with a more advanced age in the F1 through F3 
generations of mice.  Therefore future analysis should examine the state of the 
immune system in mice that are approaching 52 weeks of age rather than in mice at 
13 weeks of age.  
 
Heterozygous and Homozygous APC mNLS mice appear to have a normal lifespan 
 The normal lifespan of a mouse is between 1.5 and 2.5 years.  To assess the 
average lifespan in the APC mNLS WT, heterozygous and homozygous mutant mice, 
heterozygous mice of the F1 generation were bred to heterozygous littermates.  The 
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resulting litters contained mice of all three APC mNLS genotypes.  These mice are 
considered outbred and are expected to be only 50% identical to the C57BL/6J.  
However, because these mice would reach the estimated end of their lifespan at 
approximately the same time that the first congenic mice would be born, the use of 
these outbred mice allowed us to evaluate differences in survival nearly two years 
before this analysis could be accomplished using fully congenic mice.  The mice in 
the survival curve represent the pups from 7 separate litters yielding a total of 70 
mice.   
At one year the percentage of surviving mice is nearly identical for all three 
genotypes (Figure 3.20).  Because the mice can be expected to begin dying of old age 
at 1.5 years, the similarity in the number of surviving mice for each of the three 
genotypes would suggest that the APC mNLS mutations do not affect lifespan.  Only 
seven of the mice assigned to the survival experiment died prior to 1 year.  A 
complete necropsy was performed on one of the dead heterozygous mice.  No 
apparent cause of death was detected.  Organs were stored in formalin and subject to 
histological analysis at the Veterinary Lab Resources Department at the University of 
Kansas Medical Center.  No abnormal physiology was detected in any of the samples 
sent for analysis.  The tendency of the mice to cannibalize dead littermates made 
cause of death impossible to determine for the other six dead mice.   
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Figure 3.20
A Kaplan-Meyer plot comparing the relative survival rates of APC mNLS+/+, APC mNLS+/-
and APC mNLS-/- mice.  All mice are the result of F1 APC mNLS+/- mice bred to F1 APC 
mNLS+/+ siblings.  The curve extends 50 weeks.  The oldest litter of mice was born 2/07/07 
and the youngest litter was born 4/11/07. 
A possible dominant negative effect for the APC mNLS mutation 
We saw in the proliferation analysis that heterozygous animals appeared to 
have a slightly increased number of Ki-67 positive cells and yet displayed a 
proliferative zone that was reduced in size.  This phenotype was not seen in the 
homozygous mutant animals suggesting that a more severe phenotype may result 
from heterozygosity for the APC mNLS mutations.  There also appears to be a 
disparity in the number of heterozygous mice born in the APC mNLS mouse colony.  
In the seven litters of mice that were used for the survival curve, the ratios of APC 
mNLS+/+, APC mNLS+/- and APC mNLS-/- mice varied from the ratios expected 
based on Mendelian genetics (25:50:25) (Table 3.4).  The observed percentages, 
however, were 33:37:30, indicating that a lower than expected number of 
heterozygous mice was born.  While this disparity was surprising, the chi squared test 
gave a value of 4.743 correlating with a p-value of 0.0933, which is above the value 
at which the disparity would be considered statistically significant (a p-value of 0.05 
or below is considered statistically significant).  To determine if this disparity 
between the observed and expected distributions would persist, the genotype 
distribution of the mice in future litters was also analyzed.  At generation F5, when all 
APC mNLS pups resulting from the mating of two heterozygous parents were taken 
into account, the chi squared test gave a value of 5.9 correlating with a p-value of 
0.0524 (Table 2.3).  While this value was still above the value considered statistically 
significant, the discrepancy in the expected and observed distribution of mice was not 
only still observed but had become more pronounced.  Compared to the predicted  
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Table 3.4 A summary of the genotypes of the mice in the survival curve
 mice born dead mice
APC mNLS +/+ 23 2
APC mNLS +/- 26 4
APC mNLS -/- 21 1
χ² value 4.743 2.217
p value 0.0933 0.33
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Mendelian ratio, there was still a lower than expected number of heterozygous mice 
born. 
 A possible explanation for the lower than expected ratio of heterozygous pups, 
was that some of the APC mNLS heterozygous mice were dying prior to birth.  If the 
APC mNLS+/- mice die during development, a similar disparity in the distribution of 
progeny would be expected when the heterozygous APC mNLS mice are bred to WT 
C57BL/6J mice.  Mendelian genetics would predict when a heterozygous mutant 
mouse is bred to a WT mouse the progeny should be heterozygous mutant or WT 
with a 50:50 distribution of the two genotypes.  Currently there have been 136 pups 
born as a result of breeding APC mNLS+/- mice to C57BL/6J WT mice.  An 
evaluation of the genotypes in those litters revealed no shortage of heterozygous 
mice; instead the distribution closely resembled the expected Mendelian values 
(Table 2.3).  
 The observation that fewer than expected heterozygous animals were born 
when both parents carried the APC mNLS mutation, but a normal distribution was 
observed when one of the parents was a WT mouse suggested that there may be a 
parental effect.  To evaluate the possibility that the genotype of the dam or sire was 
affecting the genotype distribution of the pups, the litters born to heterozygous 
females bred to WT males were evaluated separately from the litters born to WT 
females bred to heterozygous males Table 3.5).  Heterozygous pups were born in 
expected numbers when either the dam or the sire was a WT mouse, regardless of 
which parent supplied the mutant Apc allele. 
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Heterozygous Sire Heterozygous Dam Total
Wild type 38 26 64
Heterozygous 48 24 72
Total 86 50 136
χ² 1.163 0.080 0.471
p-value 0.2809 0.7773 0.4927
Table 3.5 A summary of the total mice born to APC mNLS+/- mice bred to WT C57BL/6J 
mice.  The distribution of WT and hetrozygous pups born is analyzed independently for 
litters in which the mutant APC allele came from the dam versus litters in which the mutant 
allele was passed down from the sire.
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 A phenotype suggesting a subtle disadvantage for the heterozygous APC 
mNLS mice was further supported by the mice in the survival curve.  Seven of the 70 
mice included in the survival curve died prior to one year.  Interestingly, of the 7 mice 
to die within the first year, 4 of them were heterozygous for the APC mNLS 
mutation.  If mouse deaths were not connected to the APC genotype, it would be 
expected that the dead mice would be evenly distributed across all three genotypes.  
Again this discrepancy is not considered significant according a chi squared test 
(Table 3.4).  However, the higher than expected ratio of heterozygous mice to die 
early in conjunction with the lower than expected ration of heterozygous mice born is 
grounds for continued close observation of the heterozygous phenotype in the mouse 
colony. 
 
 
 
Discussion 
The APC mNLS mice carry knock-in mutations to the endogenous Apc gene.  
These mutations consist of alanine substitutions for the lysine and arginine residues 
that form the APC NLSs (Figure 2.1).  The loss of these highly charged amino acids 
prevents these sites from binding to importin-α, resulting in an APC protein that is 
deficient in its ability to be effectively targeted to the nucleus (25).  Endogenous APC 
with knock-in mutations to the NLSs was observed at normal levels in the intestinal 
epithelium with an overall localization pattern similar to WT APC.  Confocal analysis 
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of the intestinal epithelia of the APC mNLS mutant animals revealed a decrease in the 
ratio of APC in the nuclear compartment in the colon but no apparent phenotype in 
the small intestine.  APC was never observed to be completely excluded from the 
nucleus even in the homozygous mutant animals.  The continued presence of APC in 
the nucleus suggests that another method of nuclear import is able to at least partially 
compensate for the loss of APC’s NLSs.  It is currently not known if APC is routinely 
imported through this alternate method, or if the cell is initiating an alternative 
nuclear import pathway in response to APC levels in the nucleus falling below some 
critical threshold level.  The existence of a compensatory pathway is supported by the 
observation that the heterozygous mutant mice seem to be subtly disadvantaged.  It is 
conceivable that in a subset of animals with only one mutant APC allele, the nuclear 
levels of APC are too low to maintain proper tissue integrity, but high enough that no 
cellular counterbalance action is initiated.  The homozygous APC mNLS mice, which 
would be expected to completely lack nuclear APC, seem to survive as well as the 
WT animals and perhaps slightly better than their heterozygous littermates.  One 
explanation is that cells that completely lack APC mNLS activity are able to initiate 
an emergency mechanism to counteract the loss of correct APC nuclear shuttling.   
While this sustained nuclear import makes the nuclear function of APC more 
complicated to analyze in these mice, there is the potential that the APC mNLS 
mouse line will be a valuable tool for the investigation of alternate nuclear import 
strategies.  It has been observed previously that truncated forms of APC can retain 
some of their nuclear shuttling ability even after the loss of the NLSs (29).  This, 
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however, is the first reported observation of full length APC protein shuttling into the 
nucleus without the characterized NLSs. 
Further analysis of the intestinal epithelium revealed that β-catenin protein 
levels were elevated in mice that carried APC mNLS mutations.  A potential role for 
APC in the regulation of the nuclear level of β-catenin has long been supported (36, 
48, 49).   It is known that the APC NLSs are regulated by phosphorylation (25, 50).  It 
is possible that APC is phosphorylated in response to cell signaling events and that 
this modification results in APC targeting to the nucleus to down-regulate β-catenin 
transcriptional activity and facilitate β-catenin export to the cytoplasm for proteolysis 
(36, 48, 49).  The inhibition of the NLSs through mutation would then result in a loss 
of correct nuclear targeting in response to APC phosphorylation.  However, the size 
of the proliferative compartment in the intestinal epithelium of APC mNLS mutant 
mice was not what would be expected to accompany transcriptionally active β-
catenin.  While there appeared to be a slight increase in the total number of Ki-67 
positive cells in the mutant APC mNLS compared to their WT littermates, these 
differences were not significant. 
Despite some observed changes in APC localization, β-catenin abundance, 
and proliferation seen at the cellular level, at the organismic level, APC mNLS mutant 
mice appear to be phenotypically normal, with a similar lifespan as their wild type 
siblings and no apparent polyposis phenotype.  At the macroscopic level, the only 
observed difference in the intestine of the heterozygous mutant and WT APC mNLS 
animals was an increase in the number of lymphoid nodules in the intestines of the 
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mutant animals.  Lymphoid nodules are present in both mutant and WT APC mNLS 
mice and the incidence of macroscopically observable nodules increases with age for 
both genotypes.  However, the APC mNLS+/- mice appeared more likely to develop 
nodules at an earlier age and displayed a greater number of total nodules than the 
APC mNLS+/+ mice. 
A link between APC function, intestinal polyposis and inflammation has been 
suggested previously.  Both animal studies and epidemiological evidence in human 
FAP patients suggest that non-steroidal anti-inflammatory drugs (NSAIDs) are able to 
inhibit polyp development and progression in the intestine (51).  Previous APC 
mouse models have also reported a phenotype in both the local and systemic immune 
system of the mutant mice.  In general APC mutations seem to cause a decrease in 
immune function (42, 45) and a stimulation of intestinal immune activity leads to an 
inhibition of polyp formation in APC mutant mice (43, 46).  While there is no 
apparent polyposis phenotype in the APC mNLS mice, there does appear to be an age 
dependent stimulation of the gut associated lymphoid tissue.  If a local immune 
response can be stimulated by a C-terminal domain of APC in the cytoplasm it would 
explain the observations that truncated APC results in a decreased immune response.  
In that same scenario, a stimulation of the intestinal immune system would be 
expected in the APC mNLS mice in which full length APC is retained in the 
cytoplasm due to defective nuclear shuttling.  Further studies of the immune system 
in older APC mNLS mice are needed to establish a more definitive relationship 
between APC status and immune function. 
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Another hypothesis explaining why there is no apparent polyposis phenotype 
in the APC mNLS mice is that nuclear APC may not be essential for tumor 
suppression under normal physiological conditions.  This does not preclude the 
possibility that nuclear APC may play a role in other processes such as the protection 
against DNA damage or DNA repair.  Should APC participate in the cellular DNA 
damage response, a phenotype would only become apparent if the mice were to 
encounter stresses that are improbable given the highly controlled environment in 
which they are maintained.  It is also possible that one or several of APC’s multiple 
nuclear binding partners may be assisting in nuclear import.  This assisted shuttling in 
conjunction with the suspected weaker nuclear import sites may result in enough APC 
being shuttled into the nucleus to maintain at least the appearance of normalcy in a 
controlled environment.  We have received approval to conduct an animal study in 
which the APC mNLS mice will be treated with reagents that will induce genotoxic 
stress in the intestinal epithelium. However, an analysis of this magnitude can not be 
properly performed without a fully congenic APC mNLS mouse colony. 
To date, the generation of a congenic APC mNLS mouse line in the C57BL/6J 
genetic background is ongoing, with the first congenic mice expected to be born 
within by early 2009.  The establishment of a colony of congenic APC mNLS 
C57BL/6J mice will allow for a more complete evaluation of the APC mNLS 
phenotype.  The fully congenic mice will allow direct comparison of the APC mNLS 
phenotype with the WT C57BL/6J animals as well as other existing APC mouse 
models currently on the C57BL/6 background.  In addition, the congenic APC mNLS 
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mice will be bred with other mouse models that carry mutations in proteins of 
interest.  We currently have a colony of APC Min mice which we intend to breed 
with APC mNLS congenic animals.  We are also expecting delivery of mice that 
carry a Fen-1 mutation.  The Fen-1 mice carry a knock-out mutation in an allele of 
the Flap endonuclease-1 (Fen-1) gene, a component required for the base excision 
pathway of DNA repair.   An analysis of the phenotype in the congenic APC mNLS 
mice as well as APCMin/mNLS mice and Fen-1-/- APC mNLS-/- double mutant animals 
will further our understanding of the role for nuclear APC in tissue maintenance and 
tumor suppression. Preliminary data collected in the non-congenic APC mNLS 
animals over the past year has suggested a role for nuclear targeted APC in the 
regulation of cellular levels of the oncogene β-catenin.  Furthermore, our initial 
analysis has also hinted at a possible function for nuclear APC in the intestinal 
immune response.  These and other avenues of investigation will be further pursued 
using the congenic APC mNLS mouse colony. 
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CHAPTER 4 
THE APC mNLS MUTATION IN CULTURED CELLS 
 
 
Abstract 
Characterization of the mNLS mutation in mouse intestinal epithelium will 
provide the most complete view of nuclear APC’s role in tissue maintenance and 
tumor suppression.  However, a significant amount of data can also be collected in 
cultured cells that carry the APC mNLS mutations.  An evaluation of the APC mNLS 
ES cells supplied information that was required prior to generating the APC mNLS 
mouse line.  Further analysis of cells in culture was conducted to supplement the 
preliminary evaluation of the mouse model.  This chapter describes the work done in 
cultured cell lines that carry the targeted APC mNLS mutation. 
 
  
 
 
 
 
 
 
 
 
 
154
 Introduction 
In 1907, Ross Harrison used cells dissected from a frog embryo and grown in 
a hanging drop of frog lymphatic fluid to observe the out-growth of nerve fibers (1).  
While bacteria and molds had been grown using similar methods, the ground-
breaking idea that cells from a complex multi-cellular organism could be removed 
from where they grew in vivo (in life) and kept alive in vitro (in glass) began a new 
field of science known as tissue culture (reviewed in(2).  It took another 50 years of 
developing and refining techniques before the use of cells grown in culture became 
widespread.  Now nearly every aspect of biology has been impacted by this 
technology.  The ability to grow cells in culture opened up new avenues for the study 
of viruses and the development of vaccines (2). The production of monoclonal 
antibodies is reliant on the ability grow and manipulate mouse B cells in culture (3).  
Cancer research has used tumor cells grown in culture to establish much of our 
current understanding of the disease (4).  Even the current animal models used to 
study cancer and other diseases are generated using transgenic technologies which are 
possible because embryonic stem cells can be maintained in culture(5-8). 
While cells grown in culture are unable to provide the same types of data that 
can be collected from whole animals and tissues, there are a number of advantages to 
working with cultured cells (9).  Cells grown in culture exist in a controlled 
environment with limited variables.  The cellular response to chemicals, pH, 
irradiation, temperature and a variety of other factors can be conducted in a highly 
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controlled manner.  Cells grown in a dish are more available for examination, be it 
through direct observation, protein extraction or immunohistochemical analysis, and 
require less preparative processing than cells that are part of a more complex tissue.  
Maintaining cells in culture is far cheaper as well as more time and labor efficient 
than maintaining animals.  Unlike animal work, which requires extensive paperwork 
and approval, work in cell culture can be conducted as the experiments are formulated 
leading to a more direct examination of the question at hand.  For these reasons cell 
culture work often precedes and lays the foundation for work in animal models. 
 The creation of the APC mNLS mouse model began with the manipulation of 
mouse Embryonic Stem (ES) cells in culture.  ES cells are derived from 3.5 day old 
mouse embryos, and can self-renew indefinitely in culture without loosing their 
potential to differentiate into normal tissues of a variety of lineages (10).  This 
unlimited ability to self-renew is a significant advantage of working with ES cell 
lines.  Cells derived from other tissue types undergo a limited number of cell 
divisions before they become senescent and stop dividing (11).  Because most cell 
lines possess a limited mitotic potential, the long term use of other primary cells in 
culture requires that they be immortalized (4).  Immortalization of primary cell lines 
generally requires the same mutations commonly associated with cancer cells (12).   
Cells lines derived from cancerous tumors generally grow very well in culture.  The 
first widely used cultured human cells, the HeLa cell line, was derived from a 
malignant tumor (2).  Previous to the culture of ES cells, cell culture primarily used 
genetically normal cell lines with a limited life span, or immortalized cell lines that 
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were genetically abnormal.  Much of cancer research has utilized cancer derived cell 
lines and immortalized primary cell lines (4).  However, these cell lines are not 
genetically or biochemically “normal” cells, a factor that must be considered when 
evaluating experimental results.  ES cells are unique in that they retain an unlimited 
potential for self-renewal that is maintained through proper handling and media 
supplements rather than genetic alteration.  
 ES cell lines may have the potential to be grown perpetually without the need 
for genetic mutation; however, this does not mean that they can be maintained forever 
without genetic alterations occurring.  If ES cells are cultured inappropriately, they 
progressively acquire genetic lesions (10). The extensive manipulation and selection 
required to create a knock-in ES cell line increases the likelihood that some of the cell 
lines will have accumulated genetic alterations in addition to the knock-in mutation 
(10).  Therefore, an initial characterization of the seven APC mNLS candidate cell 
lines was necessary prior to generating a mouse model.  Obtaining multiple separate 
cell lines was ideal because it allowed a straightforward identification of outliers.  
Only one cell line was needed to generate each mouse model with a total of two APC 
mNLS mouse models to be established.  Therefore five of the seven cell lines were 
discarded following the preliminary characterization.  In addition to identifying which 
cell lines were to be used for the generation of the mouse model, the initial 
characterization of the APC mNLS ES cell lines represents the first data collected 
from cells that carry mNLS mutations in the endogenous Apc gene.  
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Materials and Methods 
 
Maintaining ES cells 
Wild type R1 mouse ES cells were originally received from Dr Andras Nagy, 
Dr Reka Nagy, Dr Janet Rossant and Dr Wanda Abramow-Newerly (13).  R1 mouse 
embryonic stem cells with the mNLS knock-in mutations were generated as described 
in chapter 2.  Wild type and APC mNLS  R1 mouse embryonic stem cells were 
grown in ES media [81% High Glucose DMEM (Gibco) supplemented with 15% 
Fetal Bovine Serum (ES cell certified from Hyclone), 1mM sodium pyruvate (Gibco), 
0.1mM Non-essential amino acids (Gibco), 100ng/ml of ESGRO (Chemicon), 2mM 
L-glutamine (Gibco), 0.01mM 2-mercaptoethanol (Fisher)] in a 37°C water jacketed 
incubator with 7% CO2.  Cells were split ~1:9 every 2 to 3 days as needed and plated 
directly onto a mitomycin C-treated mouse embryonic fibroblast (MEF) cells or STO 
cell feeder layer.  STO cells are derived from SIM mice and are a thioguanine- and 
ouabain-resistant sub-line of mouse fibroblast. 
 
Preparing MEF and STO feeder layer cells 
 Vials of immortalized STO cells were obtained from the KU Medical Center. 
Neomycin resistant MEF cells were purchased from Chemicon.  All feeder cell lines 
were grown in High Glucose DMEM (Gibco) supplemented with 10% Fetal Bovine 
Serum (Hyclone).  Prior to use as a feeder layer, cells were expanded and growth 
arrested with 10μg/mL mitomycin C (Sigma) as previously described (10).  Vials of 
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growth arrested cells were stored in liquid nitrogen and thawed as needed.  A feeder 
layer of STO cells was plated at least 12 hours prior to the addition of ES cells to 
allow the feeder layer to establish a uniform monolayer on which the ES cells could 
be cultured.    
 
Karyotype analysis of ES cells 
 To obtain slides with chromosome spreads, WT and APC mNLS ES cells 
were incubated for 5 hours in ES growth media supplemented with 40ng/mL 
demecolcine (Fisher) to arrest the cells in metaphase.  Cells were then rinsed with 
PBS, dispersed with trypsin and pelleted by centrifugation.  The cell pellets were 
resuspended in 1mL of hypotonic buffer (40mM KCl and 25mM sodium citrate in 
water) and incubated for 20 minutes at 37°C to swell the cells.  After 20 minutes, 
3mLs of fixative [75% methanol, 25% acidic acid] was added directly to cells in 
hypotonic buffer while vortexing.  Cells were pelleted by centrifugation at 1000xg, 
resuspended in 1mL fresh fixative while vortexing and incubated on ice for 10 
minutes.  Cells were pelleted by centrifugation at 8000xg for 2 minutes and 
resuspended in 0.5mLs fresh fixative.  Using a pasture pipette, cells in fixative were 
dropped onto clean glass slides from a height of 5-7 feet.  Slides were briefly passed 
over a flame to dry, incubated in 0.1μg/mL DAPI for 10 minutes to label the DNA 
and incubated in TBS for 5 minutes to wash away excess DAPI.  Coverslips were 
mounted with Prolong Anti-Fade (Invitrogen).  DAPI-labeled chromosomes were 
examined using a Zeiss Axiovert 135 inverted fluorescent microscope.  Images were 
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collected at 1000X magnification using an Olympus MC100spot camera and analyzed 
using Magnafire software (Olympus).   
 
Immunohistochemistry 
 Immunostaining was performed essentially as previously described (14) using 
the following antibodies: Mouse anti-β-catenin (1:1000, Transduction Laboratories), 
mouse anti-APC (Ali-12-28 1:100, Abcam), anti-APC-M2 rabbit polyclonal antibody 
made against amino acid 1000-1326 and affinity purified (1:3000), mouse anti-BrdU 
(1:1000, Becton Dickinson) goat anti-mouse IgG Alexa 488 (1:1000, Molecular 
Probes), goat anti-rabbit IgG Alexa 568 (1:1000, Molecular Probes).  DNA was 
labeled with DAPI (0.1μg/mL).  Briefly, wild type, heterozygous and homozygous 
mutant MEF cells and wild type and heterozygous mutant ES cell lines were seeded 
onto glass 22x22mm coverslips (Fisher) and allowed to adhere for at least 24 hours.  
Coverslips used in ES experiments were coated with Poly-L-Lysine (Sigma) prior use 
to enhance adhesion.  Cells on coverslips were removed from media, rinsed twice 
with PBS and fixed for 30 min on ice in 4% paraformaldehyde containing 0.1% 
Triton X-100.  Prior to incubation with primary antibody, coverslips were rinsed 
twice for 5 minutes in PBS, permeabilized with 0.2% Triton X-100 in TBS and rinsed 
3 times for 5 minutes in TBS before being inverted over drops of primary antibody 
for 90 minutes. After incubation with primary antibody, coverslips were rinsed 3 
times for 5 minutes in TBS, inverted for 30 minutes over drops of secondary antibody 
and 5 minutes over DAPI (0.1μg/mL) before being washed three times for 5 minutes 
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in TBS.  Stained coverslips were mounted onto glass slides with Prolong Anti-Fade 
(Invitrogen) and viewed on a Zeiss META 510 upright confocal microscope with a 
60X water objective or an Olympus 3I spinning disc confocal TIRF inverted 
microscope and analyzed using SlideBook software.   
   
Measuring β-catenin activity with Topflash/Fopflash assay 
Wild type and APC mNLS ES cells were plated into 12-well culture dishes 
and transfected when approximately 70% confluent.  Cells were co-transfected with 
1μg of TOPFLASH or FOPFLASH vector (15) and 50ng of a β-galactosidase vector 
using 5μL Fugene HD (Roche) per transfection and incubated according to 
manufacturer’s protocol.  Luciferase activities were determined after 48 hours using 
the Luciferase Assay System (Promega) in an LMAX II plate reader (Molecular 
Devices) using 96-well white polystyrene plates (Corning Incorporated).  All 
luciferase values were normalized for transfection efficiency based on the β-
galactosidase activity as determined using Galacto-Light Plus assay kit (Tropix).  
Each transfection was performed in triplicate. 
 
Generation of Homozygous ES cells 
 Several attempts were made to isolate ES cell lines homozygous for the APC 
mNLS mutations according to previously described methods (16).  ES cells from the 
MES-4 cell line were reselected on 4.0mg/mL G418 (Sigma or Gibco).  For these 
experiments ES cells were grown on gelatin coated wells or growth-arrested Neor 
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primary mouse embryonic fibroblasts (PMEF-NL from Chemicon) and G418 media 
was changed daily.  After 8 days of G418 selection, the surviving ES colonies were 
picked as described (10) and transferred to individual wells of duplicate 96-well 
plates over gelatin or growth-arrested PMEF-NL cells.  ES Cells were grown in high 
LIF media [51% High Glucose DMEM (Gibco) supplemented with 30% Fetal Bovine 
Serum (ES cell certified from Hyclone), 1mM sodium pyruvate (Gibco), 0.1mM Non-
essential amino acids (Gibco), 1600ng/ml of ESGRO (Chemicon), 2mM L-glutamine 
(Gibco), 0.01mM 2-mercaptoethanol (Fisher)].  Media was supplemented with 
4mg/mL G418 for an additional 4 days at which point the cells were cultured without 
selection to encourage growth.  DNA was isolated from cells in one of the 96-well 
plates as described (17) and screened using PCR to determine the APC genotype (as 
described for the original ES cell lines in Chapter 2).   
 
Isolation of Mouse Embryonic Fibroblasts 
 Mouse Embryonic Fibroblasts (MEFs) were isolated essentially as described 
(10).  Embryos were obtained by crossing an F2 APC mNLS+/- female with an APC 
mNLS+/- male sibling to produce APC mNLS-/-, APC mNLS -/+ and APC mNLS+/+ 
embryos.  Fifteen days after mating the pregnant female was sacrificed by CO2 
asphyxiation, briefly ethanol flamed to sterilize the exterior surfaces and the uterus 
was removed using aseptic technique.  Embryos were processed individually in a 
laminar flow hood to maintain pure genotypes in each of the MEF cell lines.  After 
removal of internal organs, limbs and head, the remaining embryonic tissues were 
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minced and placed into sterile tubes containing 5mM autoclaved glass beads and 
treated 3x 30 minutes with 1x trypsin while shaking at 37°C.  DMEM supplemented 
with 10% FBS and 1% Penicillin-Streptomycin (Gibco) was used to wash cells and 
seed them onto 75cm2 cell culture flasks.  The media was changed daily until the cells 
were completely confluent.  Cells were split 1:6 and again allowed to grow until 
confluent.  At this time cells from five 75cm2 flasks for each cell line were cryo-
preserved for later use as Passage 1 MEF cells.  The sixth flask of each cell line was 
split 1:5 and cells were again allowed to reach confluence before being cryo-
preserved as Passage 2 MEF cells. 
 
Maintaining MEF cells 
 MEF cell lines were stored in cryovials in liquid nitrogen until needed.  After 
thawing, cells were maintained in growth media [High Glucose DMEM (Gibco) 
supplemented with 15% FBS (Hyclone) and 1% Penicillin-Streptomycin (Gibco)].  
Cells were kept in a 37°C water jacketed incubator with 7% CO2 and split as 
necessary.  Once thawed, cells were maintained in culture for a maximum of two 
weeks.  All experiments are conducted on cells within the first 3-6 passages.  
 
Growth Curve analysis in MEF cells 
 MEF cells were thawed and grown for 1-2 passages in culture.  Following 
trypsinization, media containing FBS was added to neutralize the trypsin and cells 
were pelleted by centrifugation at 700xg for 5 minutes.  Cell pellets were resuspended 
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in fresh media and one tenth of the cells from each cell line were removed and 
quantified using a cell counter (Beckman Coulter).  The remaining cells were diluted 
as needed to achieve similar starting concentrations for all cell lines and plated into 6-
well or 24-well plates.  At the indicated time intervals all cells in a single well were 
trypsinized, pelleted and resuspended in isotonic dilution buffer (Beckman Coulter) 
and counted.  At the first time interval, the media was removed from all wells and 
replaced with fresh media to remove any non-attached cells. 
  
UV irradiation of MEF cells 
 MEF cells were plated into 2-well chamber slides and allowed to adhere.  
Regular media was removed after ~24 hours and replaced with media supplemented 
with 30μM BrdU (Sigma) for an additional 20 hours.  Prior to UV irradiation, media 
was removed and cells were rinsed once with 37°C sterile PBS.  A thin layer of PBS 
was left over cells to prevent drying.  Cells were placed into an Ultraviolet 
Crosslinker (UVP) and irradiated for 83 seconds at an intensity of 120mJ/sec 
resulting in a total exposure of ~10J/m2.  The non-irradiated control cells were 
processed identically except that the chamber slides were covered with aluminum foil 
during UV exposure.  Following UV irradiation the PBS was removed and replaced 
with fresh media.  Cells were placed back into the incubator for 1 hr to begin the 
process of DNA repair.  At the end of an hour cells were fixed and stained as 
described above. 
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Results 
Growth characteristics of the APC mNLS ES cells resemble those of WT ES cells 
 PCR screening of the targeted stem cells identified seven ES cell lines as 
potential candidates for use in generating a mouse model.  Four to six frozen vials of 
each cell line were received from the Transgenic and Gene-Targeting Institutional 
Facility at The University of Kansas Medical Center (Table 4.1).  Prior to evaluation 
of the individual cell lines, cells from each line were expanded to make additional 
frozen stocks of the early passage cells.  These stocks were thawed and used as 
needed for the following experiments.  The remaining original vials were stored in 
liquid nitrogen to be used for the generation of a mouse model.  
 All seven APC mNLS+/- cell lines and wild type ES cells were grown in 
parallel and relative growth characteristics were observed.  Most of the APC mNLS+/- 
cells were estimated to maintain an average level of growth that was comparable to 
wild type ES cells; however, there were outliers that did not fit this pattern.  Cells 
from ES line MES-3 consistently grew more rapidly than cells from other lines, 
needed to be passed more often and became confluent more quickly.  In contrast 
MES-7 cells exhibited a slower rate of growth and were rarely as confluent as the 
other cell lines when grown for an equal amount of time.  The observation that the 
majority of the APC mNLS+/- ES lines grew at  
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KU med 
designation
Neufeld lab 
designation
number of 
cells per vial
# of 
vials
3
2
3
2
4
2
2
3
3
2
1
3
4
2x106
1x106
2x106
1x106
2x106
1x106
2x106
1x106
2x106
1x106
2x106
1x106
2x106
1x106 2
PK2 II-A8
PK2 II-C2
PK2 III-D1
MES-1
MES-2
MES-3
MES-4
MES-5
MES-6
MES-7
PK1 I-A2
PK2 I-A10
PK2 I-D4
PK2 I-H3
*Mutant Embryonic Stem (MES) cell lines
*
Table 4.1 Potential knock-in mNLS stem cell lines received from
Transgenic and Gene-Targeting Institutional Facility at The Univ
Kansas Medical Center 
 the 
ersity of 
approximately the same rate as the wild type ES cells suggested that the APC mNLS 
mutation did not dramatically alter the proliferation rate of ES cells when 
heterozygous. 
 
 The transcription activity of β-catenin in APC mNLS ES cells resembles WT ES  
One of the best characterized functions of APC is its role in the down-
regulation of β-catenin.  APC is known to participate in the destruction complex that 
targets β-catenin for proteolysis in the cytoplasm (18).  APC has also been shown to 
inhibit the transcriptional activity of β-catenin in the nucleus (19).  β-catenin’s 
function as a transcriptional activator was, therefore, evaluated in APC mNLS+/- ES 
cell lines.   
When β-catenin is translocated to the nucleus, it serves as a co-activator 
protein and stimulates expression from target genes.  The use of the TOPFLASH 
reporter construct has become a standard method to measure the transcriptional 
activity of β-catenin in cells bearing Apc mutations (15).  In previous reports, Apc 
truncation corresponded with TOPFLASH reporter activity in a dose dependent 
manner (20, 21).  To test the hypothesis that the APC mNLS mutation may 
significantly alter the transcriptional activity of β-catenin in the APC mNLS ES cells, 
all seven knock-in cell lines and wild type ES cells were transfected with the 
TOPFLASH/FOPFLASH reporter system (15).  As expected, the WT ES cells 
showed slightly higher luciferase expression from the β-catenin-specific TOPFLASH 
reporter than from the FOPFLASH control reporter (Figure 4.1).  Results were similar  
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Figure 4.1
β-catenin transcriptional activity as measured by the TOPFLASH assay.  WT (blue bars) and 
APC mNLS+/- (green bars) ES cells were transfected with TOPFLASH (dark bars) or 
FOPFLASH (pale bars) luciferase expression vectors.  Luciferase intensity was normalized 
to the β-galactosidase transfection control values and expressed as an arbitrary luciferase
intensity value. 
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to relative levels of TOPFLASH and FOPFLASH activity previously reported for WT 
ES cells.  In this preliminary assessment, APC mNLS+/- cell lines MES-4, MES-5 and 
MES-6 showed relative TOPFLASH and FOPFLASH ratios similar to wild type 
cells.  MES-1 and MES-7 cells showed slightly lower TOPFLASH to FOPFLASH 
ratios while MES-2 and MES-3 cells showed slightly increased levels of TOPFLASH 
reporter activity relative to the FOPFLASH values (Figure 4.1).  Because β-catenin 
transcriptional activity is associated with cell proliferation, the observation that the 
MES-3 cell line exhibited relatively high β-catenin transcriptional activity was 
consistent with the slightly faster rate of proliferation that was previously observed.  
Similarly, the MES-7 cell line exhibited a comparatively lower level of β-catenin 
transcriptional activity compared to wild type cells and also seemed to proliferate 
more slowly.  However, MES-1 cells and MES-2 cells also demonstrated 
TOPFLASH activities that varied slightly from the wild type values, yet they 
displayed no obvious differences in proliferation.  Our observation that the 
TOPFLASH values for APC mNLS transgenic ES cells did not differ much from the 
wild type values suggests that the targeted mutation does not significantly affect β-
catenin activity, at least in ES cells heterozygous for the mutation. 
 
Karyotype analysis of APC mNLS ES cells 
A normal mouse genome contains 40 chromosomes, 19 pairs of somatic 
chromosomes and the two sex chromosomes.  Because cells that exhibit aneuploidy 
(an abnormal number of chromosomes) have low integration efficiency when injected 
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into blastocysts, it is very important that cells being used for generation of a mouse 
model display normal karyotypes.  The Gene-Targeting and Transgenic Facility at the 
University of Virginia requires that cell lines being used for injection into mouse 
blastocysts display a normal karyotype in at least 75% of the cells.  Cells still being 
considered as potential candidates for use in mouse generation were therefore subject 
to extensive karyotype evaluation.  Slides of chromosome spreads were prepared 
from the transgenic cell lines and wild type ES cells (Figure 4.2).  An initial 
evaluation was conducted by counting the number of chromosomes in 5 separate 
spreads for some of the cell lines.  This initial count revealed that MES-2 and MES-7 
had a higher number of cells with abnormal karyotypes than the wild type controls 
(Table 4.2).  In addition to a poor initial karyotype, cell lines MES-2 and MES-7 had 
given abnormal TOPFLASH and growth characteristics, respectively.  Thus they 
were eliminated from consideration as potential cell lines to be used in the generation 
of the mouse model.  Cell line MES-3, though not yet considered karyotypically 
abnormal, was also not analyzed further due to outlying results in both growth rate 
and TOPFLASH analysis. Cell lines MES-1, MES-4, MES-5 and MES-6 were 
selected for more extensive analysis of karyotype.  Over 44 individual chromosome 
spreads were counted for each of the four cell lines (Results in Table 4.3).  To be 
considered for blastocyst injections, more than 75% of the cells counted needed to 
contain 40 chromosomes.  Cell lines MES-5 and MES-6 did not pass the karyotype 
analysis with only 56% and 63.6% of the chromosome spreads containing a normal 
number of chromosomes.  This was primarily due to a single extra chromosome or a  
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Figure 4.2
An example of a typical chromosome spread prepared using mouse ES cells.  The 
chromosomes above are randomly numbered and display a correct karotype of 40 total 
chromosomes.  DNA is visualized with DAPI.  Image was captured on a Zeiss inverted 
fluorescent scope equipped with an Olympus camera.  
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Table 4.2
Initial karyotype results of the wild type and APC mNLS knock-
cell lines.  Five separate chromosome spreads were counted for ea
the indicated cells lines.  The  number of chromosomes in each s
indicated in the table below.  The mouse genome should contain
chromosomes.  Abnormal karyotypes are indicated in red. 
40394036MES-7
no viable cells for analysisMES-6
40404040MES-5
39404040MES-4
40404037MES-3
40393935MES-2
40403940MES-1
39404040WT
Table 4.3
More extensive karyotype analysis of selected APC mNLS knock-in ES cell lines.  
Cell lines with a stable enough karyotype to be considered for the generation of a 
mouse model are highlighted in yellow.
Cell line
cells with     
<40 
chromosomes
cells with        
40 
chromosomes
cells with        
>40 
chromosomes
cells with a normal 
karyotype/ total cells
% of cells with 
normal 
karyotype
MES-1 8 43 3 43/54 79.63%
MES-4 11 36 1 36/48 75%
MES-5 9 28 13 28/50 56%
MES-6 6 28 10 28/44 63.64%
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single missing chromosome, however, cell line MES-6 contained 42 chromosomes in 
18% of the cell spreads that were scored.  Cell lines MES-1 and MES-4 contained 40 
chromosomes in 79.6% and 75% of cells respectively.  These two cell lines were use 
to generate chimeric mice (Table 4.4).   
 
Optimizing conditions for ES cell immunofluorescence 
Epithelial cells and fibroblast cells will grow directly on glass slides and 
generally display a flattened morphology that facilitates microscopic imaging.  ES 
cells, however, grow in spherical clusters over a layer of feeder cells, rather than 
directly on glass, making them non-adherent and difficult to image.  In general, most 
of the ES cells were lost during the processing required for immunofluorescent 
analysis, resulting in a number of slides containing STO cells and little else.  Several 
techniques were employed to increase cell adherence when it became obvious that ES 
cells grown on glass slides would not yield enough attached ES cells for imaging.   
Initially, a Cytospin 3 cell preparation system (Shandon) was used to pellet 
suspended ES cells onto glass slides.  This did not result in an increase in the number 
of ES cells retained on the slide after processing.  The cell and tissue adhesive Cell-
Tak (BD) was added to the chamber slides at 20μL/mL in 0.1M NaHCO3 for 30 
minutes to coat the glass prior to being seeded with ES cells.  For this method, ES 
cells were mechanically disrupted from their clusters by pipetting or proteolytically 
disrupted using trypsin, added to the Cell-Tak coated chamber slides, and allowed to 
adhere for 15-90 minutes before being rinsed, fixed and stained.   This method led to  
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Table 4.4
A summary of the initial characterization of the of the APC mNLS transgenic ES cell 
lines.  Bolded entries represent ideal results, italicized entries represent results that 
eliminated the indicated cell line from further consideration for generation of a mouse 
model 
Cell line Growth rate TOPFLASH assay Karyotype
MES-1 normal slightly low Normal (79.6%)
MES-2 normal high poor in initial analysis
MES-3 fast slightly high ok in initial
MES-4 normal normal Normal (75%)
MES-5 normal normal Abnormal (56 % correct)
MES-6 normal normal Abnormal (63.6% correct)
MES-7 slow slightly low poor in initial analysis
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a slightly increased number of retained ES cells following processing for 
immunofluorescent analysis.  The resulting slides generally contained a fairly small 
number of whole ES cells and a large amount of cellular debris adhered to the Cell-
Tak.  In an attempt to further increase adherence, highly concentrated Cell-Tak was 
applied to glass slides and ES cells were plated directly on top of the Cell-Tak, which 
led to an increase in both the number of ES cells and the amount of debris retained on 
the slide.   
While this method proved to be an effective way of retaining enough ES cells 
on the slide to image, there was concern that this treatment of the cells would affect 
the observed staining pattern for some proteins.  We typically grow most cell types 
for 12-24 hours on the glass slide on which they are fixed and stained.  The use of 
Cell-Tak to enhance ES adhesion required that the ES cells be removed from the 
feeder layer and disrupted from their spherical clusters, either through mechanical 
disruption or by using trypsin, immediately prior to fixation for staining.  It was 
feared that stressing the cells in this manner would alter the localization pattern of 
APC.   To avoid this stress, ES cells would need to be grown for a more extend time 
on glass coverslips that had been treated to enhance cell adhesion.  ES cells plated on 
collagen IV coated slides were retained quite well even after extensive washes; 
however, this method also resulted in a significant increase in the non-specific 
background signal following antibody incubation.  Eventually, it was determined that 
the most effective method to retain ES cells on the slide while producing the least 
amount of background signal was to grow the ES cells on coverslips that had been 
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coated with poly-L-lysine.  Poly-L-lysine (Sigma) was applied to glass coverslips 
according to manufacturer’s instructions.  The poly-L-lysine coated coverslips were 
then sterilized under UV light and placed into the wells of a 6-well tissue culture 
plate.  ES cells were seeded into the wells and allowed to attach to the coverslips for 
at least 12 hours before being processed for imaging.  While a significant amount of 
cell loss during the staining procedure was still observed, sufficient numbers of ES 
cells were typically retained to allow imaging. 
 
β-catenin localization in the APC mNLS ES cells is unaltered 
There is evidence that APC and β-catenin interact in the nucleus and that APC 
participates in the export of β-catenin from the nuclear compartment (19, 22, 23).  It 
is therefore possible that inhibition of nuclear targeting of APC protein would result 
in a change in the localization pattern of β-catenin.  In most cell lines a majority of 
the β-catenin is localized to the adherens junctions where β-catenin interacts with E-
cadherin (24).  When the localization of β-catenin in WT ES cells was analyzed using 
confocal microscopy, the cells displayed the expected antibody staining pattern.  The 
most intense β-catenin staining was localized to the plasma membrane between cells 
with only a small signal observed in the cytoplasm and nucleus (Figure 4.3).  The β-
catenin localization in the APC mNLS ES cells showed no significant variation 
between cell lines, and the overall staining pattern was indistinguishable from the 
pattern observed in WT ES cells (Figure 4.3).  The absence of a noticeable alteration 
of the β-catenin staining pattern in the APC mNLS cells was not necessarily  
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Figure 4.3 
β-catenin localization in WT and APC mNLS+/- ES cells.  ES cells were grown on poly-L-
lysine coated coverslips and visualized using a rabbit anti-β-catenin antibody (Sigma).  
Images were taken on a Zeiss upright confocal microscope with a 60X water objective.  
Scale bar = 5μm. 
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unexpected.  These cells are heterozygous for the knock-in APC mNLS mutation; 
therefore the APC protein expressed from the WT allele is capable of normal nuclear 
import.  That amount of nuclear APC was apparently sufficient for the normal 
regulation and localization of β-catenin in these cells. 
 
The localization of APC in the APC mNLS candidate cell lines 
 Unlike β-catenin, for which numerous dependable, high quality antibodies are 
commercially available, staining for APC in ES cells proved to be much more 
difficult.  While a number of commercially available APC antibodies exist, there is 
much debate in the field as to the specificity and reliability of many of those 
antibodies (25, 26)  Furthermore, the few commercially available APC antibodies that 
are considered to be specific for APC have demonstrated a great deal of variability in 
quality between antibody batches (unpublished observations and personal 
communications).  An analysis of APC localization using multiple APC antibodies in 
all of the APC mNLS cell lines was attempted; however, the inherent difficulties 
involved in staining ES cells in conjunction with the generally poor quality and 
extreme variability in the staining patterns of the various commercially available APC 
antibodies resulted in an incomplete analysis.  In general, very little difference was 
observed in the APC localization patterns of the mutant ES cells lines.  All seven of 
the mutant cell lines were indistinguishable from each other and the WT ES cells 
(data not shown).   
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The absence of a noticeable alteration in the APC staining pattern in the APC 
mNLS ES cells was unexpected.  Even though only one allele of APC carries the 
mutant NLSs, it was anticipated that there would be some decrease in the level of 
nuclear APC in the mutant cell lines compared to WT ES cells.  It is possible that 
some threshold level of APC is maintained in the nucleus and that the APC protein 
from the WT allele was able to compensate for a decreased level of the total APC 
being targeted to the nucleus.   
 
Attempts to generate homozygous APC mNLS cells 
The Neor gene encodes the enzyme neomycin phosphotransferase II which 
confers cellular resistance to a variety of antibiotics including G418.  Cells expressing 
the WT Neor are capable of growth in 5-10mg/mL G418 at which point the 
concentration of drug in the media begins to cause a general cell toxicity (10).  The 
WT version of the Neor gene therefore provides a robust antibiotic resistance but no 
ability to select for different levels of gene expression in the targeted cells.  In 1990 a 
mutant version of this enzyme was reported with significantly reduced 
phosphotransferase activity (27).  The gene replacement vector used to target the 
APC mNLS knock-in mutations carried a copy of the mutant Neor gene.  As a result, 
APC mNLS ES cells expressing a singe copy of the mutant Neor gene were be able to 
grow in the presence of low concentrations of G418 (~0.2mg/mL) but were sensitive 
to G418 at higher concentrations.  Cells containing two copies of the mutant Neor 
gene, however, can be expected to survive G418 selection at concentrations as high as 
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4mg/mL, providing a method to differentiate between cells that were heterozygous 
for the gene replacement vector and cells that were homozygous for the targeted 
locus.     
It has been demonstrated that loss of heterozygosity (LOH) frequently occurs 
in mouse cells, usually due to a loss/duplication event at the chromosome level (28).  
It is probable that in a percentage of the APC mNLS cells LOH has already occurred.  
Selection for cells that can grow on high levels of G418 (at least 2-6x that used in the 
primary selection to identify the heterozygous ES cells) has been shown to be an 
efficient method to acquire homozygous mutant cell lines without a second round of 
targeting (16, 28). 
The heterozygous mutant APC mNLS ES cell lines demonstrated a phenotype 
that was indistinguishable from that of WT ES cells.  The localization of APC, the 
localization pattern and transcriptional activity of β-catenin and the growth rate of the 
majority of the knock-in cell lines closely resembled the characteristics of the WT ES 
cells.  This lack of detectable phenotype suggested that a heterozygous loss of the 
APC NLSs had no effect on ES cells.  We therefore wished to analyze the phenotype 
in homozygous cells.  To acquire homozygous mutant APC mNLS ES cells, MES-4 
cells were subjected to a second round of selection on G418 media.   
 To determine the optimal concentration of G418 for selection of homozygous 
cells, MES-4 cells were grown in media containing 0, 0.2, 1.2, 2.0, 3.0 and 4.0 
mg/mL G418.  Because the STO feeder layers did not express Neor and would 
therefore not survive G418 selection, 6-well tissue culture plates were treated with 
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0.1% gelatin prior to the addition of the ES cells to facilitate ES cell growth and 
adherence in the absence of a feeder layer.  Selection media was replaced daily to 
maintain a consistent concentration of the drug on the cells.  After six days, the APC 
mNLS ES cells growing in the presence of 0 and 0.2mg/mL G418 were over-crowded 
and showed evidence of differentiation.  In the wells that contained 1.2, 2.0, 3.0 and 
4.0mg/mL G418, a majority of the ES cells had died.  Clumps of dead floating cells 
were removed daily from these wells during the media changes.  However, a small 
number of ES cell colonies appeared firmly adhered and growing in the presence of 
the higher concentrations of G418, suggesting that some of the ES cells had 
duplicated the Neor gene.  Following 8 days of selection, 17 ES cell colonies were 
picked from the wells that had been treated with 3.0 and 4.0mg/mL G418.  The 
colonies were treated with trypsin to disperse the cells and re-plated in individual, 
gelatin coated wells of duplicate 96-well dishes.  These cells were grown in 
4.0mg/mL G418 for an additional three days.   DNA was isolated from the ES cells in 
one of the 96-well plates and PCR was used to screen for the presence of the mutant 
and WT Apc alleles.  All 17 samples were able to amplify product that contained the 
WT Apc allele.   
There were several explanations to account for the presence of ES cells 
retaining the WT Apc allele after selection in higher concentrations of G418.  Instead 
of chromosome loss and duplication, the Neor gene may have been duplicated 
through the process of mitotic recombination, allowing a portion, but not all, of the 
targeted chromosome to be replicated.  This could result in a LOH of the Neor gene 
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while maintaining heterozygosity for the Apc mNLSs.  In theory, mitotic 
recombination should occur rarely and be less likely than chromosome loss and 
duplication (28).  The apparent selection against an LOH event that would result in 
two copies of the mutant Apc allele suggests that nuclear APC plays an important 
function in ES cells.  A second possibility was that the cell lines were not completely 
homogeneous.  While the intent was to pick individual colonies and re-plate them into 
separate wells, heterozygous cells growing close to homozygous cells could have 
escaped being killed by the higher G418 concentrations and become contaminants in 
the homozygous cell lines after drug selection was discontinued.  Several of the 
homozygous-candidate cell lines that produced significantly less PCR product from 
the WT allele of Apc were sub-cultured and grown for several more days in the 
presence of 4mg/mL G418, however, no pure homozygous cell lines were produced. 
 A second attempt was made to select for homozygous APC mNLS ES cells.  
In the initial attempt, ES cells had been plated in gelatin coated wells and allowed to 
attach prior to beginning G418 treatment.  In an attempt to eliminate heterogeneous 
colonies of cells, MES-4 cells were dispersed with trypsin and pelleted, then the cell 
pellet was re-suspended directly in media containing 4mg/mL G418.  It was thought 
that immediate treatment with drug while the cells were still dispersed in solution 
would eliminate non-resistant cell survival by preventing them from growing in close 
association with the drug-resistant cells.  Most of the cells died in suspension and 
were removed with the first media change.  The ES cell colonies that did survive and 
adhere appeared to grow better than the colonies observed in the previous round of 
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selection.  It was likely that the ES cell colonies were able to grow better without the 
contact inhibition of dying ES colonies around them.  ES cells were sub-cultured once 
during the initial selection period.  This served both to prevent the cells from 
becoming too confluent during the 8 day selection with G418, and also to provide 
another round of drug selection on dissociated cells.  Following selection, colonies 
were picked, dispersed with trypsin and plated in individual wells of duplicate 96-
well plates.  In this round of selection, 179 ES colonies were picked.  DNA isolated 
from the cells in one set of 96-well plates was used to PCR screen for the mutant and 
WT Apc alleles by PCR.  Again, WT Apc mNLSs were detected in every cell line. 
Two of the cell lines that appeared to be potentially mixed populations of cells 
were sub-cultured and used in a second round of selection.  These cells were treated 
with trypsin and thoroughly pipetted to assure that colonies were completely 
dissociated into single cells before re-plating into gelatin coated 96-well plates.  
Approximately 200 wells for each cell line appeared to contain only one colony after 
several days of growth in selective media. Two distinct colony morphologies were 
observed, the normal spherical colonies with smooth edges and a flatter colony type 
with a more irregular edge.  Once selection with G418 was discontinued to allow for 
better cell growth, several of the wells were observed to contain bacterial 
contamination.  Uncontaminated wells were sub-cultured to fresh plates and the ES 
media was supplemented with 1% penicillin/ streptomycin (Gibco).  DNA was 
isolated from the remaining 72 cell lines and used to screen for the presence of the 
mutant and WT alleles of Apc.  Again all cell lines contained WT Apc. 
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While ES cells are capable of growing for short periods of time on gelatin in 
place of fibroblast feeder layers, the removal of a feeder layer has been known to 
induce ES cell “crisis”.  This crisis is associated with a flattened cell morphology and 
increased differentiation at the colony edges (10).  It is possible that homozygous 
mutation of APC is already a growth disadvantage in ES cells.  This disadvantage in 
combination with the stress of being grown on gelatin coated plates for the extent of 
the drug selection may have resulted in the extremely inefficient selection for 
homozygous mNLS Apc that was observed.  To prevent further negative selection due 
to ES cell crisis, Primary Mouse Embryonic Fibroblasts that express Neor (PMEF-
NL) were purchased from Chemicon.  These PMEF-NL cells were growth arrested 
using mitomycin-C so that they might serve as a feeder layer for the ES cells during 
G418 selection.  The selection for homozygous mutant APC mNLS ES cells was 
repeated using Neor feeder cells in place of gelatin during selection with 4.0mg/mL 
G418.  An initial PCR analysis revealed several potential homozygous cell lines, 
however, bacterial contamination following the discontinued use of G418 resulted in 
a loss of viable cell lines at the conclusion of the selection process. 
 
Isolating Mouse Embryonic Fibroblast cells from the APC mNLS mouse embryos 
 An alternative method for the acquisition of homozygous APC mNLS cells 
was to derive cell lines from the embryos of APC mNLS homozygous mice.  ES cells 
are somewhat complicated to derive, however mouse embryonic fibroblasts (MEFs) 
can be obtained using relatively straightforward techniques.  Unlike ES cells, primary 
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MEF lines have a limited mitotic potential in culture.  At most these cells will survive 
a few dozen passages before becoming senescent.  Therefore all experiments in MEF 
cells needed to be done in the first few passages, and further experiments required 
that a new vial of cells be thawed.  This limitation to the use of MEF cell lines was 
balanced by the fact that, unlike ES cells, MEF cells do not require a feeder layer.  
This eliminated the time and energy involved in maintaining a feeder layer as well as 
the additional processing required to remove these contaminating cells from PCR and 
protein analysis of the APC mNLS ES cells.  MEF cells are also easier to process for 
immunohistochemical analysis and imaging because they adhere easily to glass slides 
and display a flattened morphology. 
 To obtain embryos for cell derivation, an F2 heterozygous female was bred to 
an F2 heterozygous male sibling.  Mendelian genetics predicts that this cross will 
result in a mix of APC mNLS+/+, mNLS-/+ and mNLS-/- embryos.  The selection 
process required for obtaining a homozygous ES cell line has the potential to result in 
additional mutations in the genome, however, sibling embryos should provide the 
APC mNLS heterozygous and homozygous cells with the same genetic background 
as the cells derived from APC mNLS WT embryos.  At generation F2 the mice are 
estimated to be 75% C57BL/6J and 25% R1.  While the F2 mice are not considered 
congenic, they are genetically less outbred than the targeted ES cells and therefore 
represent an excellent model system in which to study the cellular effect of the APC 
mNLS mutations. 
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 Ten 13-14 day old embryos were isolated and processed separately to preserve 
uncontaminated cell lines from each embryo.  All three APC mNLS genotypes were 
represented in these embryos.  All ten embryos gave rise to MEF cell lines which 
were aliquoted and cryo-preserved in the early passages for use in future research. 
 
APC and β-catenin localization in MEF cells  
 Analysis of β-catenin staining in the APC mNLS+/+, APC mNLS+/-, and APC 
mNLS-/- MEF cell lines revealed similar staining patterns in the mutant and WT cell 
lines (Figure 4.4).  APC staining however, showed an increasing ratio of cytoplasmic 
to nuclear APC in the heterozygous and homozygous mutant cells (Figure 4.4). 
Unlike previous observations in cells expressing exogenous APC mNLS protein, 
endogenous APC was never completely excluded from the nuclear compartment, 
even in the homozygous mutant cells.  The exact method by which nuclear entry is 
achieved in the APC mNLS homozygous mutant cells is not understood; however, we 
speculate that the concentration of APC in the cytoplasm just surrounding the nucleus 
in the mutant cell lines indicates that that some cellular stress is occurring to maintain 
the detectable levels of nuclear APC. 
 
APC mNLS mutant and WT cells grow at the same rate 
 Primary MEF cells have a finite life span.  When the APC mNLS MEFs were 
first derived they grew very quickly in culture.  After several passages the growth rate 
decreased, then halted completely.  MEF cells were dividing rapidly during initial  
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β-catenin                        APC                   APC/β-catenin
APC +/+
APC +/-
APC -/-
Figure 4.4 
The co-localization of APC and β-catenin in MEF cell lines that are APC mNLS+/+, APC 
mNLS+/- or APC mNLS -/- using mouse anti-APC Ali-12-28 and rabbit anti-β-catenin.  Images 
were taken on a Zeiss upright confocal microscope with a 60X water objective.  Scale bar = 
6μm.
passages just prior to cryopreservation.  Upon being thawed and re-plated, the MEF 
lines of all APC mNLS genotypes exhibited a shorter than expected proliferative 
phase before entering senescence.  While MEF cells are generally expected to 
continue dividing for 15-30 passages in culture (11), the APC mNLS mutant and WT 
MEF lines were generally able to survive at most 10 passages before becoming 
senescent.   When the growth rate was evaluated in cells at passages 3-6, little growth 
was apparent (Figure 4.5).  This basic profile was similar for cells at various 
concentrations and the homozygous mutant or the homozygous WT APC mNLS ES 
cell lines gave comparable results. 
 
DNA damage causes the nuclear translocation of APC in APC mNLS+/+ and APC 
mNLS-/-  MEFs 
 The nuclear functions of APC are not currently well understood.  In the 
mutant APC mNLS MEF lines, APC is not excluded from the nucleus in the 
homozygous cells.  Nevertheless, nuclear targeting appears to be somewhat deficient.  
It was hypothesized that supplementary pathways might exist for APC to be 
transported into the nucleus or retained in the nucleus after the nuclear envelope 
reforms following mitosis.  It is possible that because cells were grown in optimal 
conditions, the low level of APC that was able to enter the nucleus by alternative 
means was sufficient for normal growth.  The APC mNLS mutant cells show no 
abnormal localization of β-catenin when compared with cells derived from their APC 
mNLS WT siblings.  To observe how cells react to the loss of targeted APC under  
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Figure 4.5
The growth pattern of MEF cells.  Time in hours is indicated on the x-axis and the 
concentration of cells per mL of media is indicated on the y-axis. APC mNLS-/- cell line #8 
is represented by the red lines. APC mNLS+/+ cell lines #7 and #9 are represented by the blue 
lines
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more stressful conditions, APC localization was analyzed in cells that had 
experienced DNA damage by UV light treatment.   
Exposure to UV light induces pyrimidine dimers (reviewed in(29).  These 
dimers are recognized by DNA damage-sensing proteins and removed through the 
Nucleotide Excision Repair (NER) pathway of DNA repair.  NER involves the 
removal of the dimerized bases along with the surrounding nucleotides, leaving a 
region of single stranded DNA approximately 30 bp in length (29).  A protocol 
devised by Rubbi and Milner (30) was used to detect these single stranded transients 
generated during NER.  Cells were grown in bromodeoxyuridine (BrdU) prior to UV 
light exposure, allowing the BrdU to incorporate into the newly synthesized DNA 
strand in place of thymidine.  Normal antibody detection of BrdU requires that cells 
be treated with a weak HCl acid solution to denature the DNA prior to antibody 
incubation because the double stranded nature of DNA prevents the BrdU antibody 
from finding its epitope.  However, in UV exposed cells that are not treated with HCl, 
BrdU antibodies will localize specifically to the single stranded DNA intermediates 
of NER.  Previous reports have shown that one hour after UV irradiation, BrdU was 
found in multiple repair foci in cells that had been exposed to 10-40 J/m2 of UV light 
(30). 
When mutant and WT MEF cells were grown in BrdU-supplemented media 
and exposed to 10 J/m2 of UV light, BrdU antibody staining was consistent with NER 
occurring in the nucleus (Figure 4.6).  Cells that had not been exposed to UV light 
displayed only a dim background staining with BrdU but no specific nuclear staining 
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(Figure 4.6).  When APC localization was analyzed in the UV and non UV irradiated 
MEFs several of the UV irradiate cells displayed predominantly nuclear APC (Figure 
4.6).  APC localized to the nucleus to differing degrees in different cells on the same 
slide, however both APC mNLS mutant and WT MEFs displayed a dramatically 
nuclear localization of APC in at least some of the UV irradiated cells (Figures 4.6 
and 4.7). 
The dramatic relocalization of the APC mNLS mutant protein was 
unexpected.  Others have shown that importin-α is sequestered in the nucleus 
following many types of cellular stresses, and is therefore unavailable in the 
cytoplasm to facilitate nuclear import (31).  The reduction of cytoplasmic importin-α 
causes classic nuclear import to be blocked following UV irradiation of cells in 
culture (31).  Therefore, the observed nuclear localization of APC likely takes place 
though an entirely different pathway not dependent on importin-α.  Other proteins, 
such as heat shock protein 70 (hsp70) and its cognate (hsc70) have been observed to 
localize to the nucleus during the time frame in which nuclear import is blocked (32).  
Though the mechanism by which importin-α independent nuclear import occurs is not 
currently known (33), our evidence strongly suggests that APC is also capable of 
nuclear import through this mechanism.  A novel method for APC import is a 
possible explanation for the continued presence of APC in the nucleus of 
homozygous mutant APC mNLS cells in culture and in animals. 
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WT MEF
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Figure 4.6
APC distribution in APC mNLS+/+ MEF cells with and without UV treatment.  DNA repair 
is visualized using BrdU to stain single-stranded DNA intermediates of the NER pathway.  
Rabbit anti-APC M2 was used to stain for APC.  Cells were exposed to 10J/m2 of UV light 
and allowed to recover for 1 hour before being fixed and stained. Images were captured on 
an Olympus 3I spinning disc confocal TIRF inverted microscope and analyzed using 
Slidebook software.  Scale bar = 3μm
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BrdU APC                    DAPI
APC mNLS-/-
MEF cells
10J/m2 UV
APC mNLS-/-
MEF cells
No UV
Figure 4.7
APC distribution in APC mNLS-/- MEF cells with and without UV treatment.  DNA repair is 
visualized using BrdU to stain single-stranded DNA intermediates of the NER pathway.  
Rabbit anti-APC M2 was used to stain for APC.  Cells were exposed to 10J/m2 of UV light 
and allowed to recover for 1 hour before being fixed and stained. Images were captured on 
an Olympus 3I spinning disc confocal TIRF inverted microscope and analyzed using 
Slidebook software.  Scale bar = 3μm
Discussion 
 Results from a preliminary evaluation of the APC mNLS heterozygous ES 
cell lines were used to select the cell lines used to generate our APC mNLS mouse 
model.  Early observations of growth rate revealed that cell lines MES-3 and MES-7 
represented the outliers, showing growth characteristics that were not shared by the 
other APC mNLS cell lines.  Cell line MES-3 consistently grew more rapidly than the 
other transgenic cell lines suggesting that this phenotype resulted from an unwanted 
genetic alteration rather than from a targeted mutation of Apc.  Cell line MES-3 also 
appeared to diverge slightly from the majority of the transgenic cell lines with respect 
to β-catenin transcriptional activity.  The ratio of TOPFLASH to FOPFLASH 
reporter activity in MES-3 cells suggests that the MES-3 cell line had an increased 
expression of the Wnt/β-catenin target genes.  While this discrepancy in the 
TOPFLASH to FOPFLASH ratio was slight, when viewed in conjunction with the 
previously observed increase in growth rate, it cast doubt about the integrity of the 
MES-3 genome.  It is conceivable that that the insertion of the targeting construct in 
this cell line may have altered the Apc gene beyond the intended mutations to the 
NLSs or that one or more of the other components of the Wnt signaling pathway was 
affected during the process of electroporation and selection. While these results alone 
are not definitive evidence of such an alteration, they were sufficient to remove the 
MES-3 cell line from consideration for further study.  Similarly, the cell line MES-7 
was eliminated from consideration for exhibiting characteristics that varied from the 
mean in the opposing direction.  The MES-7 cell line displayed a low TOPFLASH to 
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FOPFLASH ratio that correlated with a slower rate of growth when compared to the 
other APC mNLS transgenic cell lines.  The MES-2 cell line was observed to 
proliferate at an expected rate, yet demonstrated the most divergent TOPFLASH to 
FOPFLASH ratio. An initial inspection of the chromosome number suggested that 
many MES-2 cells displayed abnormal karyotypes, and thus the MES-2 line was 
considered a poor choice to use in the generation of a mouse model.  After the 
elimination of cell lines MES-2, MES-3 and MES-7, a more extensive karyotype 
analysis was performed with the remaining cell lines.  Two of these cell lines, MES-1 
and MES-4, displayed normal karyotypes in over 75% of cells and were considered 
for further use.  The other two cell lines, MES-5 and MES-6, were determined to have 
an abnormal number of chromosomes in greater than 25% of the chromosome spreads 
counted and therefore were not good candidates for generation of a knock-in mouse 
model.  
 The cell lines MES-1 and MES-4 were identified as potential candidates for 
the generation of a mouse model (Table 4.4).  Further PCR analysis was used to 
confirm that the ends of the gene replacement vector had appropriately inserted (see 
Chapter 2 for details).  The MES-4 cell line was used for injection into blastocysts to 
generate the first set of chimeric mice.  The MES-1 cell line was also used to generate 
a mouse model, but at a later date.   
The evaluation of β-catenin localization by immunohistochemistry revealed 
no significant differences between APC mNLS+/- and WT ES cells or between APC 
mNLS+/+, APC mNLS+/- or APC mNLS-/- MEF cell lines suggesting that altering the 
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nuclear targeting of APC does not have a large affect on the localization of the β-
catenin protein.  More surprising was that the APC mNLS+/- ES cell and WT ES cells 
showed no differences in APC localization.  Because the APC mNLS+/- ES cells still 
express WT APC from the non-targeted allele, at least half of the APC protein in the 
cells is still capable of nuclear import.  The cell may be able to utilize the WT protein 
to maintain a threshold level of APC in the nuclear compartment while the APC 
mNLS mutant protein fulfills the cytoplasmic functions.  In contrast, analysis of APC 
localization in the MEF cells revealed a different pattern of staining for the mutant 
and WT protein.  APC mNLS+/+ cells show a very diffuse pattern of staining with 
little difference in the nuclear and cytoplasmic levels of APC.  The APC mNLS 
heterozygous and homozygous cells showed a definite decrease in the ratio of nuclear 
to cytoplasmic APC.  Furthermore, the cytoplasmic APC staining in the mutant cells 
was observed to be the most intense in the area immediately surrounding the nuclear 
compartment.  However, APC was never completely excluded from the nucleus.  
Some APC protein was visible in the nuclear compartment in even the homozygous 
mutant MEFs.  This suggests that there are other methods for APC to gain entry into 
the nucleus.   
It has been hypothesized that supplementary NLSs or NLS-like regions exist 
in the ARM domain of APC which could lead to a low level of APC translocation 
into the nucleus (34).  In addition to APC’s own nuclear import abilities, other APC 
binding partners such as β-catenin, PCNA, topo IIα and DNA polymerase β have the 
ability to localize to the nucleus (24, 35-37)  Furthermore APC has been shown to 
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interact with microtubules at the kinetochore (38), localizing to the DNA following 
the breakdown of the nuclear envelope during mitosis (39).  It is possible that some 
APC can be carried into the nucleus, or that APC is retained at the DNA after cell 
division, through interactions with APC binding partners in the nucleus.  
The potential for an alternative nuclear import strategy was revealed by 
experiments in which APC mNLS MEF cell lines were irradiated with UV light.  
Following a DNA damaging dose of UV irradiation, APC protein in mutant and WT 
cells relocalized to the nucleus.  This new phenomenon will be further explored in 
Chapter 5, but the preliminary results suggest that APC is required in the nucleus 
after certain types of DNA damaging events and that the method by which APC is 
targeted to the nucleus is not dependent on the characterized NLSs.  An alternate 
means of nuclear import could explain the continued presence of APC in the nucleus 
of the mutant cell lines.  The APC mNLS cell lines and mouse model might prove 
useful to study this alternate pathway of nuclear localization. 
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CHAPTER 5 
NUCLEAR RELOCALIZATION OF APC IN UV-TREATED CELLS 
 
 
Abstract 
 We observed APC to localize predominantly to the nucleus in a subset of the 
APC mNLS MEF cells that were exposed to UV light.  It has been suggested that 
APC may play a role in DNA repair, though no mechanism for such a role has been 
elucidated.  Due to the limited lifespan of primary MEF cell lines, the HCT116βw 
human colon cancer cell line was chosen for evaluation of APC in the nucleus 
following DNA damage.  This chapter discusses the characterization of the nuclear 
accumulation of APC following UV induced DNA damage in HCT116βw cells. 
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Introduction 
 Cancer is a disease caused by an accumulation of mutations to cellular DNA 
(1).  Therefore, in the prevention of cancer, the ability to maintain the integrity of the 
genome is paramount (2).  For this reason, mammalian cells have multiple pathways 
for the detection and repair of damage to their DNA (reviewed in(3).  A number of 
different cellular mechanisms exist to cope with the range of possible types of DNA 
damage and to delay or arrest the cell cycle to allow repair to proceed before the cell 
enters mitosis (3).   
The cell cycle is made up of several distinct phases (4) (Figure 5.1).  
Following mitosis, cells enter a growth phase referred to as G1.  Following G1 the cell 
enters S-phase during which the DNA is replicated.  At the end of S-phase the cell, 
containing two full copies of the genome, enters a second growth phase referred to as 
G2 during which the cell prepares for another round of cell division.  The actual 
process of nuclear division followed by cell division is called M-phase.  At the end of 
M-phase, the two daughter cells re-enter G1 and the process begins again (reviewed 
in(4).  At several stages during this cycle, mechanisms exist to halt progression and 
delay the transition to the next phase of the cell cycle.  These decisive stages have 
been termed “cell cycle checkpoints” (5, 6).  These checkpoints are activated by 
replicative stress and in response to the detection of damaged DNA (6).  The cellular 
DNA damage response consists of three steps: 1) recognition of a damaged region of 
DNA, 2) activation of the mitotic checkpoint machinery to halt progression of the cell  
 
 
203
Cell Cycle
G0 
non-proliferative
cells
G1 
G2 
S
M
DNA replication
Grow and prepare
to replicate DNAGrow and prepareto enter mitosis
Mitosis/Cell division
intra-S checkpoint
G2/M checkpoint
G1/S checkpoint
 
 
204
Figure 5.1
A simplified diagram of the phases of the cell cycle.  Cell cycle checkpoints that respond to 
DNA damage are indicated in blue. Adapted from Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, 
J. D. (1994) Molecular Biology of the Cell, Garland Publishing Inc., New York 
cycle and 3) the resolution of the crisis, either through repair of the damage or 
initiation of apoptosis (3). 
 There are multiple and somewhat contradictory reports in the literature of 
potential roles for APC in the DNA damage response.  In cultured human cells and in 
mouse models, data indicates that mutations to APC result in a reduced ability to cope 
with UV and ionizing radiation (7, 8).  These studies suggest that APC may play a 
supporting role in the cellular DNA damage response, but do not suggest the step in 
which APC is involved.  These data are not in agreement with reports that cells with 
mutant APC are less sensitive to DNA methylating agents, and that APC directly 
interacts with and inhibits the DNA repair proteins polymerase-β and Flap 
endonuclease 1 (Fen-1) in vitro (9, 10).   The reports that APC inhibits repair of 
methylated DNA seem incongruent with reports that APC is up-regulated by p53 in 
response to DNA damage caused by methylating agents (11, 12).  In addition to 
evidence for a direct interaction between APC and DNA repair proteins, there are also 
reports that APC may play a role in the DNA damage checkpoint.  The activation of 
the G2/M checkpoint leading to cell cycle arrest has been reported following the 
stabilization of endogenous APC (13).  Our own lab has recently demonstrated that 
over-expression of an APC fragment encompassing amino acids 1000-1326 also leads 
to G2 arrest (14).    
In Chapter 4 we reported that APC was observed to accumulate in the nucleus 
of primary MEF cells in response to UV irradiation.  In this chapter, we further 
characterize APC localization in UV-irradiated HCT116βw cells.  We show that APC 
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is transiently targeted to the nucleus in response to UV irradiation in a cell cycle 
dependent manner.  Furthermore, optimal nuclear accumulation appears to be 
dependent on the function of cell cycle checkpoint kinases. 
 
Materials and Methods 
 
Cell culture and synchronization 
 HCT116βw human epithelial cell lines, originally derived from colon cancer 
tissue were received from Bert Volgelstein (15) and maintained in growth media 
[McCoy’s 5A Media (Cellgro) supplemented with 10% Fetal Bovine Serum 
(Hyclone)].  Cells were kept in a 37°C water jacketed incubator with 7% CO2 and 
passaged when they reached confluence.   
 To obtain synchronized cells, HCT116βw cells were plated at approximately 
50% confluency.  Cell cycle was blocked by the addition of 1μg/mL aphidicolin 
(Sigma or Calbiochem) to the normal growth media.  Following 24 hours in 
aphidicolin, cells were washed 3 times with fresh McCoy’s 5A media and allowed to 
resume cycling in normal growth media for the desired length of time. 
  
UV irradiation 
Prior to UV irradiation, growth media was removed and cells were rinsed with 
sterile PBS.  A thin layer of PBS was maintained to prevent drying.  Cells were 
placed in an Ultraviolet Crosslinker (UVP) and irradiated for 2.8 minutes at an 
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intensity of 240mJ/sec resulting in a total exposure of ~40J/m2.  The sham-irradiated 
control cells were processed identically except that cells were covered with aluminum 
foil during UV exposure.  Following UV irradiation, the PBS was removed and 
replaced with fresh growth media.  Cells were incubated at 37°C for the indicated 
time before being processed.   
 
Inhibition of DNA repair kinases  
 To inhibit kinases involved in DNA repair, the following inhibitors were 
added to the normal growth media 30 minutes prior to UV irradiation of the cells.  
Wortmannin (Calbiochem) was used at a final concentration of 20μM.  Chk 2 
inhibitor [2-(4-(4-Chlorophenoxy)phenyl)-1H-benzimidole-5-carboxamide 
(Calbiochem)] was used at 10μM.  Chk 1 inhibitor [SB-218078 (Calbiochem)] was 
used at 5μM.    Inhibitors were made up at a 250X concentration in DMSO and added 
to media 4μL/mL.  Control cells were incubated in 4μL/mL DMSO for the same 
duration.   
 
Immunofluorescence 
 Immunostaining was performed essentially as previously described (16) using 
the following antibodies:  Mouse anti-APC (Ali-12-28 1:50, Abcam), anti-APC-M2 
rabbit polyclonal antibody made against amino acids 1000-1326 and affinity purified 
(1:3000), mouse anti-β-catenin (1:1000 Transduction Laboratories), rabbit anti-β-
catenin (1:1000, Sigma), mouse anti-PCNA (1:500, Zymed) goat anti-mouse IgG 
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Alexa 488 (1:1000, Molecular Probes), goat anti-rabbit IgG Alexa 568 (1:1000, 
Molecular Probes).  DNA was labeled with DAPI   (0.1μg/mL).  Briefly, cells were 
seeded on 22x22mm glass coverslips (Fisher) and allowed to settle overnight.  
Following the desired treatment, coverslips containing cells were rinsed 2 times with 
PBS then fixed (4% paraformaldehyde and 0.1% Triton X-100 in PBS) on ice for 30 
minutes.  Cells were either stained immediately or stored for up to a week in PBS at 
4°C.  Cells were made permeable by incubation in 0.2% Triton X-100 (in TBS) or        
-20°C methanol for 5 minutes and rinsed 2 times in TBS prior to incubation with 
primary antibody.  Coverslips were inverted over drops of primary antibody for 90 
minutes, rinsed 3 times in TBS, inverted over drops of secondary antibody for 30 
minutes, DAPI   (0.1μg/mL) for 5 minutes and again washed 3 times for 5 minutes in 
TBS.  Stained coverslips were mounted onto glass microscope slides (Fisher) using 
ProLong Antifade (Invitrogen) and the edges were sealed with nail polish (Revlon).  
Images were captured using one of the following: a Zeiss inverted fluorescent 
microscope equipped with an Olympus camera and analyzed using Magnafire 
software, a Nikon TU2000 microscope equipped with a Letiga EXI camera (Q 
Imaging) and analyzed using Phylum Live software, or an Olympus 3I spinning disc 
confocal TIRF inverted microscope and analyzed using SlideBook software. 
 
Flow Cytometry 
 Propidium iodide staining of synchronized and unsynchronized HCT116βw 
cells in solution was performed using a standard protocol (17).  Briefly, HCT116βw 
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cells at 50% confluencey were synchronized by incubation with aphidicolin for 24 
hours then washed 3 times with fresh McCoy’s 5A media.  Cells were allowed to 
resume cell cycle progression for 0, 2, 4, or 7 hours before being trypsinized, pelleted, 
and fixed in cold 100% ethanol.  Cells were fixed for 30 minutes on ice then washed 
2 times for 10 minutes with PBS to rehydrate.  Rehydrated cells were then stained 
with 40μg/ml propidium iodide (Sigma) in PBS for 1 hour.  Cells were pelleted and 
resuspended in 400μL PBS and filtered through a 40μm nylon cell strainer (BD 
Falcon) to remove cell aggregates.  FACS analysis was performed using a Becton 
Dickinson FACScan and evaluated using CellQuest software.  At least 10,000 cells 
were analyzed for each time point. 
 
Immunoprecipitation and western blot analysis 
 Immunoprecipitation and western blots were performed using standard 
protocols (18).  HCT 116 cells used to prepare lysates were grown in 10cm tissue 
culture dishes (Falcon) until approximately 50% confluent.  Cells were synchronized 
using aphidicolin to block cell cycle progression and allowed to resume cycling for 4 
hours after the removal of the drug.  Following UV or sham irradiation, cells were 
placed in growth media for 40 minutes before being processed.  To prepare lysates, 
cells were placed on ice and washed 2 times with cold PBS.  Roughly 2x107 cells 
were lysed using 1mL of cold Lysis Buffer [50mM Tris pH 7.5. 0.1% NP40, 00mM 
NaCl, 1mM MgCl2, 5mM EDTA].  Immediately prior to use, Protease Inhibitors 
[100mM PMSF (Sigma), 1mg/mL Apoprotinin (MP Biomedicals), 1mg/mL 
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Leupeptin trifluoroacetate (MP Biomedicals), 1mg/mL Pepstatin A (MP Biomedicals) 
all in 200 proof ethanol] were added to the Lysis Buffer at a concentration of 1:50.  A 
cell scraper was used to mechanically dislodge cells and suspend them in Lysis 
Buffer.  Cell suspensions were moved to 1.5mL ependorf tubes which were placed on 
an orbital shaker at 4°C for 8 minutes.  Cells were sonicated for 10 seconds (tip 
setting of 1) every 2 minutes for the duration of the 8 minute incubation.  Lysates 
were then centrifuged at 13,000xg for 20 minutes at 4°C to remove any insoluble 
material.  Following centrifugation the supernatant was removed and placed in a fresh 
tube.  The insoluble pellets were resuspended in 3X SDS Loading dye [6% w/v 
Sodium Dodecyl Sulfate, 30% Glycerol, 150mM Tris pH 6.8, ~0.2mg/mL 
Bromophenol Blue in water] and heated to 95°C for 10 minutes before storage at -
20°C.  The protein concentrations of the supernatant fluids were determined using the 
Bio-Rad Protein Assay reagent according the manufacturer’s instructions.  The 
lysates were placed into tubes containing 30μl of Protein A Dynabeads (Invitrogen) 
conjugated to rabbit anti-APC M2 antibody (generated against APC amino acids 
1000-1326 in the Neufeld and Azuma labs) or rabbit IgG control (Sigma).  An equal 
protein concentration was used for each tube and the final volume was adjusted to 
0.8mL using fresh Lysis Buffer.  Tubes were placed on an orbital shaker at 4°C 
overnight.  The following day the supernatant for each tube was removed and saved 
as the “unbound fraction”.  The Dynabeads were washed 2x15 minutes with 0.5mL 
Lysis Buffer and 1x 15 minutes with PBS-T at 4°C and then protein was eluted from 
the beads in 80μL of PBS (1/10th the volume of the original lysates) and 40μL of 3X 
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SDS loading buffer.  Loading buffer was also added 1:3 to the unbound fractions for 
each tube and to the 250μg of total lysate frozen the previous day.  All tubes were 
heated to 95°C for 10 minutes to denature the protein.  Samples were resolved using 
SDS PAGE.  Western blots were probed with anti-APC-M2 rabbit polyclonal 
antibody (1:3000) and rabbit anti-β-catenin (1:1000, Sigma). 
 
Results 
 
APC protein associates with the nucleus after UV irradiation 
 In the APC mNLS MEF cell lines, APC was observed to dramatically shift 
from a diffuse nuclear and cytoplasmic localization pattern to a predominantly 
nuclear localization pattern after exposure to UV light (Figure 4.6 and 4.7).  This shift 
was observed in both the APC mNLS WT MEF lines and the APC mNLS 
homozygous mutant cell lines.  Because the homozygous mutant MEFS lack the 
characterized NLS domains which interact with importin-α to achieve nuclear import, 
we hypothesized that this dramatic relocalization of APC was occurring through an 
alternate mechanism.  Furthermore, this shift was not observed in every cell that was 
exposed to UV light.  BrdU staining, used to identify cells with single stranded DNA 
intermediates of NER, revealed that a majority of the cells irradiated were undergoing 
DNA repair (data not shown).  However, only a subset of these cells exhibited a 
striking alteration in APC localization (Figure 4.6).  This selective APC response 
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suggested that additional control mechanisms must also play a role in the regulation 
of APC targeting.   
 Further analysis of the APC relocalization phenomenon required a large 
number of cells for experimentation.  The MEF lines had the advantage of being a 
primary cell line lacking mutations typical of cells adapted to growth in culture (19).  
However, MEF cells entered senescence after a small number of population 
doublings, making generation of the quantity of cells necessary for analysis extremely 
difficult.  For this reason, HCT116βw cells, an immortalized epithelial cell line 
originally derived from a human colonic carcinoma (20), were used for the evaluation 
of this phenotype.  HCT116 cells grow very well in culture and have a short doubling 
time, facilitating the generation of large quantities of cells.  Unlike many colon cancer 
cell lines the HCT116 cells express full length APC (21) and a mutant allele of β-
catenin (22).  The HCT116 cells also exhibit a normal mitotic check point response 
(23) and normal p53-mediated growth arrest (24).  The HCT116βw cell line that was 
used in the following experiments has been engineered to eliminate the oncogenic 
allele of β-catenin, leaving only the WT β-catenin in these cells (15) 
  
The nuclear localization of APC after UV irradiation is cell cycle dependent 
We observed that some, but not all UV irradiated MEF cells displayed 
prominent nuclear localization of APC (Figure 4.6) suggesting that factors regulating 
the cellular response to DNA damage were differentially directing APC localization.  
We hypothesized that cell cycle would affect the nature of the DNA damage response 
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and could therefore be involved in the variation in APC localization that was 
observed.  To test this hypothesis, cells were synchronized by the addition of 
aphidicolin to the growth media prior to UV irradiation.   
Aphidicolin is a drug that specifically inhibits DNA polymerase-α, the 
primary polymerase responsible for the replication of nuclear DNA (25).  Unlike 
many other inhibitors of DNA synthesis, aphidicolin does not bind directly to DNA, 
does not interfere with RNA or protein synthesis and has a very low toxicity (25).  
The addition of aphidicolin to the medium of growing cells causes an immediate 
inhibition of DNA synthesis that is completely reversible following the removal of 
the drug (25).  Aphidicolin treatment is a well established method for cell 
synchronization, blocking cell cycle at the beginning of S-phase upon addition and 
allowing the cell cycle to resume within 15 minutes of removal (17).  
Following the removal of aphidicolin, cells were allowed to continue cycling 
in a synchronized manner for various lengths of time.  Examination of APC 
localization in the synchronized UV-irradiated HCT116βw cells revealed a noticeable 
homogeneity of response to UV exposure (data not shown).  The more uniform APC 
response of synchronized cells supported our hypothesis that cell cycle stage is an 
important factor in determining how APC was targeted following DNA damage.   
The non-irradiated control cells released from aphidicolin block for 3 or 4 
hours were observed to have nearly identical APC localization. These cells exhibited 
APC at nearly equal nuclear and cytoplasmic proportions.  This APC staining was 
punctate in the cytoplasm and nuclear compartments with slightly increased APC 
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localized along cellular junctions and at the leading edge of cell extensions, consistent 
with previous reports (16, 26) (Figure 5.2 B and D).  On the other hand, the UV-
irradiated cells released from aphidicolin for 4 hours had at strikingly different APC 
staining pattern from the cells that were released from aphidicolin block for only 3 
hours prior to UV irradiation.  Approximately 40 minutes after UV irradiation, cells 
that had been released from aphidicolin block for 4 hours had a vastly decreased level 
of cytoplasmic APC and an evident increase in the level of APC located within the 
nuclear compartment (Figure 5.2 C).  In cells released for only 3 hours prior to UV 
irradiation APC appeared to be essentially excluded from the nucleus.  While some 
APC was always visible in the nuclear compartment, a vast majority of the APC in 
these cells was localized to the cytoplasm surrounding the nuclear compartment 
(Figure 5.2 A).   
 
UV-induced nuclear accumulation of APC correlates with the G2/M checkpoint 
 The most significant change in APC localization appeared to occur in cells 
that had been released from aphidicolin block for 4 hours.  To determine which phase 
of the cell cycle this time point represented, cells were fixed, permeabilized and 
incubated in saturating amounts of propidium iodide, which fluoresces when 
intercalated into double stranded DNA (27).  This resulted in fluorescently labeled 
cells, in which the intensity of the fluorescence emitted was directly proportional to 
the amount of DNA contained within the cell (27).   
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Figure 5.2
APC distribution in cells synchronized by aphidicolin block and released for 3 or 4 hours 
prior to UV-irradiation or sham-irradiation.  Cells were fixed 40 minutes after irradiation and 
stained with rabbit anti-APC M2 antibody.  DNA was visualized with DAPI.  Images were 
taken with a Zeiss inverted fluorescent microscope equipped with an Olympus camera and 
analyzed using Magnafire software.  Scale bar = 3μm.
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At the time of fixation, cells that were in G0 and quiescent, or cells in G1 that had 
recently undergone division and had not yet re-entered the cell cycle would contain a 
single copy of the genome (4).  G2 cells and M-phase cells, that had replicated their 
DNA but had not completed cell division contained two full copies of the genome (4).  
When stained with propidium iodide, cells in G2/M fluoresce at twice the intensity of 
the cells in the G0/G1 phases of the cell cycle .   Cells in S-phase contain a full copy 
of the genome as well as a partially replicated portion of the genome.  The S-phase 
cells therefore emit an intermediate amount of fluorescent signal, more intense than 
the G0/G1 cells but less intense than the G2/M cells.  Cells in late S-phase are 
expected to have fluorescent intensities that approach cells in G2/M.  The intensity of 
the propidium iodide staining was determined in 10,000 cells for each time point 
using a flow cytometer.  In this device, cells are pulled single-file past a detector 
which records the intensity of the fluorescent signal being emitted (28).  The cell 
intensities were displayed as histogram plots in which relative propidium iodide 
intensity was expressed on the x-axis and the number of cells was expressed on the y-
axis (Figure 5.3). 
The unsynchronized HCT116βw cells displayed a typical cell cycle 
distribution (Figure 5.3).  A little over one third of the cell population resided in a 
concise peak representing the G0/G1 cells.  A slightly smaller peak with twice the 
relative fluorescent intensity represented the G2/M cells.  Between these two peaks 
were the cells in the various points of S-phase.  Because the drug aphidicolin blocks 
polymerase activity, the cells that had already entered S-phase were halted there.   
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Figure 5.3
Analysis of APC distribution in UV-irradiated and sham-irradiated cells at various points 
of the cell cycle.  Cells were synchronized using aphidicolin block and released for the 
indicated amount of time before being UV/sham-irradiated or processed for FACs
analysis.  Cells for images were fixed 40 minutes after irradiation and stained with rabbit 
anti-APC M2 antibody.  DNA was visualized with DAPI.  Images were taken with an 
Olympus 3I spinning disc confocal TIRF inverted microscope and analyzed using 
Slidebook software.  Scale bar = 3μm.
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Cells that were in the G0/G1 or G2 phases of the cell cycle when aphidicolin was 
introduced would be expected continue to cycle until they reached the beginning of S-
phase.  In the cells that were released for 0 hours following aphidicolin block, a small 
number of cells were observed in mid and late S-phase; however, as expected, most 
of the cells accumulated in a peak representing the beginning of S-phase (Figure 5.3).  
Two hours after aphidicolin was removed, cells were observed to be in S-phase and 
the peak population of cells had shifted to the right signifying that synthesis of DNA 
had resumed in all cells (Figure 5.3).  Four hours after cells were released from 
aphidicolin block the peak population of cells was again shifted to the right (Figure 
5.3).  Using the relative intensities observed in asynchronous cells for comparison, 
these cells appeared to straddle the late S-phase to G2 and M phases of the cell cycle.  
In the cells that were released from aphidicolin block for 7 hours the main peak of 
cells appeared in G2/M.  These cells have two full copies of the genome and were 
likely committed to undergoing mitosis.  Some of the cells were also observed to 
have completed cell division, as a small peak was visible representing a G0/G1 
population of cells (Figure 5.3). 
APC localization at 0, 2, 4 and 7 hours following release from aphidicolin 
block confirmed that nuclear accumulation was only observed when cells were UV 
treated at the 4 hour time point.  At all other points in the cell cycle, APC was both 
nuclear and cytoplasmic or predominantly cytoplasmic following UV irradiation.  
APC has previously been implicated in control of the G2/M checkpoint (13, 14).  
Upregulation of endogenous full length APC by zinc treatment or exogenous 
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expression of specific APC protein fragments have been shown to induce cell cycle 
arrest in G2 (13, 14).  Our results are consistent with a proposed role for APC in the 
G2/M transition.  
 
Alternate pathway implicated in nuclear import of APC 
 Classical import through the nuclear pore complex requires a cargo protein 
that carries an NLS as well as the function of importin-α and importin-β (29).  
Importin-α binds directly to the NLS(s) of the cargo protein in the cytoplasm and 
facilitates the interaction with importin-β.  Importin-β docks to the nuclear pore 
complex where an energy-dependent, Ran-dependent translocation moves the 
importin-α/importin-β/cargo complex from the cytoplasm to the nucleus through the 
nuclear pore (29).  APC contains two characterized monopartite NLSs (Figure 2.5) 
(30, 31).  It was assumed that the nuclear cytoplasmic shuttling of full length WT 
APC occurred predominantly through the NLS/importin pathway.  However, the 
localization of APC to the nucleus of UV irradiated cells is unlikely to occur through 
the interaction between the APC NLSs and importin-α for two reasons.  First, the 
redistribution of APC to the nucleus following DNA damage was observed in 
homozygous mutant APC mNLS MEF cells.  In these cells both Apc alleles express a 
mutant APC protein that lacks functional NLSs and therefore should be unable to 
interact with importin-α.  Second, several types of cell stresses including starvation, 
heat shock, ethanol, oxidative stress and UV irradiation result in inhibition of 
classical nuclear import (32, 33).  It has been demonstrated that UV irradiation 
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induces the nuclear accumulation of importin-α, which suppresses nuclear import of 
NLS bearing proteins.  Because dramatic nuclear accumulation of APC was observed 
in cells lacking both APC NLSs and available importin-α, we assume that a novel 
method of nuclear import mediates nuclear APC relocalization following UV 
treatment.  
 Import of APC through this novel pathway is selectively accessible: the cell 
cycle stage dictates whether APC is translocated into the nucleus by this as yet 
uncharacterized mechanism for nuclear entry.  APC was observed to localize to the 
nucleus after UV irradiation in cells that were at the end of S or in the G2-phase of the 
cell cycle (Figure 5.3).  However, cells in other phases of the cell cycle often showed 
a decreased level of nuclear APC (Figures 5.2 and 5.3).  The stress induced block of 
classical nuclear import was likely the reason for the cytoplasmic accumulation of 
APC in the majority of the UV irradiated cells.  In both APC mNLS-/- MEF cells and 
intestinal tissue of the APC mNLS-/- mice, when importin-α mediated nuclear entry is 
inhibited, APC accumulates around the nuclear envelope (Figure 5.4). 
  
APC does not relocate in response to double-strand DNA breaks 
 Other proteins have demonstrated the ability to enter the nucleus despite a 
cell-stress-mediated block of nuclear import.  Heat shock cognate protein 70 (hsc70) 
has been shown to localize to the nuclear compartment in response to cellular heat 
stress (34, 35).  However, hsc70 enters the nucleus in response to cellular stress in 
unsynchronized HeLa cells, suggesting that the reaction is not cell cycle specific (34).   
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Figure 5.4
A comparison of APC distribution in cells/tissue in which APC NLS/importin-α import is 
suspected to be blocked.  A) Intestinal epithelia from the colon of APC mNLS-/-.  B) APC 
mNLS-/- MEF cells.  C) HCT116βw cells UV irradiated 3 hours after release from 
aphidicolin block
Intestinal epithelium from
homozygous mutant APC mNLS
mouse model
(from Figure 3.14)
MEF cells derived from
homozygous mutant APC mNLS
mouse model
(from Figure 4.4)
HCT116 cells that were UV
irradiated 3 hours after release 
from aphidicolin block
(from Figure 5.2)
A
B
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The observation that APC is not translocated to the nucleus during a majority of the 
cell cycle and dramatically accumulates in the nucleus at the late S and G2 phases 
implies that APC may have a specific role in the nucleus at this time.  It is possible 
that APC performs a specific task in the G2/M DNA damage checkpoint.  
Alternatively, APC may play a role in the homologous repair of DNA double-strand 
breaks.  Generally double-strand DNA breaks are produced by ionizing radiation 
while UV irradiation is associated with pyrimidine dimer formation (3).  However, 
during DNA replication, UV-induced DNA lesions can result in stalled replication 
forks which can lead to double-strand breaks (36).  If the nuclear accumulation of 
APC is a response to a specific type of DNA damage, in this case double-strand 
breaks, an increased level of UV-induced double strand breaks in late S-phase may 
create the appearance of cell cycle specificity.  To determine if APC accumulation in 
the nucleus was in response to double strand breaks, unsynchronized HCT116βw 
cells were exposed to ionizing radiation to induce DNA double-strand breaks in cells 
of all phases of the cell cycle.   
One of the earliest cellular events associated with DNA double-strand breaks 
is a serine phosphorylation of the histone H2A variant H2AX to create γH2AX.  
γH2AX accumulates at sites of DNA damage within minutes of exposure to ionizing 
radiation (37).  An antibody to γH2AX was used to verify that double-strand breaks 
had occurred following exposure to γ-irradiation and to serve as a marker for the 
location of the repair foci.  As expected, there was little visible γH2AX in un-
irradiated HCT116 cells (Figure 5.5).  In contrast the HCT116 cells that were exposed 
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to γ-irradiation displayed prominent nuclear staining of γH2AX, which localized to 
sub-nuclear foci (Figure 5.5).  APC localization was examined 20, 40 and 60 minutes 
after γ-irradiation.  In the irradiated cells, APC displayed both a nuclear and 
cytoplasmic distribution that was indistinguishable from the non-irradiated control 
cells.  Furthermore, the APC staining that was visible in the nucleus did not coincide 
with the γH2AX marker for double stand break repair foci (Figure 5.5).  
While these results do not rule out the possibility that APC plays a role in 
some aspect of the cellular response to DNA double strand breaks, they support that 
UV induced double-strand breaks are not the reason for the nuclear targeting of APC.  
It is therefore more likely that the observed accumulation of APC in the nuclear 
compartment is specific to a mechanism involved in G2/M checkpoint of the cell 
cycle.   
 
APC localization to the nucleus is transient  
 Importin-α localizes to the nucleus within 30 minutes of UV irradiation (32).  
If the nuclear accumulation of APC precedes the nuclear accumulation of importin-α, 
it is possible that the classical nuclear import pathway may still play a role in the 
nuclear targeting of APC.  To evaluate how long APC is targeted to the nucleus, 
synchronized HCT116βw cells were exposed to UV irradiation and fixed at different 
time intervals following UV exposure.  APC localization in cells that were fixed 20 
and 30 minutes after UV irradiation revealed a nuclear and cytoplasmic localization 
pattern that did not differ significantly from APC in the sham-irradiated control cells  
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Figure 5.5
APC distribution in HCT116 cells exposed to ionizing-irradiation.  Unsynchronized 
HCT116βw cells were exposed 10Gy of γ-irradiation to induce DNA double-strand breaks.  
Cells were fixed 40 minutes (above) and 60 minutes (data not shown) after irradiation and 
stained with rabbit anti-APC M2 and mouse anti-γH2AX (to visualize DNA double-strand 
breaks) DNA was visualized with DAPI.  Images were captured using a Nikon TU2000 
microscope equipped with a Letiga EXI camera (Q Imaging) and analyzed using Phylum Live
software. Scale bar = 3μm.
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(Figure 5.6).  It was not until 40 minutes after UV irradiation that APC was observed 
to be targeted to the nucleus.  APC was observed to reach a maximal level of nuclear 
accumulation approximately  40 minutes following exposure to UV (Figure 5.6).  One 
hour after UV irradiation, APC appeared to be redistributed back to the cytoplasm in 
most cells (Figure 5.6).   
 APC did not accumulate in the nucleus until 40 minutes after UV irradiation.  
Importin-α is reported to be completely translocated to the nuclear compartment prior 
to 40 minutes following cellular stress implying that cytoplasmic importin-α would be 
unavailable to bind to and facilitate the nuclear targeting of APC (32).  The targeting 
of APC to the nucleus that we observed in cells treated with UV light was also 
transient.  The nuclear accumulation of APC was only clearly seen during a short 
window of time, between 30 and 50 minutes following exposure to UV irradiation.  
 
APC localization to the nucleus occurs only in sub-confluent cells 
 In the course of characterizing the accumulation of nuclear APC in cells 
exposed to UV light, it became clear that the cellular density at the time of UV 
exposure influenced the response of APC.  Cells exhibited far less nuclear 
accumulation of APC when grown more densely on the coverslips prior to UV 
irradiation.  In completely confluent cultures, there was often no visible nuclear 
accumulation of APC in any of the cells.  Cultures approaching confluency often 
displayed nuclear targeted APC only at the periphery of the slide where cells were the 
least dense (Figure 5.7).  Initially it was hypothesized that more confluent cultures did  
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Figure 5.6
Analysis of APC distribution in UV-irradiated and sham-irradiated cells at various points 
following irradiation.  Cells were synchronized using aphidicolin block and released 4 
hours before being UV/sham-irradiated.  Cells for images were fixed the indicated 
amount of time following irradiation and stained with rabbit anti-APC M2 antibody.  
DNA was visualized with DAPI.  Images were captured on a Nikon TU2000 microscope 
equipped with a Letiga EXI camera (Q Imaging) and analyzed using Phylum Live
software.  Scale bar = 3μm.
APC                          APC/DAPI
Figure 5.7
APC distribution in confluent and sub-confluent cells.  Images of cells from different regions 
of the same 22x22mm glass coverslip.  Cells were synchronized by aphidicolin block and 
released for 4 hours prior to UV-irradiation.  Cells were fixed 40 minutes after irradiation 
and stained with rabbit anti-APC M2 antibody.  DNA was visualized with DAPI.  Scale bar 
= 7μm.
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not synchronize as well as sub-confluent cultures or that confluent cells did not 
resume progress through the cell cycle at the same rate as sub-confluent cells.  
However it was observed using flow cytometry that aphidicolin treated cells did 
synchronize, even when cells were confluent (data not shown).   
 The nuclear localization of APC was previously observed to be affected by 
cell density (38).  However, it was determined that increased cell density altered 
phosphorylation of the APC NLSs leading to increased nuclear translocation through 
the importin-α pathway (38).  Because it is probable that UV induced nuclear import 
occurs through an importin-α-independent pathway, this previously described 
mechanism of cell density controlled nuclear targeting is not necessarily applicable.  
However, this does not rule out the possibility that similar post-transcriptional 
modifications to the APC protein also mediate the nuclear accumulation of APC 
following UV irradiation.  The hsc70 protein has been shown to accumulate in the 
nuclear compartment of HeLa cells following heat shock through an NLS/importin 
independent mechanism (35).  The nuclear targeting of hsp70 was also inhibited in 
confluent cells (34), further supporting a cell density regulated modification of stress 
related nuclear import.       
  
APC displays a mobility shift following UV irradiation 
 In an attempt to better define a function for nuclear targeted APC, APC was 
immunoprecipitated (IP) from the lysates of cells that had been exposed to UV 
irradiation.  Western blots revealed that nearly all of the APC in the lysates from both 
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the UV irradiated cells and the non-irradiated control cells immunoprecipitated with 
beads conjugated to a specific anti-APC antibody while little to no APC could be 
detected in the protein eluted from the IgG-conjugated control beads (data not 
shown).   
The western blot of APC from non-irradiated control cells produced the 
expected band at 312 kDa representing full length APC (Figure 5.8).  This was not 
the case for the cells exposed to UV irradiation.  APC antibody detected a band from 
UV irradiated cell lysates that migrated slower than the full length APC from non-
irradiated cells.  It appeared that APC from the lysate of UV-irradiated cells was 
immobilized in the well and at the interface between the stacking gel and the 
resolving gel (Figure 5.8).  When proteins were resolved on a 4-12% gradient gel to 
eliminate the stacking gel interface, two distinct APC bands could be resolved in the 
UV-irradiated lysate (Figure 5.9).  Cell lysates from the UV-irradiated cells were 
treated with DNase, RNase, shrimp alkaline phosphatase or all three enzymes to 
determine if the observed APC mobility shift was due to a specific interaction 
stimulated by UV-induced DNA damage.  The mobility shift of APC could not be 
completely reversed with any of the treatments (Figure 5.9).   
To determine if the observed mobility shift occurred specifically in cells that 
displayed APC accumulation in the nucleus, cell lysates were prepared from cells that 
were UV or sham-irradiated either 2 or 4 hours after release from aphidicolin.  Cells 
released from aphidicolin block for two hours were predominantly in early S-phase 
and showed no nuclear accumulation of APC when exposed to UV light (Figure 5.3).    
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Figure 5.8
Western immunoblot probed with rabbit anti-APC M2 antibody.  HCT116βw cells were 
synchronized using aphidicolin block and released for 4 hours prior to sham or UV-
irradiation.  Cell lysates were prepared 40 minutes after irradiation.  IP was preformed with 
protein A beads conjugated to APC specific antibody (rabbit anti-APC M2).  Proteins were 
resolved on a 7% polyacrylimide gel with a 3% stacking gel.
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Figure 5.9
Western immunoblot probed with rabbit anti-APC M2 antibody.  HCT116βw cells were 
synchronized using aphidicolin block and released for 4 hours prior to sham or UV-
irradiation.  Cell lysates were prepared 40 minutes after irradiation and resolved on a 4-12% 
gradient gel. Lysates were treated with 2μL of shrimp alkaline phosphatase (Roche), DNase
(Invotrogen) or a 10mg/mL stock of RNase A in a 25μL volume on ice for 30 minutes.
Western blot analysis of lysates from cells irradiated following a two hour release 
from aphidicolin block revealed a mobility shift for APC that was identical to the 
shift observed when cells were irradiated 4 hours after release from aphidicolin block 
(Figure 5.10).  The observation that the mobility shift was not limited to the G2/M 
phase of the cell cycle suggests that this APC modification is unrelated to the nuclear 
targeting of APC.  Furthermore, when control cell lysate from the non-irradiated cells 
was exposed to UV light, the 312 kDa APC band displayed the same mobility shift 
seen in lysates from UV irradiated cells (Figure 5.10).  The observation that APC 
mobility is shifted in the absence of intact cells and in the absence of intact DNA 
implies that the observed shift is an artifact of UV irradiation rather than a specific 
interaction due to the cellular response to DNA damage.  It is possible that APC 
formed a UV-induced crosslink to another cellular molecule upon exposure to UV 
light.  Another possibility is that a UV-crosslink was induced within the polypeptide 
chain of APC and prevented APC from completely denaturing prior to being loaded 
on the gel.  The mobility shift of APC in response to UV irradiation is previously 
unreported and currently uncharacterized.   
It is important to note that whatever induces the observed APC mobility shift 
also occurs in the cells in which APC nuclear accumulation is observed.  Because the 
nature of the mobility shift is undefined, the effect on the cellular function of APC is 
unknown.  If amino acid residues were cross-linked within the APC polypeptide 
chain, there may have been no resulting alteration in the globular structure.  This type 
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of modification could, in theory, have resulted in little to no cellular effect. It is 
unlikely  
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Figure 5.10
Western immunoblot probed with rabbit anti-APC M2 antibody.  HCT116βw cells were 
synchronized using aphidicolin block and released for 4 hours prior to sham or UV-
irradiation.  Cell lysates were prepared 40 minutes after irradiation and resolved on a 4-12% 
gradient gel. An immunoblot of cell lysates from synchronized cells released from 
aphidicolin block for 2 or 4 hours.  Probed with rabbit anti-APC M2 antibody.  Lysate from 
cells that were UV irradiated 2 or 4 hours after aphidicolin release demonstrate the APC 
mobility shift.  An aliquot of control lysate from the cells released from aphidicolin block for 
4 hours and UV irradiated on a glass slide demonstrates the same APC mobility shift as the 
APC from cells that were UV irradiated.
that the nuclear accumulation of APC induced by UV irradiation results from this 
non-specific modification because, unlike the observed nuclear targeting, the change 
in mobility showed no cell cycle specificity.  The APC mobility shift was observed in 
cells UV irradiated 2 and 4 hours after aphidicolin release while the nuclear 
accumulation of APC is specific for the 4 hour time point.  Because there was no 
evidence for a connection between the UV induced mobility shift and the UV/cell 
cycle specific nuclear accumulation of APC, the nature of the mobility shift was not 
further examined.   
 
APC binding to β-catenin does not appear altered by UV irradiation  
 In the non-irradiated control cells, β-catenin was consistently observed to co-
precipitate with APC (Figure 5.11).  β-catenin is a well characterized APC binding 
partner so this interaction was expected.  In all immunoprecipitation experiments, 
protein was eluted from the antibody conjugated beads in one-tenth of the original 
lysate volume and equal volumes of the bound and unbound samples were loaded for 
SDS-PAGE and western blot analysis.  Therefore, the protein in the “IP” lanes should 
be ten times more concentrated than it was in the “unbound” fraction.  The intensity 
of the β-catenin band that co-precipitated with APC was observed to be 
approximately equal to the intensity of the β-catenin band in the fraction that did not 
co-precipitate with APC.  Taking into account the relative concentrations of these two 
fractions, we determined that approximately one tenth of the total β-catenin in the cell 
was interacting with APC.  Surprisingly there was no significant difference between  
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WL    M2-S   M2-P IgG-S  IgG-P WL  M2-S   M2-P IgG-S  IgG-P 
UV irradiated cells
Sham-irradiated control cells
WL = whole lysate
M2-S = unbound supernatant
M2-P = co-precipitated with APC
IgG-S = unbound super from control beads
IgG-P = co-precipitated with IgG control
Figure 5.11
Western immunoblot probed with rabbit anti-β-catenin antibody.  HCT116βw cells were 
synchronized using aphidicolin block and released for 4 hours prior to sham or UV-
irradiation.  Cell lysates were prepared 40 minutes after irradiation.  IP was preformed with 
protein A beads conjugated to APC specific antibody (rabbit anti-APC M2).  Protein was 
eluted from the beads in 1/10th the volume of the original lysate.  Proteins were resolved on a 
4-12% gradient gel.
the amount of β-catenin that co-precipitated with APC from UV irradiated cells 
versus non-irradiated control cells.  We had anticipated that a dramatic shift in the 
localization of APC would result in a similarly dramatic change in the observed 
protein interactions; however, at least in the case of β-catenin, no such alteration is 
induced.  APC and β-catenin continue to interact at the same level before and after 
UV irradiation. 
 
The transient localization of APC to the nucleus is mirrored by β-catenin 
 Co-immunoprecipitation experiments suggested that APC and β-catenin may 
continue to interact during the nuclear accumulation of APC.  To ascertain if β-
catenin is also influenced by exposure to UV light, synchronized cells were UV 
irradiated and co-stained with antibodies to APC and β-catenin.  In the non-irradiated 
control cells, APC and β-catenin did not show substantial co-localization (Figures 
5.12).  Like APC, β-catenin was also observed in the nuclear and cytoplasmic 
compartments (Figures 5.12).  In UV irradiated cells, however, β-catenin displayed 
the same nuclear accumulation that was observed for APC (Figures 5.12).  
Furthermore, β-catenin demonstrated a transient nuclear localization similar to the 
time course of nuclear accumulation observed for APC (Figure 5.13).  However, 
despite the observation that APC and β-catenin both accumulated in the nucleus, they 
did not seem to do so as a complex.  Western blots did not reveal an increased level 
of β-catenin co-precipitating with APC in the UV-irradiated cell  
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Figure 5.12
The co-localization of APC and β-catenin in irradiated and non-irradiated cells using two 
sets of antibodies.  A) Mouse anti-APC (12-28, Abcam) and rabbit anti-β-cateinin (Sigma).  
B) Rabbit anti-APC M2 (developed in the Neufeld and Azuma labs) and mouse anti-β-
catenin (Transduction Laboratories). Cells were synchronized using aphidicolin block and 
released for 4 hours before being UV/sham-irradiated.  Cells for images were fixed 40 
minutes after irradiation and stained.  Scale bar = 3μm.
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Figure 5.13
Analysis of β-catenin distribution in UV-irradiated and sham-irradiated cells at various 
points following irradiation.  Cells were synchronized using aphidicolin block and 
released 4 hours before being UV/sham-irradiated.  Cells for images were fixed the 
indicated amount of time following irradiation and stained with mouse anti-β-catenin 
antibody.  DNA was visualized with DAPI.  Images were captured on a Nikon TU2000 
microscope equipped with a Letiga EXI camera (Q Imaging) and analyzed using Phylum
Live software.  Scale bar = 3μm.
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Figure 5.14
Optical slices of APC and β-catenin distribution in the nucleus of a UV-irradiated cell.  
Cells were synchronized using aphidicolin block and released for the indicated amount of 
time before being UV-irradiated.  Cells were fixed 40 minutes after irradiation and 
stained with rabbit anti-APC M2 antibody and mouse anti-β-catenin.  DNA was 
visualized with DAPI.  Images were taken with an Olympus 3I spinning disc confocal
TIRF inverted microscope and analyzed using Slidebook software.  Scale bar = 3μm.
lysates (Figure 5.11) and optical slices through UV irradiated cells showed numerous 
distinct APC and β-catenin puncta within the nucleus (Figure 5.14). 
 
Optimal nuclear localization of APC requires checkpoint kinase activity 
 Members of the phosphatidylinositol-3-kinase (PI-3-K) family of kinases are 
key initiators of the G2/M checkpoint.  These kinases, including DNA-dependent 
protein kinase (DNA-PK), Ataxia-Telangiectasia mutated (ATM) and Ataxia-
Telangiectasia mutated and RAD3-related (ATR) are responsible for the activation 
and/or stabilization of many of the effector proteins responsible for NER repair of 
UV-induced lesions and the cellular response to double-strand DNA breaks (3, 39).  
To determine if the nuclear accumulation of APC was dependent on ATM/ATR 
kinase activity, synchronized HCT116βw cells were grown in the presence of 
wortmannin, a widely used G2/M checkpoint kinase inhibitor (40, 41).  In our 
experiments, wortmannin appeared to have no effect on APC localization in the non-
irradiated control cells (Figure 5.15).  However, the UV irradiated cells treated with 
wortmannin showed significantly less nuclear accumulation of APC when compared 
to cells treated with DMSO only (Figure 5.15).  In some experiments wortmannin 
treatment also resulted in sub-nuclear APC foci in the UV-irradiated cells (Figure 
5.15). 
 ATM and ATR initiate the checkpoint phosphorylation cascade through the 
signal transducer kinases Chk1 and Chk2 (3).  Generally ATM is associated with 
signal transduction through Chk2 while ATR is associated with signal transduction 
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through Chk1; however, there is overlap between the functions of these proteins (3).  
Because wortmannin inhibits the kinase activity of both ATM and ATR, specific 
inhibitors for Chk1 and Chk2 were used in an attempt to further refine the signaling 
pathway leading to the nuclear accumulation of APC.   
 2-(4-(4-Chlorophenoxy)phenyl)-1H-benzimidole-5-carboxamide is a specific 
inhibitor of Chk2 (42).  Cells treated with this Chk2 inhibitor displayed less nuclear 
accumulation of APC compared to the DMSO treated control cells following 
exposure to UV light (Figure 5.16).  The ATM/Chk2 pathway is predominantly 
associated with the response to DNA double-strand breaks.  This pathway may be 
responsible for some of the checkpoint response in UV irradiated cells due to some 
UV-induced double strand breaks as well as “cross-talk” between the two checkpoint 
kinase pathways.  However the primary pathway expected to be induced by UV 
irradiation is the ATR/Chk1 signal transduction pathway.   SB-218078 is a specific 
inhibitor that blocks the in vivo function of Chk1 (43).   Surprisingly, when 
synchronized cells were treated with Chk1 inhibitor they displayed nuclear targeted 
APC following UV irradiation.  Because the ATR/Chk1 pathway responds by 
initiating NER repair of thymidine dimers, it would be expected that Chk1 would be 
the primary transducer kinase activated upon detection of UV-induced DNA damage.  
However, unlike the wortmannin treatment, treatment with Chk1 inhibitor did not 
appear to inhibit the nuclear accumulation of APC (Figure 5.17).  
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Figure 5.15
Wortmannin (Calbiochem) was used at a final concentration of 20μM to inhibit PI-3-kinases 
in synchronized HCT116βw cells UV-irradiated or sham-irradiated 4 hours after release 
from aphidiclolin block.  Scale bar = 3μm.
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Figure 5.16
Chk 2 inhibitor [2-(4-(4-Chlorophenoxy)phenyl)-1H-benzimidole-5-carboxamide 
(Calbiochem) was used at 10μM to inhibit Chk 2 in synchronized HCT116βw cells UV-
irradiated or sham-irradiated 4 hours after release from aphidicolin block.  Scale bar = 3μm
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Figure 5.17
Chk 1 inhibitor [SB-218078 (Calbiochem)]was used at 5μM to inhibit Chk 1 in synchronized 
HCT116βw cells UV-irradiated or sham-irradiated 4 hours after release from aphidicolin
block.  Scale bar = 3μm.
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Discussion 
 We observed that APC was transiently targeted to the nucleus in what 
appeared to be a cell cycle specific response to UV irradiation.  APC was observed to 
translocate to the nucleus in response to UV light exposure in both primary mouse 
fibroblast cells and the human colon cancer cell line HCT116βw.  Further evaluation 
of this phenomenon in the HCT116βw cell line revealed that APC was selectively 
targeted to the nucleus during the late S and G2/M phases of the cell cycle, a time 
point that appeared to roughly correlate with the G2/M cell cycle checkpoint.  The 
stabilization of endogenous APC in HCT116 cells in response to ZnCl2 has been 
reported to result in increased arrest at the G2/M phase of the cell cycle (13).  A 
fragment of APC (amino acids 1000-1326) containing no characterized NLS 
sequences was observed to localize to the nucleus in HCT116βw cells and over 
expression of this fragment induced cell cycle arrest at G2 (14).  This evidence 
suggests a role for APC in cell cycle control and G2/M transition.  It is possible that 
APC is selectively targeted to the nucleus during this phase of the cell cycle to halt 
cell cycle progression in response to the detection of DNA damage or the initiation of 
NER. 
 The nuclear targeting of APC appears to be dependent on the checkpoint 
kinases.  Inhibition of DNA-PK, ATM and ATR by treatment with wortmannin 
reduced the nuclear accumulation of APC.  Treatment with a specific inhibitor of 
Chk1 resulted in no visible reduction in nuclear APC following UV-irradiation.  
Inhibition of Chk2 resulted in some inhibition of the nuclear accumulation of APC, 
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though not the same degree as treatment with wortmannin.  This might suggest that 
APC is not downstream of Chk1 or Chk2, but instead receives a nuclear targeting 
signal more directly from the ATM/ATR initiator kinases.  The inability of either 
Chk1 or Chk2 inhibition to fully repress the nuclear accumulation of APC could also 
mean that there is redundancy between the two pathways and that either Chk1 or 
Chk2 alone can lead to the nuclear accumulation of APC.  Wortmannin would be 
expected be more effective than either of the specific inhibitors alone because 
wortmannin is able to repress the upstream activation of both ATM and ATR.  
Finally, it is the possible that neither ATM nor ATR is upstream of APC, but the 
more broad-based inhibitor wortmannin prevents the nuclear accumulation of APC 
through repression of a separate pathway. 
 The exact nature of APC’s role in the G2/M checkpoint is unclear.  It seems 
likely that APC is acting as a signal transduction molecule rather than an effector 
molecule based on the transient nature of APC’s nuclear translocation.  The DNA 
repair protein xeroderma pigmentosum group A (XPA) is involved in DNA repair 
after UV irradiation (3).  Similar to the observed time course for APC, XPA begins to 
accumulate in the nucleus approximately 30 minutes after exposure to UV light.  
However, for XPA, the peak level of nuclear accumulation is reached 8 hours after 
the initial DNA damage (39).  APC was observed to reach its peak level of nuclear 
accumulation approximately 40 minutes after exposure to UV light and redistributed 
to the cytoplasm in approximately one hour, suggesting that APC does not directly 
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participate in the process of sustained DNA repair or in the continued maintenance of 
the cell cycle block. 
Interestingly, β-catenin was also observed to accumulate in the nucleus 
following UV irradiation with a time table that mirrored those of APC.  This was 
unexpected because β-catenin is considered to be an oncogene.  When up-regulated 
either at the protein level or the level of transcriptional activity, β-catenin is 
associated with increased cellular proliferation and neoplastic transformation (44).  
Proteins that are involved in the cellular response to DNA damage are typically tumor 
suppressors because a loss of function results in a decreased ability to respond to 
DNA damage and increased tumorigenesis (44).  It was surprising to see such a 
striking β-catenin response to UV irradiation.  The nuclear localization of β-catenin 
has previously been associated with an increase in transcriptional activity from the 
Wnt target genes and the promotion of cellular proliferation (45).  It seemed 
counterintuitive that β-catenin would be targeted to the nucleus at a time when the 
cell cycle should be arrested.  
The interaction of APC with β-catenin and other members of the Wnt 
signaling pathway is one of the most investigated areas of APC research.  APC is 
known to directly interact with β-catenin and has been shown to be important for β-
catenin degradation (44, 45).  APC and β-catenin have been shown to interact at the 
promoter of Wnt target genes (46) and the nuclear shuttling of APC is suspected to 
play a role in determining the level of nuclear β-catenin (47-49).  Remarkably, despite 
the observation that APC and β-catenin respond in nearly the same manner to UV-
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irradiation, exposure to UV light did not appear to increase interaction between these 
two proteins (Figure 5.11) nor do they co-localize significantly within the nucleus 
suggesting that they are both targeted to the nucleus independently.   
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CHAPTER 6 
DISCUSSION AND FUTURE DIRECTIONS 
 
Numerous reports in the literature suggest that APC can shuttle in and out of 
the nucleus (1, 2) interact with a variety of nuclear proteins (3, 4), both facilitate and 
impede DNA repair (5-8), regulate transcription (9), participate in the cell cycle 
checkpoints (3, 10) and directly interact with DNA itself (11).  Taken together these 
data result in a considerable number of proposed nuclear functions for APC.  A great 
deal more study is required to elucidate the mechanisms by which APC is able to 
accomplish the current suggested functions and to evaluate how those cellular 
functions contribute to its role as a tumor suppressor in whole tissue.  
To further clarify the role of nuclear APC in tissue, we generated a mouse 
model lacking the characterized APC NLSs.  Multiple existing APC mouse models 
have demonstrated that both truncation and decreased expression of APC are 
associated with the development of intestinal adenomas (12-19).  However, mutations 
resulting in altered protein levels or the deletion of substantial regions of APC make it 
difficult to examine how the various functions of APC are contributing to overall 
tumor suppression.  The APC mNLS mouse model is unique in that a specific aspect 
of APC was altered, nuclear import through the NLS/importin pathway, while 
preserving the domains required for APC’s other functions. 
  Targeted mutations were introduced into both NLSs of endogenous Apc in 
mouse ES cells using standard techniques (20-22).   These mutations alter a total of 6 
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amino acids in full length APC and disrupt binding to importin-α (23).  Because 
interaction with importin-α mediates translocation through the nuclear pore, these 
mutations inhibit the nuclear import of APC (24).  Following the identification of an 
ES cell line with the correct incorporation of the knock-in mutations, an APC mNLS 
mouse line was generated.  Normal levels of full length APC were detected in tissue 
from the mutant mice, confirming that the introduction of the APC mNLS mutations 
did not alter normal Apc expression.  Because genetic background can influence 
phenotype (25, 26), we are in the process of generating a congenic mouse line.  In the 
interim we began a preliminary analysis on cells carrying the APC mNLS mutations 
as well as the pre-congenic animals.  In addition to variable defects in APC targeting, 
we also observed subtle defects in β-catenin regulation and immune function in the 
mutant mice.  Further analysis of APC nuclear import in cells carrying mutant and 
WT APC also revealed a previously uncharacterized response to DNA damage, which 
resulted in the nuclear accumulation of APC through an unknown import mechanism. 
 
The nuclear import of APC in NLS deficient cells 
Surprisingly, our observations revealed that APC was not excluded from the 
nucleus in APC mNLS-/- cells or in tissue from the APC mNLS-/- mice.  Some amount 
of nuclear APC was observed, regardless of the type of cells being examined.  
However, the degree of cellular differentiation appeared to influence the extent to 
which APC targeting was affected.   Confocal microscopy of frozen tissue sections 
revealed that APC distribution in the undifferentiated cells at the base of the crypts in 
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both the colon and small intestine was nearly identical in the APC mNLS-/-, APC 
mNLS +/- and APC mNLS+/+ mice.  Similarly the localization of APC in the APC 
mNLS+/- ES cells was indistinguishable from WT R1 ES cells.  In contrast, the APC 
mNLS MEF cell lines displayed a noticeably decreased level of nuclear APC in the 
APC mNLS+/-, and APC mNLS-/- cells when compared to APC mNLS+/+ control 
cells.  A similar observation was made in the intestines of the mNLS mice.  The most 
differentiated cells, located at the luminal surface, displayed a reduced level of 
nuclear APC in tissue from APC mNLS+/- and APC mNLS-/- mice when compared to 
tissue from their APC mNLS+/+ littermates.    
The observation that mutations to the APC mNLSs resulted in a more 
apparent phenotype in differentiated cells implied that APC targeting may not be 
regulated in the same manner in differentiated and undifferentiated cells.  It is known 
that APC participates in a number of cellular pathways (27-29). It is probable that 
APC performs different functions in different cell types. The more surprising 
observation was that some of APC’s nuclear functions, particularly in stem cells, 
appeared to allow nuclear import of full length APC in the absence of the 
characterized NLSs.   
 
Regulation of β-catenin in APC mNLS cells 
 Western immunoblot analysis of β-catenin levels in the intestinal epithelia of 
the APC mNLS mice revealed an increased level of β-catenin in the APC mNLS+/- 
and APC mNLS-/- mice compared to their APC mNLS+/+ littermates.  The observation 
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that mutation to APC resulted in increased β-catenin levels was not surprising.  APC 
has been previously shown to be important in the regulation of β-catenin (30, 31).  
While the ability of the NLS-deficient APC to participate in β-catenin down-
regulation in the cytoplasm should be unaltered, APC and β-catenin have also been 
observed to associate in the nucleus (2, 31, 32).  Altered nuclear targeting of APC 
would therefore be expected to impact its interaction with β-catenin.  Surprisingly, the 
observed increase in β-catenin level was not associated with an alteration in the 
cellular localization of β-catenin.  In both the tissue of the APC mNLS mice and in 
the APC mNLS MEF cell lines, the pattern of β-catenin staining appeared to be 
identical in the APC mNLS+/+, APC mNLS+/- and APC mNLS-/- cells.  Traditional 
dogma assumes that increased β-catenin in the cell results in increased translocation 
of β-catenin to the nucleus (33).  This correlation between total β-catenin levels and 
localization of β-catenin has also been observed in the previous APC mouse models 
(16, 34, 35).  Our observations suggest that the NLS-deficient APC leads to both an 
increase in cellular β-catenin levels and a decrease in β-catenin nuclear import.   
The obvious initial conclusion would be a role for APC in the nuclear import 
of β-catenin; however, this explanation contradicts much of the established ideas in 
the field (33).  Another possibility is that APC is targeted to the nucleus to interact 
with β-catenin via the NLS/importin pathway in differentiated cells.  In cells 
expressing NLS-deficient APC, translocation fails to occur and results in increased 
APC interacting with β-catenin in the cytoplasm.  The number of β-catenin 
destruction complexes in the cytoplasm is restricted not only by the presence of APC, 
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but also by the availability of the other members of the protein complex, therefore 
excess APC in the cytoplasm may not be equivalent to increased β-catenin down-
regulation.  It is possible that interacting with free APC may prevent β-catenin 
proteolysis by competing with APC in the β-catenin degradation complexes for 
cellular β-catenin.  The observation that APC shows increased localization to the 
lateral junctions in cells with reduced nuclear APC seems to support the idea that 
APC is associating with but not degrading cytoplasmic β-catenin in these cells. Thus 
the increased levels of β-catenin may result from the presence of excess APC in the 
cytoplasm rather than from a deficient level of APC in the nucleus. 
 
Immune function in APC mutant mice 
The observation that APC mNLS+/- mice display intestinal hyperplastic 
lymphoid nodules with an increased frequency compared to their APC mNLS+/+ 
littermates suggests that APC may play a role in immune regulation in the intestine.  
There have also been reports of immune system phenotypes in previous mouse 
models that express APC mutations (36-39).  
 The APC 1638N mouse carries a WT Apc allele and a truncated Apc allele 
that expresses at only 2% of the WT level (34).  Mice that carry the APC 1638N 
mutation essentially express APC at half the level of a WT mouse.  APC 1638N mice 
display a decreased immune response to Helicobacter infection when compared to 
WT mice (38).  Not only did the intestinal tissue of the APC 1638N mice lack the 
normal local inflammatory and proliferative responses to the bacterial infection, but 
 
 
257
the APC mutant animals displayed a decreased systemic antibody response despite 
demonstrating higher bacterial loads than the WT mice (38).   
APC’s effect on polyposis and local immune response has also been explored 
in the APC Min mouse (36, 37, 39).  The APC Min mouse displays an extensive 
polyposis phenotype with numerous intestinal lesions occurring early in the life of the 
mouse (12).  This has made the Min mouse a popular model in which to study the 
effect of chemotherapeutics, diet and exercise on the process of polyposis in the 
intestine (40).  In two separate reports, diets that stimulate immune function in the 
intestine also led to decrease in polyp number in the APC Min mice (36, 37).   
 The observation that the stimulation of an intestinal immune response in the 
APC Min mice leads to a decrease in polyp number while APC 1638N mutant mice 
appear to be deficient in their ability to mount a normal immune response in the 
intestine may initially seem incongruent.  It is possible that the dissimilar results stem 
from the type of Apc mutation, and that a reduced level of total APC protein (APC 
1638N) affects immune function differently than a truncation of the APC protein 
(APC Min).  However, other factors may also play a role in the divergence of 
phenotypes, including the timescale of the experiments.  APC Min mice begin 
developing intestinal polyps within 5 weeks of birth and have short lifespans, 
averaging only 120 days (12).  Therefore, the analysis of diet in the APC Min mice 
takes place within the first 100 days, with mice sacrificed for analysis at 91 (39) and 
110 (36) days.  The APC 1639N mice do not begin developing polyps until nearly 10 
weeks of age and have an average lifespan of over 1 year (13).  In the analysis of 
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Helicobacter infection, the APC 1638N mice were sacrificed at 135, 180 and 225 
days of age (38).  In the heterozygous APC mNLS we saw an age dependent increase 
on hyperplastic lymphoid nodules in mice between 294 and 434 days of age. 
 Observations in the APC 1638N mouse suggest that decreased APC results in 
decreased immune function both in the intestine and systemically (38).  Observations 
in the APC Min mouse suggest that immune stimulation represses intestinal polyposis 
(36, 37, 39).  There was no polyposis phenotype observed in the APC mNLS mouse; 
however, an increase in immune tissue was detected in the older mice.  This could 
suggest that the inhibition of the nuclear targeting of APC enhances immune 
stimulation.  Alternatively, the presence of the correct level of full length APC may 
allow for normal immune function in the APC mNLS mice and the increase in 
localized immune tissue could be in response to the need to prevent the growth of 
pre-neoplastic cells in the mutant mice.  It will be interesting to see if the APC mNLS 
mice displayed an enhanced polyposis phenotype in immune-deficient mice. 
 
The nuclear accumulation of APC in response to UV light 
A transient nuclear accumulation of APC was observed in cells exposed to 
UV light, suggesting a previously uncharacterized role for APC in the cellular 
response to DNA damage.  Previous reports indicate that cell stress, including UV 
irradiation, induced the blockage of classic nuclear import by sequestering importin-α 
(41).  These data led to the suggestion that the UV-dependent nuclear targeting of 
APC occurs through an NLS/importin-α-independent pathway.  The observation that 
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UV irradiation induced the nuclear accumulation of APC in APC mNLS-/- MEF cells 
lends further support to an alternative pathway for APC nuclear import.  
Cell-stress induced block of nuclear import has been observed in response to 
starvation, heat shock, ethanol, oxidative stress, and UV irradiation (41-43).  
Different cellular stresses also induce the nuclear localization of specific stress-
response proteins including heat shock proteins and cognate proteins, transcription 
factors and DNA repair proteins (42-46).  While the mechanism of import has not 
been evaluated in all cases, there is evidence for NLS/importin-independent nuclear 
import of several proteins characterized to have vital nuclear functions (46-48).  The 
pathway by which this import occurs is currently unknown (47, 49).   
Our evidence suggests that APC is also able to achieve nuclear import through 
an unknown importin-α-independent pathway.  APC nuclear import is specific to cell 
cycle stage and time following UV irradiation, suggesting that post-translational 
modification to APC is contributing to this nuclear import.  Because inhibition of the 
PI-3-K family of serine/threonine kinases is able to repress nuclear accumulation of 
APC, it is likely that the signal cascade initiated by DNA damage is responsible for 
APC re-localization following UV irradiation.  Further study is needed to elucidate 
the mechanism underlying nuclear import of APC and the role for nuclear APC 
following UV irradiation 
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Future directions  
We have provided evidence for nuclear import of APC through at least two 
independent pathways.  It is possible that more pathways exist, since undifferentiated 
cells were able to import full length APC under normal cellular conditions in the 
absence of the endogenous APC NLSs.   While the NLS-independent mechanism(s) 
that allow for nuclear import are currently uncharacterized, it is probable that both 
NLS- dependent and NLS-independent nuclear import are required for tumor 
suppression.  APC has been observed to shuttle in and out of the nucleus in cancer 
cell lines containing a truncated APC lacking the NLSs (50), suggesting the presence 
of an alternative nuclear import pathway mediated by an N-terminal domain of APC.  
However, the function of the APC NLSs has also been characterized in cancer cell 
lines (23).  Nuclear exclusion of full-length exogenous APC with mutant NLSs was 
observed in the SW480 human colon cancer cell line while WT APC appeared to 
shuttle normally (31).  These observations suggest that NLS-dependent nuclear 
import is also required in these cells.  Because the nuclear functions of APC are not 
yet defined, it is unknown if these independent nuclear import mechanisms serve a 
redundant function or if they represent separate cellular pathways leading to discrete 
nuclear tasks.  The APC mNLS mouse was generated to allow the further evaluation 
of the role of nuclear APC in tissue development, maintenance and tumor 
suppression.  The APC mNLS mouse model may also be useful in the evaluation of 
alternative import mechanisms required for proper APC shuttling.   
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